MCM15 Student Poster Listing

2015 ASHP Midyear Clinical Meeting Student Poster Listing by Primary Author Last Name

1 | P a g e

StudentPosterPresenters:

Congratulations!Belowisyourscheduledposterpresentationtimendboardnumber.ThislistissortedbytheLastNameofthePrimaryAuthor—notbypresentationtime.YoumayalsosearchthelistbyusingyourSubmissionID.Ifyouhavetroublelocatingyourposter,[email protected].

Allowthreebusinessdaysforaresponse.Date,time,andboardnumbercannotbechanged.ASHPwillnotedittitles,abstracts,orpresenters.Ifyouwishtowithdrawyourposter,pleasecontacteducserv@ashp.org.BesuretoreadthePosterPresenterHandbooklocatedathttp://www.ashp.org/Get_Involvedforadditionalinstructions.

We’llseeyouinNewOrleans!

EducationalServicesDivision

Submission ID

First Name Last Name Session/ Board #

Session Title Date Time

388703 Huldah Abaidoo 5B‐009 Observational audit of standard sterile compounding procedures in a hospital pharmacy setting

Tuesday, December 8

11:30 am ‐ 12:30 pm

388616 Yasser Abdelaziz 2‐088 Appropriateness of venous thromboembolism prophylaxis: a comparison of assessments

Monday, December 7

10:45 am ‐11:45 am

387371 Grigor Abelian 5A‐247 Comparative validity of identifying venous thromboembolic events with ICD‐9 discharge diagnosis codes versus a research database

Tuesday, December 8

10:00 am ‐ 11:00 am

385776 Olawonuola Abiona 2‐246 Central Harlem community residents perceptions and knowledge of the role and capabilities of the pharmacist in the community setting.

Monday, December 7

10:45 am ‐11:45 am

388843 Marwa Abouomar 3‐199 Assessment of cultural sensitivities of televised direct‐to‐consumer pharmaceutical advertisements (DTCPA)

Monday, December 7

12:00 pm ‐ 1:00 pm

385957 Lidia Abrahalei 5A‐143 Case report of olanzapine induced type 2 diabetes

Tuesday, December 8

10:00 am ‐ 11:00 am

387464 Oluwabunmi Abraham 2‐089 On the Brink of Life and Death : Monday, 10:45 am ‐11:45 am


2 | P a g e

Submission ID



A Case of Metformin Associated Lactic Acidosis

December 7

384352 Inna Abramova 2‐168 Lidocaine and bupivacaine syringe stability study

Monday, December 7

10:45 am ‐11:45 am

386881 Shaili Adani 3‐264 Analysis of an autophagy inhibitor in paclitaxel‐resistant ovarian cancer cells.

Monday, December 7

12:00 pm ‐ 1:00 pm

386888 Adetokunbo Adedokun 5A‐311 Evaluation of educational and social interventions that enhance cultural awareness of pharmacy students at a rural college of pharmacy

Tuesday, December 8

10:00 am ‐ 11:00 am

389653 Oyinlola Adeyanju 3‐047 Effectiveness of garlic in the treatment of hypercholesterolemia: systematic review

Monday, December 7

12:00 pm ‐ 1:00 pm

387203 Priscilla Adjei‐Baffour 5B‐374 Attitudes and perceptions towards pharmacogenomics education and relevance in pharmacy practice in doctor of pharmacy candidates in the Appalachian region

Tuesday, December 8

11:30 am ‐ 12:30 pm

386015 Ava Afshar 5B‐084 Comparing outcomes of venous thromboembolism (VTE) prophylaxis agents in post‐operative orthopedic patients

Tuesday, December 8

11:30 am ‐ 12:30 pm

384492 Paul Ahearn 3‐021 Adverse effects from unrecognized vitamin D toxicity results in avoidable drug related problems, emergency room visits, and hospitalizations

Monday, December 7

12:00 pm ‐ 1:00 pm

389260 Farhan Ahmed 5B‐010 Medical use evaluation of vancomycin dosing to create hospital‐specific vancomycin nomogram

Tuesday, December 8

11:30 am ‐ 12:30 pm

386562 Maryam Ahmed 2‐169 Comparison of rehospitalization rates of schizophrenic patients discharged after receiving paliperidone palmitate versus risperidone long‐acting injection

Monday, December 7

10:45 am ‐11:45 am

388683 Chalsea Aiwohi 5B‐104 Local prevalence of the Tuesday, 11:30 am ‐ 12:30 pm


3 | P a g e

Submission ID



cefazolin inoculum effect on methicillin‐susceptible staphylococcus aureus (MSSA) isolates from four major Chicago medical institutions

December 8

385912 Olaide Aiyegbusi 7‐220 Analysis of antihypertensive therapy prescribing practices for patients with diabetes in a primary care setting

Wednesday, December 9

8:30 am ‐ 9:30 am

385701 Svetlana Akbasheva 2‐170 Retrospective analysis of the use and clinical applications of the VerifyNow P2Y12 platelet reactivity test in patients on P2Y12 inhibitors

Monday, December 7

10:45 am ‐11:45 am

389450 Traci Aladeen 2‐171 Generic clopidogrel: Has substitution for brand name Plavix been safe and effective?

Monday, December 7

10:45 am ‐11:45 am

388006 Ruhaniyah Alam 5B‐275 Effects of using indomethacin vs. ibuprofen for patent ductus arteriosus (PDA) closure in the neonatal intensive case unit (NICU)

Tuesday, December 8

11:30 am ‐ 12:30 pm

384768 Sumaiah Alarfaj 3‐130 Association of antibiotic use and statin use in adults with diabetes

Monday, December 7

12:00 pm ‐ 1:00 pm

385938 Kyle Albanese 7‐221 Evaluation of risk factors for thirty‐day readmissions following intraabdominal surgeries


8:30 am ‐ 9:30 am

388508 Anthony Albert 3‐200 Comparative effectiveness analysis of single and combination therapies for pulmonary arterial hypertension in a tertiary healthcare system

Monday, December 7

12:00 pm ‐ 1:00 pm

386355 Benjamin Albrecht 5B‐011 Evaluation of fluoroquinolone prophylaxis in allogeneic hematopoietic cell transplant patients at an academic medical center.

Tuesday, December 8

11:30 am ‐ 12:30 pm

389119 William Alegria 5B‐096 Use of weighted‐incidence syndromic antibiogram data to

Tuesday, December 8

11:30 am ‐ 12:30 pm


4 | P a g e

Submission ID



guide empiric antimicrobial recommendations

385373 Megan Alfonso 3‐048 If Cannabis goes clinical, are you ready? investigation of Florida pharmacists knowledge regarding clinical Cannabis

Monday, December 7

12:00 pm ‐ 1:00 pm

387268 Taylor Alford 3‐005 Placenta encapsulation: postpartum miracle or public health hazard? A FDA regulatory perspective

Monday, December 7

12:00 pm ‐ 1:00 pm

386224 Ahlam Alghamdi 3‐131 Impact of advanced pharmacy practice experience duration on students' NAPLEX performance

Monday, December 7

12:00 pm ‐ 1:00 pm

387249 Amie Algrim 3‐151 Assessing effectiveness of a comprehensive medication reconciliation program at a hospital pharmacy department after 6 months

Monday, December 7

12:00 pm ‐ 1:00 pm

388099 Julie Alhady 5B‐200 Incident of very low LDL level with the application of the American College of Cardiology/American Heart Association guideline for the treatment of blood cholesterol

Tuesday, December 8

11:30 am ‐ 12:30 pm

389481 Yasmine Alhasan 3‐323 VTE Treatment Outcomes of Cancer Patients: Oral anticoagulants versus Low Molecular Weight Heparin

Monday, December 7

12:00 pm ‐ 1:00 pm

386863 Alaa Alhubaishi 5A‐121 Exchange protein directly activated by cAMP (Epac) as a novel regulator of airway smooth muscle functions in asthma

Tuesday, December 8

10:00 am ‐ 11:00 am

389333 Rahma Ali 2‐011 Comparing the efficacy of direct acting antiviral agents for the treatment of hepatitis C virus genotype 1

Monday, December 7

10:45 am ‐11:45 am

386399 Rania Aljehani 2‐149 Evaluation of compliance with infliximab dose rounding protocol and cost savings

Monday, December 7

10:45 am ‐11:45 am

385636 Shyema Alkhalaf 3‐160 Review of Infliximab use at Morristown and Overlook

Monday, December 7

12:00 pm ‐ 1:00 pm


5 | P a g e

Submission ID



Medical Centers' outpatient infusion centers

387604 Heather Allen 5B‐276 Evaluation of LDL response after implementation of the ACC/AHA 2013 cholesterol guidelines in a veteran affairs extended care facility

Tuesday, December 8

11:30 am ‐ 12:30 pm

388307 Joye Allen 7‐052 Predictors of receiving guideline recommended antiretroviral treatment: an evaluation of commercially insured patients living in the United States


8:30 am ‐ 9:30 am

388304 Michael Allen 7‐053 Evaluation of Parenteral Nutrition Feeding Formula Macronutrients in Obese Patients in a Community Hospital Inpatient Setting


8:30 am ‐ 9:30 am

388122 Andrew Allison 7‐222 Comparison of lansoprazole suspension compounding kits with traditional compounding methods for lansoprazole suspensions


8:30 am ‐ 9:30 am

387423 Ahlam Al‐Mansoub 7‐113 Antibiotic appropriateness and transitions of care in the department of emergency medicine


8:30 am ‐ 9:30 am

383028 ghadeer almutairi 7‐208 Protective Effects of Grape Seed Extract and Raspberry Leaf Extract on Carbon Tetrachloride‐induced Acute Liver Injury in Rats.


8:30 am ‐ 9:30 am

382717 Kristin Aloi 5A‐198 Assessment of Safety of Intramuscular Testosterone Therapy Prescribing within the Durham VA Medical Center

Tuesday, December 8

10:00 am ‐ 11:00 am

388738 Sebastian Al‐Saiegh 2‐039 Lifestyle habits of pharmacy and medical students in California: differences between Caucasian and Asian students

Monday, December 7

10:45 am ‐11:45 am

388141 Susan Alsaras 2‐172 Effects of Targeting High vs. Low Mean Arterial Pressure on 28 Day Mortality in Patients

Monday, December 7

10:45 am ‐11:45 am


6 | P a g e

Submission ID



with Sepsis in the Surgical Intensive Care Unit

388039 Sean Altendorf 7‐002 Predictors of extended n‐acetylcysteine dosing in pediatric patients with acetaminophen toxicity


8:30 am ‐ 9:30 am

383247 Michela Altergott 3‐419 Pharmacy student scholarly activities: awareness, participation and perception

Monday, December 7

12:00 pm ‐ 1:00 pm

386017 Farihah Amatullah 3‐201 Prevalence of the term suffering in common medication‐related resources for patients and healthcare professionals

Monday, December 7

12:00 pm ‐ 1:00 pm

385795 Evelyn Ambush 2‐167 Evaluation of Antidiabetic Activity of Taraxacum officinale (Dandelion)

Monday, December 7

10:45 am ‐11:45 am

386171 Marwa Amer 2‐173 Safety and efficacy of insulin guideline for controlling perioperative hyperglycemia

Monday, December 7

10:45 am ‐11:45 am

389479 Kanish Amin 7‐223 How students view the safety of e‐cigarettes


8:30 am ‐ 9:30 am

386616 Shelby Ammirati 5B‐277 Evaluation of intravenous iron utilization at an outpatient oncology clinic: a retrospective chart review

Tuesday, December 8

11:30 am ‐ 12:30 pm

387825 Charlotte Amponsah 2‐174 For patients who are intolerable to statins or those with familial hypercholesterolemia, is proprotein convertase subtilisin‐kexin type 9 (PCSK9) inhibitor the drug of choice?

Monday, December 7

10:45 am ‐11:45 am

386802 Adaolisa Anaka 3‐202 Evaluating pharmacist impact on chronic disease management (EPIC DM)

Monday, December 7

12:00 pm ‐ 1:00 pm

388117 Evellyn Ancheschi 5A‐009 Improving inventory management and efficiency in the community pharmacy setting

Tuesday, December 8

10:00 am ‐ 11:00 am

386333 Rebecca Andersen 5A‐199 Personalizing supportive care in oncology patients using

Tuesday, December 8

10:00 am ‐ 11:00 am


7 | P a g e

Submission ID



pharmacogenetic‐driven treatment pathways

388334 Katelin Anderson 7‐170 Impact of procalcitonin on appropriate antibiotic days in patients with lower respiratory tract infections: a retrospective study


8:30 am ‐ 9:30 am

388380 Kevin Anderson 5B‐278 Review of the efficacy and efficiency of an IV chemotherapy‐compounding robot utilized in an outpatient oncology infusion center

Tuesday, December 8

11:30 am ‐ 12:30 pm

385743 Ryan Anderson 5B‐396 Assessment of opioid prescribing practices versus patient opioid utilization in the post‐operative setting prior to clinical decision support tool implementation.

Tuesday, December 8

11:30 am ‐ 12:30 pm

386492 Christina Andros 5A‐122 Utilization of pharmacy students in elementary schools to provide tobacco education: first year experience and survey results

Tuesday, December 8

10:00 am ‐ 11:00 am

386925 Sara Andrus 5A‐010 Healthcare professionals as study subjects: scoping review

Tuesday, December 8

10:00 am ‐ 11:00 am

388965 Rebecca Andruski 5B‐085 Reviewing Android mobile device applications: focus on Hepatitis C

Tuesday, December 8

11:30 am ‐ 12:30 pm

387761 Annalise Anise 3‐049 Pharmacists' Participation in National Associations

Monday, December 7

12:00 pm ‐ 1:00 pm

383199 Vicente Aparicio 3‐324 Effectiveness of a diabetes screening protocol for preventing type 2 diabetes in a pediatric population

Monday, December 7

12:00 pm ‐ 1:00 pm

385633 Omaima arab 5A‐123 Opioids pharmacogenomics Tuesday, December 8

10:00 am ‐ 11:00 am

383303 Geoffrey Arentz 3‐203 Implementation of a pharmacy driven medication reconciliation program in a small community hospital emergency department

Monday, December 7

12:00 pm ‐ 1:00 pm

386245 Liliana Argento 2‐247 Tacrolimus‐induced Monday, 10:45 am ‐11:45 am


8 | P a g e

Submission ID



hyperalgesia December 7

388698 Andre Arizpe 5A‐277 Impact of a fluoroquinolone formulary switch on antibiotic use in a large academic teaching hospital

Tuesday, December 8

10:00 am ‐ 11:00 am

387967 Christian Armstrong 5B‐364 Assessing medication adherence in cystic fibrosis patients admitted for cystic fibrosis pulmonary exacerbations

Tuesday, December 8

11:30 am ‐ 12:30 pm

387384 Serena Arnouk 3‐161 Impact of a pharmacy consult service on reducing medication misadventures in geriatric trauma patients

Monday, December 7

12:00 pm ‐ 1:00 pm

389537 Anna Arthur 5B‐105 Prophylactic indomethacin for the prevention of intraventricular hemorrhage in preterm neonates: a continuation

Tuesday, December 8

11:30 am ‐ 12:30 pm

389343 Frank Asare 5A‐124 Gene Expression Differences in Breast Cancer between Pre‐ and Post‐menopausal Women

Tuesday, December 8

10:00 am ‐ 11:00 am

386232 Tomefa Asempa 7‐076 Evaluation of urine analysis and empiric antibiotics for management of urinary tract infection in hospitalized patients


8:30 am ‐ 9:30 am

386486 Cameron Asgharpour 5A‐312 Comparison of plasma erythropoietin and vascular endothelial growth factor levels between chronic kidney disease and cardio‐renal syndrome patients

Tuesday, December 8

10:00 am ‐ 11:00 am

385740 Michelle Aslami 5B‐012 Evaluation of clinical and economic outcomes of inhaled nitric oxide versus inhaled epoprostenol in critically ill patients with refractory hypoxemia at a large academic institution

Tuesday, December 8

11:30 am ‐ 12:30 pm

388993 Nathan Asmer 3‐298 Assessment of pre‐pharmacy students' personalities as

Monday, December 7

12:00 pm ‐ 1:00 pm


9 | P a g e

Submission ID



performance indicators within the profession of pharmacy

389211 Daria Atkinson 3‐050 The evaluation of rapid diagnostic testing for the detection of staph aureus/methicillin‐resistant staph aureus in blood cultures in intensive care unit patients

Monday, December 7

12:00 pm ‐ 1:00 pm

389393 Munjal Attawala 3‐139 Increased medication adherence of medicaid patients in a medication adherence program and its correlation with pharmacy services provided

Monday, December 7

12:00 pm ‐ 1:00 pm

389552 Erene Attia 3‐325 Ceftaroline‐induced transaminitis in an adolescent cystic fibrosis patient

Monday, December 7

12:00 pm ‐ 1:00 pm

385607 Mark Attilio 3‐204 Glycemic Control Changes After Switching to Insulin R U‐500 In A Patient With Type 2 Diabetes

Monday, December 7

12:00 pm ‐ 1:00 pm

388818 Elise Aucoin 7‐003 Safety and tolerability of efavirenz‐based therapy in a veteran population


8:30 am ‐ 9:30 am

387489 Aivan Augustin 5B‐201 Pharmacy student use of a data collection tool for pre‐travel consultations in an interprofessional travel health clinic

Tuesday, December 8

11:30 am ‐ 12:30 pm

385943 Claire Austin 5B‐279 Assessing students needs for clinical pharmacy services at a university campus health center

Tuesday, December 8

11:30 am ‐ 12:30 pm

389274 Jeffrey Auten 5B‐273 Collaboration between pharmacist and advanced care practitioners to optimize heart failure pharmacotherapy in an outpatient heart failure clinic

Tuesday, December 8

11:30 am ‐ 12:30 pm

389421 Edward Avanessians 3‐205 Role of pharmacy with computerized provider order entry (CPOE) and preventing medication errors

Monday, December 7

12:00 pm ‐ 1:00 pm

385770 Cale Averill 5A‐107 Effects of thyme essential oil chemotypes on breast and

Tuesday, December 8

10:00 am ‐ 11:00 am


10 | P a g e

Submission ID



cervical cancer cell lineages

385919 Gina Ayers 7‐224 Evaluation of the frequency of glutamate receptor, ionotropic, kainate 4 (GRIK4) polymorphisms in depressed and non‐depressed individuals


8:30 am ‐ 9:30 am

388179 Sarah Ayers 2‐366 Perioperative blood glucose in orthopedic surgery patients

Monday, December 7

10:45 am ‐11:45 am

387721 Mohammed Azam 2‐130 Characteristics of patients receiving low‐dose and high‐dose intravenous thiamine for treatment of Wernicke encephalopathy

Monday, December 7

10:45 am ‐11:45 am

386832 Monica Azer 3‐189 Retrospective analysis of the safety and efficacy of probiotics for prevention of antibiotic‐associated diarrhea in pediatric patients

Monday, December 7

12:00 pm ‐ 1:00 pm

386149 Quyen Bach 5B‐013 Evaluation and comparison of the SHEA‐IDSA and the American Journal of Gastroenterology severity classification for Clostridium difficile infection in hospitalized adult patients

Tuesday, December 8

11:30 am ‐ 12:30 pm

387058 Allen Bagalso 2‐073 Impact of student pharmacist telephone interventions on decreasing the use of unnecessary medications

Monday, December 7

10:45 am ‐11:45 am

386341 Jessica Bai 2‐273 Hemorrhagic transformation risk factors after thrombolytic therapy in today's stroke telemedicine system

Monday, December 7

10:45 am ‐11:45 am

387872 Sandra Bai 5B‐198 Andi, Chase, and the Mysterious Case: Interdisciplinary children's book on the importance of antimicrobial stewardship

Tuesday, December 8

11:30 am ‐ 12:30 pm

386160 Paula Baichoo 2‐260 Effectiveness of intravenous acetaminophen in the management of pain and in reducing opioid requirements in

Monday, December 7

10:45 am ‐11:45 am


11 | P a g e

Submission ID



children presenting with a sickle cell pain crisis

389455 Umima Baig 3‐051 Flibanserin: the pink pill for hypoactive sexual desire disorder (HSDD) in premenopausal women

Monday, December 7

12:00 pm ‐ 1:00 pm

388598 Andrea Bailey 5A‐261 Microparticle isolation and the role of VCAM‐1, Spred‐1, and microRNA 126 in endothelial senescence

Tuesday, December 8

10:00 am ‐ 11:00 am

387553 Brett Bailey 2‐003 Perceived motivating factors and barriers for the completion of postgraduate training in American pharmacy students

Monday, December 7

10:45 am ‐11:45 am

387595 Emily Bailey 7‐225 Geriatric education in United States schools of pharmacy


8:30 am ‐ 9:30 am

387029 Janay Bailey 3‐326 Health and economic benefits of pneumococcal vaccines in patients with diabetes: a meta‐analysis

Monday, December 7

12:00 pm ‐ 1:00 pm

389214 Brandon Bair 3‐022 Evaluation of a pharmacokinetically optimized twice‐weekly IV levothyroxine dosing protocol

Monday, December 7

12:00 pm ‐ 1:00 pm

386842 Patrick Baldwin 7‐004 Evaluation of a physician education program on the use of statins and metformin in patients with type 2 diabetes


8:30 am ‐ 9:30 am

383301 Arlene Balian 5B‐086 Medication use evaluation of liposomal bupivacaine

Tuesday, December 8

11:30 am ‐ 12:30 pm

388109 Samuelle Bampi 7‐203 Pharmaceutical care in ambulatory hemodialysis patients: a randomized controlled pilot study


8:30 am ‐ 9:30 am

387873 Sowmya Banda 5A‐179 Investigation of the 2015 anti‐pseudomonal beta‐lactam shortage in a community hospital: Communication channels, changes in clinical practice, and cost impact

Tuesday, December 8

10:00 am ‐ 11:00 am

388795 Nicole Banks 5B‐106 Incorporating Cooperative Learning in a Jigsaw Flipped

Tuesday, December 8

11:30 am ‐ 12:30 pm


12 | P a g e

Submission ID



Classroom Model in a Complementary Alternative Medicine (CAM) Course

387207 Lauren Barbour 7‐077 Association between anti‐VEGF treatment and self‐reported health and ambulation in Medicare beneficiaries


8:30 am ‐ 9:30 am

388836 Serena Barden 7‐226 Medication use evaluation of gentamicin in adult patients at Virginia Commonwealth University (VCU) Health System


8:30 am ‐ 9:30 am

388654 Nicole Baren 7‐005 Antibiotic usage and risk of secondary bacterial infection in children with respiratory syncytial virus (RSV)


8:30 am ‐ 9:30 am

387808 Amanda Barnett 5B‐014 Impact of an emergency department community acquired urinary tract infection antibiogram and suggested treatment algorithm on changes in antibiotic susceptibility patterns

Tuesday, December 8

11:30 am ‐ 12:30 pm

386823 Marie Barnicoat 3‐132 Identifying risk factors associated with drug induced liver injury to develop a dynamic risk model

Monday, December 7

12:00 pm ‐ 1:00 pm

386278 Neelam Barot 7‐175 Assessing heart health awareness in the Indian community


8:30 am ‐ 9:30 am

385612 Stephanie Barquero 5B‐280 Comparison of short acting vs long acting opioid treatment of moderate to severe osteoarthritic patients in a primary care pain management program

Tuesday, December 8

11:30 am ‐ 12:30 pm

385821 Raquel Barrack 5A‐292 Retrospective Analysis of the Prevalence of Herbal Product and Alternative Therapy Use in Cancer Patients Receiving Chemotherapy at a Single Infusion Center

Tuesday, December 8

10:00 am ‐ 11:00 am

388243 Cynthia Bartha 7‐210 Results from a medication use Wednesday, 8:30 am ‐ 9:30 am


13 | P a g e

Submission ID



evaluation of opioids and multiple benzodiazepines at a rural Veterans Affairs Healthcare System

December 9

387948 Barrett Beach 5B‐146 The use of Twitter to identify novel adverse drug event reports

Tuesday, December 8

11:30 am ‐ 12:30 pm

388131 Candace Beam 2‐367 Impact of medications on hospital‐based falls with injury

Monday, December 7

10:45 am ‐11:45 am

385732 Julie Beck 5A‐166 Characterization of pediatric adverse drug reactions in an urgent care or emergency department visit

Tuesday, December 8

10:00 am ‐ 11:00 am

387535 Debra Beckstrom 5A‐293 Are precepting pharmacists happy pharmacists?

Tuesday, December 8

10:00 am ‐ 11:00 am

387875 Johanna Behrens 7‐227 Effect of varying the ratio of cases to controls in an evaluation of risk factors associated with hospital‐acquired venous thromboembolism


8:30 am ‐ 9:30 am

389528 Catherine Behret 5B‐202 Creative chaos to critical thinking: Evaluation of a pharmacy student's ability to critically think

Tuesday, December 8

11:30 am ‐ 12:30 pm

385572 D. Danielle Beltz 2‐274 Implementation and results of a pharmacist driven renal dosing initiative for outpatients

Monday, December 7

10:45 am ‐11:45 am

387987 Karina Benitez 3‐052 Antipsychotics in elderly dementia patients: appropriate therapy or chemical restraint?

Monday, December 7

12:00 pm ‐ 1:00 pm

383027 LaToya Benjamin 3‐053 Flakka a new dangerous drug epidemic

Monday, December 7

12:00 pm ‐ 1:00 pm

389454 Keith Bennett 5A‐342 Medication‐Use Evaluation (MUE) of Testosterone Within a VA Health System

Tuesday, December 8

10:00 am ‐ 11:00 am

386238 Jade Bensink 2‐275 Evaluating the use of proton pump inhibitors in preventing gastrointestinal bleeding in patients with HeartMate II left ventricular assist devices

Monday, December 7

10:45 am ‐11:45 am

389063 Catherine Benton 2‐276 Effect of Behavioral Health Monday, 10:45 am ‐11:45 am


14 | P a g e

Submission ID



Consultants on diabetic patient care management in an established internal medicine clinic

December 7

382973 Kaitlin Berger 5A‐011 Pharmacist implementation of continuing education into practice post 2014 Arizona Pharmacy Association (AzPA) Annual Convention

Tuesday, December 8

10:00 am ‐ 11:00 am

385268 Alta Bergquist 3‐393 Medication utilization evaluation of intravenous immune globin (IVIG) across two academic medical centers

Monday, December 7

12:00 pm ‐ 1:00 pm

387200 Fidelia Bernice 3‐265 Examining predictors of an interdisciplinary, outpatient transitions of care service using the Anderson healthcare utilization model

Monday, December 7

12:00 pm ‐ 1:00 pm

387745 Whitney Bernreuter 7‐006 Comparison of home and hospital intravenous antibiotic therapy for cystic fibrosis exacerbation


8:30 am ‐ 9:30 am

387609 Adam Bernstein 5B‐281 Advanced Practice Pharmacists: cost‐effectiveness of ClinicaL Pharmacist PractitionErs (CPPs) in the management of ambulatory Medicare patients in North Carolina (APPLE‐NC)

Tuesday, December 8

11:30 am ‐ 12:30 pm

386901 Elizabeth Berryman 5A‐271 Impact of Multimodal Level Interventions on Patients in an Adult Sickle Cell Disease Clinic.

Tuesday, December 8

10:00 am ‐ 11:00 am

389231 Thomas Beuschel 7‐116 Rapid Gram negative pathogen identification using PCR FilmArray diagnostics


8:30 am ‐ 9:30 am

386847 Priya Bhimani 3‐266 Renal dysfunction associated with polymyxin B and polymyxin E

Monday, December 7

12:00 pm ‐ 1:00 pm

383283 Teryn Bibb 3‐327 Effect of Interprofessional Team Care on Clinical Outcomes of Low‐Income Diabetic Patients in an Outpatient Charitable Clinic

Monday, December 7

12:00 pm ‐ 1:00 pm


15 | P a g e

Submission ID



385746 Ellen Bickel 5A‐052 Pharmacy student peer‐to‐peer mentoring in a student‐run free clinic

Tuesday, December 8

10:00 am ‐ 11:00 am

386122 Alyssa Billmeyer 5B‐417 Development of a Protocol at an Anticoagulation Clinic for Supra‐therapeutic INRs Performed on a Point of Care Testing Device

Tuesday, December 8

11:30 am ‐ 12:30 pm

388035 Patrick Binaday 5B‐107 Central line‐associated bloodstream infection caused by Candida glabrata in an intensive care unit patient: a case report

Tuesday, December 8

11:30 am ‐ 12:30 pm

386996 William Binder 2‐012 Effect of adherence to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines on chronic obstructive pulmonary disease related readmissions in a community hospital

Monday, December 7

10:45 am ‐11:45 am

389448 Lida Binesheian 3‐328 Impact of Active Heart Failure Management in the Veteran Affairs CLC Population

Monday, December 7

12:00 pm ‐ 1:00 pm

384487 Bailee Binks 5A‐294 Increasing medication communication scores and retail volume at a community hospital by instituting discharge medication bedside delivery and counseling

Tuesday, December 8

10:00 am ‐ 11:00 am

384796 Asha Birmingham 2‐343 Effect of amiodarone on the incidence of post‐operative atrial fibrillation after esophagectomy: a retrospective chart review

Monday, December 7

10:45 am ‐11:45 am

384780 Allison Bisson 5B‐203 Assessment of over‐the‐counter medication information resources for community pharmacists ‐ an industry perspective

Tuesday, December 8

11:30 am ‐ 12:30 pm

386000 Sarah Bissonnette 2‐344 Hospital readmission rates decrease with increasing pharmacy density in rural and

Monday, December 7

10:45 am ‐11:45 am


16 | P a g e

Submission ID



urban communities in Oregon

388888 Kevin Bitar 7‐198 Patient‐tailored dosing formulations: the age of three‐dimensional printing


8:30 am ‐ 9:30 am

387778 Emily Blaiklock 5A‐108 Medication use evaluation of HIV post‐exposure prophylaxis in patients presenting to the emergency department after occupational and non‐occupational exposure

Tuesday, December 8

10:00 am ‐ 11:00 am

385791 Linda Blake 3‐394 Medication utilization review of intravenous colistin and polymyxin B for the treatment of multidrug resistant infections in non‐cystic fibrosis patients

Monday, December 7

12:00 pm ‐ 1:00 pm

388761 Alex Blalock 5B‐360 Evaluation of workstations‐on‐wheels (WOWs) microbial etiology and their role in the transmission of hospital associated infections

Tuesday, December 8

11:30 am ‐ 12:30 pm

386758 Delilah Blanco 5A‐278 Evaluation of the 2014‐2015 influenza vaccine within a pediatric clinic

Tuesday, December 8

10:00 am ‐ 11:00 am

389495 Lauren Blandford Schmitt

7‐054 Retrospective observational study evaluating the impact of a newly implemented Meds 2 Beds program with respect to financial impact and patient satisfaction


8:30 am ‐ 9:30 am

386577 Adam Blevins 3‐140 Assessing compliance with the Joint Commission standard for an identifiable reason for inpatient medication orders.

Monday, December 7

12:00 pm ‐ 1:00 pm

387080 Danielle Bley 3‐054 Correlation of platelet factor 4 optical density values with serotonin release assay results in patients with suspected heparin induced thrombocytopenia and associated medication cost savings

Monday, December 7

12:00 pm ‐ 1:00 pm


17 | P a g e

Submission ID



387686 Madison Block 3‐395 Experiences involving an international advanced pharmacy practice experience (APPE) rotation in Ecuador: review of prescribing practices and preparation for future trips

Monday, December 7

12:00 pm ‐ 1:00 pm

389074 Lauren Bode 2‐368 Evaluation of protocol‐based treatment regimens for neonatal abstinence syndrome

Monday, December 7

10:45 am ‐11:45 am

389009 Taylor Bogue 7‐176 Patient perceptions of isotretinoin


8:30 am ‐ 9:30 am

385241 Kristin Bohannon 3‐329 Efficacy and safety of intravenous vitamin K versus subcutaneous vitamin K in the peri‐operative setting

Monday, December 7

12:00 pm ‐ 1:00 pm

386494 Kayla Boles 2‐369 Determining effectiveness of a nurse managed heparin protocol in a surgical intensive care unit: a retrospective cohort analysis

Monday, December 7

10:45 am ‐11:45 am

386966 Rachel Booze 5B‐147 Comparison of adverse event reporting rates for intravenous versus oral chemotherapeutic agents with consideration for outpatient monitoring programs to decrease hospitalization

Tuesday, December 8

11:30 am ‐ 12:30 pm

389630 Lacey Boren 3‐396 Help for HELLP syndrome‐ a case report on the tragic and rare complication during pregnancy

Monday, December 7

12:00 pm ‐ 1:00 pm

388196 Stephanie Borzaga 2‐040 Evaluation of the stress ulcer prophylactic regimens in non‐critically ill hospitalized patients

Monday, December 7

10:45 am ‐11:45 am

388439 Rocky Bostian 5B‐282 Evaluation of hepatitis B vaccination practices in the neonatal intensive care patient population at a tertiary medical center

Tuesday, December 8

11:30 am ‐ 12:30 pm

387843 Alyssa Boutin 3‐023 Paliperidone palmitate: medication use evaluation at a tertiary care referral center

Monday, December 7

12:00 pm ‐ 1:00 pm


18 | P a g e

Submission ID



387738 Laura Bowers 5A‐168 Evaluation of student perceptions and behaviors following implementation of an e‐portfolio of professional activities

Tuesday, December 8

10:00 am ‐ 11:00 am

386708 Alyssa Bowling 7‐117 Effect of a patient‐centered medical home (PCMH) practice model on diabetes quality indicators in those with developmental disabilities


8:30 am ‐ 9:30 am

383208 Allison Boyd 5B‐148 Supplemented discharge through Pharmacy as a Preventative Readmission Tactic (SUPPoRT)

Tuesday, December 8

11:30 am ‐ 12:30 pm

385769 Angela Boyd 3‐133 Medication use evaluation (MUE) of intravenous chlorothiazide in a large community hospital

Monday, December 7

12:00 pm ‐ 1:00 pm

388981 Jayzle Joy Boyd 5B‐108 Impact of total antimicrobial exposure on the recurrence of Clostridium difficile associated diarrhea

Tuesday, December 8

11:30 am ‐ 12:30 pm

386277 Kelley Braden 3‐055 Pharmacy student perceptions of preparation for and exposure to post‐graduate residency training in a PharmD degree curriculum

Monday, December 7

12:00 pm ‐ 1:00 pm

389025 Johnathan Bradford 7‐055 Evaluation of self‐monitoring education given to advanced heart failure patients during and upon discharge from a skilled nursing facility


8:30 am ‐ 9:30 am

384784 Rebekah Bradford 7‐007 Relationship between oxidant production and sexual adverse effects of antidepressant medications


8:30 am ‐ 9:30 am

387560 Holly Brady 5B‐283 Impact of outpatient U‐500 regular insulin clinical practice standards on prescribing practices in ambulatory care clinics at an academic medical center.

Tuesday, December 8

11:30 am ‐ 12:30 pm


19 | P a g e

Submission ID



385695 Kourtney Brammeier 2‐131 Appropriate dose evaluation of micafungin for the prophylaxis of invasive fungal infections in patients with a hematologic malignancy

Monday, December 7

10:45 am ‐11:45 am

387520 Ryan Brandeberry 2‐277 Benefits of a medication reconciliation pharmacist‐ biggest bang for the buck

Monday, December 7

10:45 am ‐11:45 am

388219 Carter Brashears 2‐332 Implementation of a health system wide vancomycin monitoring service using electronic medical records as part of a medication safety initiative

Monday, December 7

10:45 am ‐11:45 am

388345 Lillian Brennan 2‐175 Assessment of scheduled mealtime insulin administration compared to room service dining program delivery of meals.

Monday, December 7

10:45 am ‐11:45 am

386316 Laura Brickett 3‐206 Development of a statewide antibiogram to guide pharmacist recommendations for the treatment of antibiotic‐resistant ESKAPE organisms

Monday, December 7

12:00 pm ‐ 1:00 pm

387372 Lauren Briggs 3‐056 Use of ciprofloxacin as prophylaxis to prevent BK virus (BKV) infection in high‐risk hematopoietic stem cell transplant (HSCT) patients

Monday, December 7

12:00 pm ‐ 1:00 pm

385083 Amanda Bright 3‐162 Retrospective analysis of adherence to cytomegalovirus prophylaxis protocol in renal transplant patients treated with valganciclovir

Monday, December 7

12:00 pm ‐ 1:00 pm

385725 Jessica Brinkmeyer 2‐365 Characteristics of patients requiring eight hour vancomycin dosing: a retrospective chart review

Monday, December 7

10:45 am ‐11:45 am

386101 Kelly Brookbank 5A‐220 Pharmacist's impact on door to needle time of administration of recombinant tissue plasminogen activator in acute

Tuesday, December 8

10:00 am ‐ 11:00 am


20 | P a g e

Submission ID



ischemic stroke

384354 Kelsey Browder 5B‐284 Characterizing warfarin versus novel oral anticoagulant use in patients admitted with a major bleed

Tuesday, December 8

11:30 am ‐ 12:30 pm

389646 Tasha Brower 5A‐120 Evaluating the perception of pharmacy students on their role to promote and educate patients on smoking cessation

Tuesday, December 8

10:00 am ‐ 11:00 am

388961 Jennifer Brown 3‐207 Vancomycin dosing considerations in patients with liver cirrhosis

Monday, December 7

12:00 pm ‐ 1:00 pm

385792 Nairobi Brown 3‐057 Healthcare professionals knowledge regarding non‐controlled medications not typically associated with abuse potential

Monday, December 7

12:00 pm ‐ 1:00 pm

388169 Kathryn Broze 3‐330 Cost comparison of high bolus dose tirofiban versus other treatment strategies in percutaneous coronary intervention

Monday, December 7

12:00 pm ‐ 1:00 pm

384745 Rachel Bruns 2‐132 Appropriateness of prescribing of methylnaltrexone within a metropolitan health system

Monday, December 7

10:45 am ‐11:45 am

388373 Chelsea Bryan 5A‐075 Assessment of antimicrobials prescribed before and after implementation of a pharmacist‐directed penicillin skin testing consult service for patients with a self‐reported penicillin allergy

Tuesday, December 8

10:00 am ‐ 11:00 am

384726 Kristina Bryce 2‐176 Evaluation of community pharmacists recommendations regarding the use of probiotics

Monday, December 7

10:45 am ‐11:45 am

386493 Rachel Bubik 5A‐102 Optimization of the advanced clinical evaluation (ACE) program for ambulatory oncology infusion

Tuesday, December 8

10:00 am ‐ 11:00 am

385046 Heather Buehrer 2‐133 Knowledge, Beliefs, and Attitudes of Kansas City Metropolitan Pharmacists,

Monday, December 7

10:45 am ‐11:45 am


21 | P a g e

Submission ID



Interns, and Technicians Toward Cannabinoid Medicines and Medical Marijuana

385852 Kassandra Bugg 3‐208 Adverse drug report: levetiracetam induced vivid dreams

Monday, December 7

12:00 pm ‐ 1:00 pm

385715 Annie Bui 3‐331 Feasibility of Motivational Interviewing (MI) training for pharmacy students on Advanced Pharmacy Practice Experience (APPE) rotations in a Medicare Advantage with Prescription Drug Plan (MAPDP) setting

Monday, December 7

12:00 pm ‐ 1:00 pm

388270 Doan‐Si Bui 3‐397 Optimizing antimicrobial selection through microarray‐based gram‐positive blood culture systems

Monday, December 7

12:00 pm ‐ 1:00 pm

385937 Tram Bui 2‐090 A review of IV haloperidol use and baseline EKG measurements on internal medicine units

Monday, December 7

10:45 am ‐11:45 am

387310 Katelyn Bull 5A‐262 Evaluation of common medications and risk of necrotizing enterocolitis in very low birth weight infants

Tuesday, December 8

10:00 am ‐ 11:00 am

387124 Kasey Burge 7‐056 Prevalence of positive drug screen for cannabinoids in patients admitted to a psychiatric facility with psychosis


8:30 am ‐ 9:30 am

389196 Leon Burgess 2‐091 Case of Pseudomonas aeruginosa endocarditis in a transgender woman with intravenous drug use, and Human Immunodeficiency Virus

Monday, December 7

10:45 am ‐11:45 am

387777 Kelly Burke 2‐177 Sleep and its effects on GPA in DYouville College pharmacy students

Monday, December 7

10:45 am ‐11:45 am

382726 Rachna Burman 2‐178 Evaluation of clozapine use at Long Island Jewish Medical Center

Monday, December 7

10:45 am ‐11:45 am


22 | P a g e

Submission ID



384566 Allison Burns 5B‐204 Overcoming the opioid epidemic: community pharmacy‐based naloxone programs and how pharmacists can be the difference

Tuesday, December 8

11:30 am ‐ 12:30 pm

387255 Emily Burns 7‐228 Retrospective review of dexmedetomidine and benzodiazepine use in critically ill patients with alcohol withdrawal syndrome (AWS)


8:30 am ‐ 9:30 am

387993 Michael Burns 2‐179 Assessing the impact of ambulatory care pharmacists on Medicare Star Ratings in a level 3 patient‐centered medical home

Monday, December 7

10:45 am ‐11:45 am

388619 Andrew Burton 7‐008 Review of pharmacy students' understanding of hazardous drug handling and dispensing


8:30 am ‐ 9:30 am

385286 Kelcymarie Bye 7‐078 Attitudes and application of the 2013 ACC/AHA guidelines to reduce atherosclerotic cardiovascular disease risk and the 2014 JNC 8 guidelines for hypertension


8:30 am ‐ 9:30 am

384799 Mackenzie Byron 7‐211 Analysis of the potential clinical and financial impact of a pharmacist‐managed anticoagulation service in an ambulatory oncology clinic


8:30 am ‐ 9:30 am

386544 Pierina Cabrera 3‐058 Evaluation of parenteral anticoagulant therapies in a large academic medical center

Monday, December 7

12:00 pm ‐ 1:00 pm

385236 Erin Cady 2‐405 Antibiotic lock therapy on catheter salvage in central line‐associated bloodstream infections

Monday, December 7

10:45 am ‐11:45 am

385624 Vincent Cagonot 2‐041 Evaluation of appropriate venous thromboembolism (VTE) prophylaxis in hospitalized pregnant women undergoing cesarean section

Monday, December 7

10:45 am ‐11:45 am

387610 Songlin Cai 3‐420 Description and impact of a Monday, 12:00 pm ‐ 1:00 pm


23 | P a g e

Submission ID



pharmacist‐driven anticoagulation quality improvement project at an outpatient family medicine residency clinic

December 7

386852 Elizabeth Caliman 7‐118 Impact of prescription insurance on healthcare utilization and expenditures according to Medical Expenditure Panel Survey (MEPS) 2012 data


8:30 am ‐ 9:30 am

385127 Marlene Calix 3‐059 Minimizing complications with fluorouracil home infusion pumps

Monday, December 7

12:00 pm ‐ 1:00 pm

388572 Samantha Calogero 3‐033 Use of amiodarone prophylactically to prevent postoperative atrial fibrillation

Monday, December 7

12:00 pm ‐ 1:00 pm

385922 Kelsie Cameron 7‐177 Correlations between exercise regimen and antidepressant use in adults ages 18‐64


8:30 am ‐ 9:30 am

385414 Ashley Camilo 5B‐205 Potential cost savings associated with implementation of guideline‐directed protocol for phytonadione use in international normalized ratio (INR) reversal

Tuesday, December 8

11:30 am ‐ 12:30 pm

386690 Nicole Camp 2‐180 Stability of extemporaneously prepared ophthalmic solutions

Monday, December 7

10:45 am ‐11:45 am

388127 Tavajay Campbell 5A‐184 Prevalence and risk factors of prediabetes in a human immunodeficiency virus (HIV) infected patient cohort

Tuesday, December 8

10:00 am ‐ 11:00 am

382638 Matias Campos 5B‐206 Value of pharmacy perspectives in research and development

Tuesday, December 8

11:30 am ‐ 12:30 pm

389511 Alyissa Canady 2‐153 Evaluation of asthma self‐management education during a five‐day asthma camp for children

Monday, December 7

10:45 am ‐11:45 am

388599 Laura Cannon 7‐057 Impact of social support and partner supportive behaviors on time to first treatment in


8:30 am ‐ 9:30 am


24 | P a g e

Submission ID



women with breast cancer

388013 Leany Capote 3‐134 Evaluating the impact of incorporating a care coordination team on heart failure readmission rates

Monday, December 7

12:00 pm ‐ 1:00 pm

388666 Maria Caraballo 5A‐217 Quality assessment of a professional portfolio development workshop for pharmacy students

Tuesday, December 8

10:00 am ‐ 11:00 am

382636 Jessica Carey 5B‐363 Assessing the Use of Rituximab in Hospitalized Neuroscience Patients

Tuesday, December 8

11:30 am ‐ 12:30 pm

382719 Jennifer Carmical 2‐406 Effect of phospholipid removal on the determination of buprenorphine, norbuprenorphine, methadone, and glucuronide metabolites in umbilical cord plasma

Monday, December 7

10:45 am ‐11:45 am

388662 Ashley‐Nicole

Carmichael 7‐229 Student perspectives on the educational value of volunteering experiences through a pharmacy student run clinic


8:30 am ‐ 9:30 am

386250 Hannah Carr 5B‐285 Development of an institution‐specific severe sepsis antibiogram

Tuesday, December 8

11:30 am ‐ 12:30 pm

386579 Megan Carr 3‐141 Pharmacy student intervention in an interprofessional teaching clinic and their potential role for improving diabetic patient clinical outcomes

Monday, December 7

12:00 pm ‐ 1:00 pm

387188 Michelle Carrasquillo 3‐060 Determining trends in atrial fibrillation thromboprophylaxis at an academic medical center

Monday, December 7

12:00 pm ‐ 1:00 pm

387728 Dustin Carrel 2‐278 Impact of treatment regimens on depression symptoms and glycemic control

Monday, December 7

10:45 am ‐11:45 am

387201 Laura Carrell 7‐009 Impact analysis of interventions by fourth year student pharmacists in affiliated practice sites during advanced pharmacy practice experiences


8:30 am ‐ 9:30 am


25 | P a g e

Submission ID



389318 Jordan Carrera 5B‐286 Retrospective evaluation of the epidemiology of ventilator‐associated events (VAE) and ventilator‐associated pneumonias (VAP) at UNC Medical Center (UNCMC)

Tuesday, December 8

11:30 am ‐ 12:30 pm

389649 James Carroll 7‐010 Surveying health‐system pharmacies in Alabama: what qualities do employers value in a new hire?


8:30 am ‐ 9:30 am

385827 Megan Carroll 2‐345 Evaluation of the oral anticoagulant prior authorization policy in the Oregon Medicaid program

Monday, December 7

10:45 am ‐11:45 am

388263 Jasmine Carter 3‐332 Evaluation of antibiotic prescribing practices of urinary tract infections at a tertiary academic medical center: a quality improvement project

Monday, December 7

12:00 pm ‐ 1:00 pm

383291 Jessica Carter 7‐058 Evaluation of the occurrence of prolonged QTc interval in patients receiving antimicrobial therapy using macrolides


8:30 am ‐ 9:30 am

385230 Jordan Carter 7‐059 Incidence and patterns of ischemia in various organ systems in patients receiving bevacizumab


8:30 am ‐ 9:30 am

384332 Kelsea Caruso 5B‐004 Gender and sex related differences in PharmD. curriculum

Tuesday, December 8

11:30 am ‐ 12:30 pm

386539 Jovanna Casas 2‐346 A phone‐based protocol for optimizing metformin and basal insulin dosing from the perspective of population panel management

Monday, December 7

10:45 am ‐11:45 am

386610 Laura Case 5B‐397 Required critical care knowledge base for practicing hospital pharmacists in Wisconsin

Tuesday, December 8

11:30 am ‐ 12:30 pm

385152 Amanda Cass 7‐060 Predictors of fosaprepitant‐induced phlebitis: a retrospective chart review


8:30 am ‐ 9:30 am


26 | P a g e

Submission ID



386482 Lucas Casserlie 5A‐221 Ohio pharmacists' perceptions on non‐dispensing services and medication therapy management

Tuesday, December 8

10:00 am ‐ 11:00 am

389693 Saul Castaneda Hernandez

2‐001 Efficacy and safety of propranolol in Mexican patients with infantile hemangioma

Monday, December 7

10:45 am ‐11:45 am

386869 Natalie Catalano 5A‐012 Assessing best practice alerts contributing to alert fatigue in an electronic health record system

Tuesday, December 8

10:00 am ‐ 11:00 am

389621 Erreca Cato 2‐092 Evaluating chronic stress and its effect on blood pressure and overall health among pharmacy students

Monday, December 7

10:45 am ‐11:45 am

387261 Lejla Catovic 5A‐080 Impact of targeted antimicrobial stewardship interventions using rapid laboratory diagnostics

Tuesday, December 8

10:00 am ‐ 11:00 am

386480 Sarah Caulfield 5B‐087 Retrospective evaluation of age and clinical predictors of response to immunotherapy in metastatic melanoma

Tuesday, December 8

11:30 am ‐ 12:30 pm

388812 Amanda Cavness 2‐370 Comprehensive analysis of brown recluse envenomation at a freestanding pediatric hospital

Monday, December 7

10:45 am ‐11:45 am

385243 Sebastian Cerdena 5B‐287 Adherence to chemotherapy‐induced nausea and vomiting protocol in stage IIIB non‐small‐cell lung cancer patients receiving cisplatin, etoposide and chest radiotherapy at an academic medical center

Tuesday, December 8

11:30 am ‐ 12:30 pm

387387 Jessica Cerullo 7‐230 Evaluation of the impact of a nurse driven protocol on pneumococcal vaccination in an academic medical center


8:30 am ‐ 9:30 am

385712 Alex Chaben 7‐171 Student pharmacist education in COPD patients (SPECOPD) and hospital readmission


8:30 am ‐ 9:30 am

388118 Jin Chae 5B‐015 Use and appropriateness of Tuesday, 11:30 am ‐ 12:30 pm


27 | P a g e

Submission ID



venous thromboembolism (VTE) prophylaxis in patients admitted with chronic obstructive pulmonary disease (COPD) exacerbation at an academic medical center

December 8

387788 Chava Chaitin 5A‐215 Impact of pre‐injury HMG‐CoA reductase inhibitors on outcomes in older, seriously injured trauma patients

Tuesday, December 8

10:00 am ‐ 11:00 am

388737 Jamie Chambers 7‐011 Evaluation of paliperidone palmitate use on frequency of psychiatric‐related hospital readmissions and emergency department visits


8:30 am ‐ 9:30 am

386738 Kasandra Chambers 2‐279 Using relative‐value units (RVUs) to distribute workload and justify services in an investigational drug service (IDS) pharmacy

Monday, December 7

10:45 am ‐11:45 am

386870 Amanda Chan 2‐042 Caloric Restriction and Health Outcome: A Systematic Review

Monday, December 7

10:45 am ‐11:45 am

387115 Hoyi Vanya Chan 7‐199 Education of college students on safe medication disposal through student pharmacist led presentation


8:30 am ‐ 9:30 am

383009 Lewey Chan 2‐181 Evaluation of antimicrobial order stacking after the implementation of computerized physician order entry (CPOE) in a health system.

Monday, December 7

10:45 am ‐11:45 am

386271 Tsz Chan 5A‐313 Microbial growth of non‐sterile compounded preparations when compared to the traditional USP Beyond Use Dating

Tuesday, December 8

10:00 am ‐ 11:00 am

385412 Alice Chandler 3‐299 Factors associated with antiretroviral errors in HIV‐infected patients in the intensive care unit (ICU)

Monday, December 7

12:00 pm ‐ 1:00 pm

387305 Alice Chang 5A‐103 Utilization of time and motion analysis to characterize the

Tuesday, December 8

10:00 am ‐ 11:00 am


28 | P a g e

Submission ID



delivery of medication therapy management (MTM) to Medicare Part D patients

389031 Ting‐Ju Chang 5B‐196 Evaluation of a protocol for blood culture testing in a cardiac critical care unit (CCU) in Western Kenya

Tuesday, December 8

11:30 am ‐ 12:30 pm

386623 Marissa Chapman 2‐150 Dosing practices of zolpidem in hospitalized patients in a large Midwest healthcare system

Monday, December 7

10:45 am ‐11:45 am

386848 Marciha Chatman 2‐085 Intensive Lifestyle Intervention for Diabetes, Hypertension, Dyslipidemia, and Obesity

Monday, December 7

10:45 am ‐11:45 am

388943 Jason Chau 3‐333 Predictive relationship of Medication Regimen Complexity Index on 8‐item Morisky Medication Adherence Scale scores for patients in a behavioral health transitions of care program

Monday, December 7

12:00 pm ‐ 1:00 pm

385815 Maheen Chaudhry 5B‐263 Use of angiotensin‐neprilysin inhibitor LCZ696 in heart failure

Tuesday, December 8

11:30 am ‐ 12:30 pm

385935 Amanda Chee 5B‐207 Gestational diabetes mellitus: a small bump along the road

Tuesday, December 8

11:30 am ‐ 12:30 pm

385921 Allen Chen 5B‐375 Retrospective comparison of standard versus high dosing of oseltamivir for the treatment of influenza in intensive care unit patients

Tuesday, December 8

11:30 am ‐ 12:30 pm

387281 Emily Chen 7‐079 Albumin utilization in post‐orthotopic liver transplant patients in the intensive care unit: a retrospective chart review


8:30 am ‐ 9:30 am

389370 Ivory Chen 5A‐263 Pharmacy informatics interventions at an academic medical center using barcode validation to mitigate gaps that are inherent in the pharmaceutical supply‐chain

Tuesday, December 8

10:00 am ‐ 11:00 am

383717 Jinyao Chen 3‐296 Incidence of ifosfamide‐induced neurotoxicity with the use of

Monday, December 7

12:00 pm ‐ 1:00 pm


29 | P a g e

Submission ID



neurokinin‐1 receptor antagonists at an academic medical center

387066 Linda Chen 2‐043 Medication errors reported in an ambulatory care clinic

Monday, December 7

10:45 am ‐11:45 am

384790 Melanie Chen 5A‐180 Multidisciplinary Interventions to Reduce Inappropriately Withheld Basal Insulin

Tuesday, December 8

10:00 am ‐ 11:00 am

385202 Ruby Chen 2‐347 Quantification of QTc prolongation effects associated with antidepressant and antipsychotic therapies

Monday, December 7

10:45 am ‐11:45 am

387571 Melanie Cheng 5A‐279 Single center experience with anakinra in children and adolescents

Tuesday, December 8

10:00 am ‐ 11:00 am

387393 Hanan Cherqaoui 5B‐208 Is soda the new cigarette? Tuesday, December 8

11:30 am ‐ 12:30 pm

389408 Linda Chestnut 3‐142 A retrospective study of ticagrelor loading dose discrepancies within one health care system.

Monday, December 7

12:00 pm ‐ 1:00 pm

385800 Jeffery Cheung 5B‐016 Characteristics and treatment of patients with healthcare facility‐associated Clostridium difficile infection (CDI) at a community hospital.

Tuesday, December 8

11:30 am ‐ 12:30 pm

384792 serena chew 2‐182 Use of intranasal ketamine in sub‐dissociative doses for laceration repair in the emergency department

Monday, December 7

10:45 am ‐11:45 am

388688 Tina Chhabra 7‐231 Evaluation of pre‐ and post‐computerized physician order entry (CPOE) guideline implementation on antibiotic usage of urinary tract infections and pyelonephritis in a community teaching hospital


8:30 am ‐ 9:30 am

386274 Janice Chheda 2‐183 Providing interdisciplinary healthcare in resource poor regions of Intibuca, Honduras

Monday, December 7

10:45 am ‐11:45 am

389648 Rosannara Chhun 5A‐319 Development of a discharge counseling protocol for patients

Tuesday, December 8

10:00 am ‐ 11:00 am


30 | P a g e

Submission ID



with congestive heart failure

388566 Kevin Chiang 3‐334 A survey of fourth year pharmacy student interests and concerns regarding the residency application and match process

Monday, December 7

12:00 pm ‐ 1:00 pm

385879 Deborah Chien 2‐064 PAIN MANAGEMENT ANALYSIS ON MOBILE MEDICAL CLINICS IN CAMBODIA

Monday, December 7

10:45 am ‐11:45 am

388251 Swetha Chikoti 7‐232 Evaluation of the efficacy, adverse events, and weight loss of canagliflozin in diabetic patients


8:30 am ‐ 9:30 am

383482 Helen Chim 7‐196 Enoxaparin dosing in specific patient populations


8:30 am ‐ 9:30 am

385942 Ikjae Chin 7‐080 Evaluating benefits of Hepatitis C Virus (HCV) clinics at Indian Health Service hospitals


8:30 am ‐ 9:30 am

386965 Jane Ching 7‐081 Retrospective chart review for risk evaluation in patients who develop hospital‐acquired Clostridium difficile infections


8:30 am ‐ 9:30 am

386430 Ruthanne Chiotti 2‐070 Implementation of a student‐led medication counseling service at an urban free clinic

Monday, December 7

10:45 am ‐11:45 am

385975 Jacqueline Chirico 2‐184 Evaluating the incidence of hypoglycemia after the removal of sulfonylureas from a hospital formulary

Monday, December 7

10:45 am ‐11:45 am

389877 Tiffany Chiu 5A‐008 Healthcare providers knowledge of and opinions regarding medication costs in critically ill patients

Tuesday, December 8

10:00 am ‐ 11:00 am

387651 Jared Chiusano 5B‐288 Negative predictive value of nasal swab polymerase chain reaction screening test in hospitalized patients for methicillin‐resistant staphylococcus aureus culture positive pneumonia.

Tuesday, December 8

11:30 am ‐ 12:30 pm

385784 Christian Cho 3‐209 Effect of appropriate empiric therapy in patients with

Monday, December 7

12:00 pm ‐ 1:00 pm


31 | P a g e

Submission ID



culture‐positive intra‐abdominal infections

385173 Yoonjoo Cho 5A‐167 Clinical characteristics of adverse drug reactions reported from the community pharmacy

Tuesday, December 8

10:00 am ‐ 11:00 am

388089 Christine Choi 5A‐034 Safety and efficacy of unfractionated heparin continuous infusion post‐aPTT range adjustment

Tuesday, December 8

10:00 am ‐ 11:00 am

388199 David Choi 3‐006 Utilizing pharmacy student volunteers to improve hospital consumer assessment of healthcare providers and systems (HCAHPS) survey scores: a patient education initiative

Monday, December 7

12:00 pm ‐ 1:00 pm

387210 Min Choi 3‐038 PHARMACISTS' PREFERENCE AND UTILIZATION OF DRUG INFORMATION RESOURCES

Monday, December 7

12:00 pm ‐ 1:00 pm

385764 Seohyun Choi 2‐280 Tapering of benzodiazepine therapy in a patient with anxiety and depression

Monday, December 7

10:45 am ‐11:45 am

385808 Ye Choi 2‐271 Nephrotoxicity in a pediatric patient due to low dose methotrexate (LDMTX) during interim maintenance treatment for acute lymphoblastic leukemia

Monday, December 7

10:45 am ‐11:45 am

384339 Yookyung Choi 3‐391 Examining urban patient information‐seeking behavior on over‐the‐counter (OTC) medication selection

Monday, December 7

12:00 pm ‐ 1:00 pm

388292 Jacklyn Chong 2‐044 Assessment of pharmacist managed adult vancomycin protocol and goal therapeutic troughs

Monday, December 7

10:45 am ‐11:45 am

386936 Jennifer Chou 7‐119 Fluid balance and weight discordance in acute decompensated heart failure


8:30 am ‐ 9:30 am

388496 Rowshan Chowdhury 5A‐053 Perceptions of healthcare providers on mobile health

Tuesday, December 8

10:00 am ‐ 11:00 am


32 | P a g e

Submission ID



technologies in a potential patient‐centered health information exchange model

385047 Rachel Christiansen 3‐398 Assessing the risk of warfarin therapy replacement with target specific oral anticoagulants (TSOACs): a retrospective chart review of anticoagulation clinic patients

Monday, December 7

12:00 pm ‐ 1:00 pm

384561 Matthew Christie 2‐113 Outpatient to Inpatient Detoxification Clinic: A Transition of Care

Monday, December 7

10:45 am ‐11:45 am

389186 Sanjeda Chumki 2‐185 Medical marijuana: a non‐conventional approach in the treatment of parkinson's disease

Monday, December 7

10:45 am ‐11:45 am

385952 Grace Chun 3‐210 Rates of influenza vaccination over time for early/late adopting states: pharmacists right to vaccinate and diffusion of innovation

Monday, December 7

12:00 pm ‐ 1:00 pm

388248 Sandy Chung 5A‐320 Enriching student educational experience with the incorporation of IPPE interns in the medication reconciliation process upon patient admission

Tuesday, December 8

10:00 am ‐ 11:00 am

387538 Christopher Cicero 3‐277 Improving discharge medication counseling through the use of the Brief Health Literacy Screening (BHLS) tool

Monday, December 7

12:00 pm ‐ 1:00 pm

385304 Stephanie Cimoch 5B‐209 Retrospective Drug Utilization Review of Rivaroxaban for Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE)

Tuesday, December 8

11:30 am ‐ 12:30 pm

389336 Kerra Cissne 3‐143 Incidence and evaluation of naloxone administration in patients receiving hydromorphone

Monday, December 7

12:00 pm ‐ 1:00 pm

388399 Chrysanthia Claiborne 7‐178 Impact of educational intervention on knowledge of Human Papillomavirus among


8:30 am ‐ 9:30 am


33 | P a g e

Submission ID



high school junior and senior females.

388479 Jenna Clark 2‐186 Adherence to the 2013 American College of Cardiology (ACC)/American Heart Association (AHA) blood cholesterol guidelines: are we following recommendations for statin therapy?

Monday, December 7

10:45 am ‐11:45 am

388126 Kelsey Clark 2‐093 Assessment of pharmacy students' knowledge and level of preparedness for the roles they are expected to perform in relation to the topic of substance abuse

Monday, December 7

10:45 am ‐11:45 am

385226 Patricia Clark 3‐135 Affordability of healthcare amongst college students

Monday, December 7

12:00 pm ‐ 1:00 pm

387908 Lori Clauss 5B‐210 Healthy plate to manage weight Tuesday, December 8

11:30 am ‐ 12:30 pm

386033 Tyler Clay 5A‐336 Meds‐to‐Beds: A proposed workflow for daily operations of a hospital based bedside delivery program

Tuesday, December 8

10:00 am ‐ 11:00 am

389308 Zach Click 2‐281 Antibiotic therapy in a rare and resistant bacteria: aeromonas hydrophilia

Monday, December 7

10:45 am ‐11:45 am

389188 Cody Clifton 7‐179 Retrospective review of glyburide utilization patterns in the Mississippi Medicaid pharmacy program


8:30 am ‐ 9:30 am

389372 Bridget Cloonan 5B‐211 Vancomycin nomogram evaluation at a large teaching hospital

Tuesday, December 8

11:30 am ‐ 12:30 pm

389314 Cameron Cluff 5A‐099 Urinary kidney injury molecule‐1 (KIM‐1) as a marker of vancomycin associated kidney injury in rats.

Tuesday, December 8

10:00 am ‐ 11:00 am

383287 Hannah Cockrell 2‐371 A case of heparin‐induced hyponatremia

Monday, December 7

10:45 am ‐11:45 am

385296 Morgan Coffey 7‐012 Pharmacists impact on the health literacy of elementary school children


8:30 am ‐ 9:30 am


34 | P a g e

Submission ID



383243 Ryan Cole 7‐194 Patients confidence in pharmacy services and whether patients check prescriptions before they leave the pharmacy


8:30 am ‐ 9:30 am

386114 Mary Coleman 5B‐289 Gentamicin dosing in pediatric patients: a retrospective review of the clinical implications of extended interval dosing

Tuesday, December 8

11:30 am ‐ 12:30 pm

386502 Jennifer Collins 2‐372 Antimicrobial stewardship: considerations for primary care

Monday, December 7

10:45 am ‐11:45 am

389218 Meredith Collins 7‐013 Appropriateness of acid suppressing agent use in a community hospital: a retrospective review


8:30 am ‐ 9:30 am

382937 Ellen Colman 5B‐212 Design and assessment of pharmacists' role in a post‐acute care transitions program

Tuesday, December 8

11:30 am ‐ 12:30 pm

389369 Evan Colmenares 5A‐169 Utilizing student pharmacist interns in non‐traditional pharmacy administration roles

Tuesday, December 8

10:00 am ‐ 11:00 am

382713 Natasha Colvin 3‐300 Effectiveness of a comprehensive medication review (CMR) on patient education

Monday, December 7

12:00 pm ‐ 1:00 pm

387392 Kelsy Combs 5B‐290 Characterization of medication utilization in agitated delirious critically ill patients

Tuesday, December 8

11:30 am ‐ 12:30 pm

388327 Amanda Conenna 2‐248 Transition‐of‐care pharmacist impact on hospital readmissions and avoidable emergency visits

Monday, December 7

10:45 am ‐11:45 am

388020 Christopher Conkling 2‐373 Retrospective analysis of vancomycin goal trough attainment and incidence of acute kidney injury in hospitalized patients with pharmacist managed vancomycin dosing

Monday, December 7

10:45 am ‐11:45 am

386302 Bailey Constantine 5B‐150 Cost implications of the presence of an emergency medicine pharmacist during critical care patient

Tuesday, December 8

11:30 am ‐ 12:30 pm


35 | P a g e

Submission ID



resuscitation

385266 Gregory Cook 2‐282 Retrospective review of the treatment of Clostridium difficile at a community teaching hospital

Monday, December 7

10:45 am ‐11:45 am

387593 Katherine Cook 5A‐314 Retrospective analysis of missing and delayed medications in a level 1 trauma center emergency department

Tuesday, December 8

10:00 am ‐ 11:00 am

385598 Kathryn Cook 7‐180 What did we learn? A look into Mississippi's knowledge of the human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS)


8:30 am ‐ 9:30 am

386955 Aimee Cooke 3‐399 Evaluation of lactobacillus utilization during inpatient hospitalization at University of Washington Medical Center and Harborview Medical Center

Monday, December 7

12:00 pm ‐ 1:00 pm

386334 Kaitlin Cooper‐Johnson

5B‐398 Efficacy of amphotericin B bladder irrigation in the management of urinary tract infections caused by Candida species in anuric patients receiving continuous renal replacement therapy

Tuesday, December 8

11:30 am ‐ 12:30 pm

388526 Melissa Copley 2‐327 Inappropriate Discharge Asthma Exacerbation Therapy in Pediatric Patients Who Present to the Emergency Room

Monday, December 7

10:45 am ‐11:45 am

386736 Morgan Corbin 2‐374 Mannitol prescribing practices before and after an educational newsletter intervention

Monday, December 7

10:45 am ‐11:45 am

388079 Jessica Corio 3‐278 Predictors of successful aging: a survey of health behaviors and lifestyle satisfaction in older adults

Monday, December 7

12:00 pm ‐ 1:00 pm

386212 Morgan Corkish 5B‐291 Tolerability of evidence‐based heart failure medications and effect on outcomes in patients

Tuesday, December 8

11:30 am ‐ 12:30 pm


36 | P a g e

Submission ID



with continuous‐flow left ventricular assist devices

386168 Lauren Corry 2‐187 Demonstration of see‐saw effect in a patient with methacillin resistant s. aureus bacteremia

Monday, December 7

10:45 am ‐11:45 am

383167 Megan Corsi 5A‐295 Retrospective analysis of clinical response in children with severe immune thrombocytopenia undergoing treatment with intravenous immune globulin

Tuesday, December 8

10:00 am ‐ 11:00 am

387916 Manuel Cortez 7‐216 Human immunodeficiency virus (HIV) geno‐ and phenotypic mutation and antiretroviral therapy characterization in Kentucky


8:30 am ‐ 9:30 am

386208 Anna Cosnahan 5B‐292 Adherence to guideline‐based antimicrobial therapy for pneumonia in the emergency department

Tuesday, December 8

11:30 am ‐ 12:30 pm

388221 Alyssa Cosnek 2‐081 Pharmacists impact within the community setting: educating the safety of medication utilization in those with low health literacy

Monday, December 7

10:45 am ‐11:45 am

389002 Mariesa Cote 5B‐213 Appropriateness of discharge therapy and clinical characteristics of hospitalized cellulitis patients admitted through the emergency department (ED)

Tuesday, December 8

11:30 am ‐ 12:30 pm

386108 Joe Cotton 5A‐001 Impact on the utilization of total parental nutrition by pharmacist

Tuesday, December 8

10:00 am ‐ 11:00 am

388417 Eva Coulson 3‐385 Project Timeline: Helping P4 students in a clinically based pharmacy curriculum succeed in the residency application and match process.

Monday, December 7

12:00 pm ‐ 1:00 pm

386884 Cody Coulter 2‐375 Four‐factor inactivated prothrombin complex

Monday, December 7

10:45 am ‐11:45 am


37 | P a g e

Submission ID



concentrate use in a patient with prolonged major bleeding requiring INR reversal for urgent invasive surgery

385680 Melissa Coward 5A‐181 Correlation of medication therapy in chronic obstructive pulmonary disease patients with 30‐day readmission rates.

Tuesday, December 8

10:00 am ‐ 11:00 am

387935 Brooke Cowles 2‐114 Icosapent ethyl: new drug review and cost‐minimization analysis

Monday, December 7

10:45 am ‐11:45 am

388478 Christina Coy 2‐376 Implementation of updated palivizumab use guidelines to computerized physician order entry (CPOE) administration criteria at a childrens hospital

Monday, December 7

10:45 am ‐11:45 am

384747 William Coyne 5A‐196 Energy drinks: a survey of pharmacy student and faculty consumption and knowledge of ingredients

Tuesday, December 8

10:00 am ‐ 11:00 am

386320 Christopher Creary 3‐061 Are Haitian patients on warfarin more likely to experience labile INR results?

Monday, December 7

12:00 pm ‐ 1:00 pm

386887 Elizabeth Crish 3‐192 Evaluation of the implementation of delirium screening and a non‐pharmacologic delirium prevention protocol in intensive care units

Monday, December 7

12:00 pm ‐ 1:00 pm

388448 MacKenzie Crist 5A‐185 Assessing the immunogenicity of enteric acrylic polymers used in oral vaccines

Tuesday, December 8

10:00 am ‐ 11:00 am

387406 Amber Crites 2‐134 Evaluation on the use of methylnaltrexone in a community hospital

Monday, December 7

10:45 am ‐11:45 am

384574 Magen Cross 5B‐293 Risk factors for nephrotoxicity in children receiving vancomycin therapy

Tuesday, December 8

11:30 am ‐ 12:30 pm

388842 Caroline Cruce 5B‐017 The effect of postgraduate year 1 (PGY1) residency interviews on missed Advance Pharmacy Practice Experiences (APPEs)

Tuesday, December 8

11:30 am ‐ 12:30 pm


38 | P a g e

Submission ID



389573 joanel cruet 3‐062 Hepcidin modulation in human diseases

Monday, December 7

12:00 pm ‐ 1:00 pm

385617 Ashley Cubillos 3‐063 Description of micafungin prescribing within a multicenter community health system

Monday, December 7

12:00 pm ‐ 1:00 pm

386251 Jennifer Cullins 7‐181 Evaluation of publicly available automated blood pressure machines


8:30 am ‐ 9:30 am

389068 Caitlyn Cummings 2‐188 Enhancing interprofessional education between pharmacy and physician assistant students using human patient simulation

Monday, December 7

10:45 am ‐11:45 am

384554 Matthew Cummings 2‐045 Aprepitant as a treatment for delayed‐onset chemotherapy‐induced nausea and vomiting following a highly emetogenic preparative regimen with cyclophosphamide

Monday, December 7

10:45 am ‐11:45 am

385804 Jessica Cunio 3‐064 Implementation of a comprehensive tobacco cessation protocol in a student‐run free clinic: a retrospective, non‐comparative, interventional cohort study

Monday, December 7

12:00 pm ‐ 1:00 pm

387683 Gabriel Cuny 3‐007 Evaluation of clinical and patient reported outcomes in type 1 and type 2 diabetes patients using a 24‐hour insulin delivery device.

Monday, December 7

12:00 pm ‐ 1:00 pm

389136 Heather Curry 3‐301 Procalcitonin in infectious disease: procalcitonin rise associated with specific pathogens and increased risk of mortality and/or duration of hospital stay

Monday, December 7

12:00 pm ‐ 1:00 pm

386348 Emily Cushman 5B‐214 Addressing the opioid epidemic: survey and analysis of tools and resources in higher education

Tuesday, December 8

11:30 am ‐ 12:30 pm

386714 Laura Cwengros 7‐120 Evaluation of periprocedural anticoagulation management


8:30 am ‐ 9:30 am


39 | P a g e

Submission ID



provided by centralized service

388485 David Dadiomov 7‐121 Retinol binding protein 4 gene, insulin resistance, and metabolic syndrome in schizophrenia patients


8:30 am ‐ 9:30 am

388100 Mack Daeda 5B‐399 Pilot report assessing pharmacist‐led discharge medication counseling services at a 25‐bed critical access hospital

Tuesday, December 8

11:30 am ‐ 12:30 pm

387978 Morgan Dameron 5A‐264 Use of dipeptidyl peptidase‐4 inhibitors and the potential risk of pancreatic cancer: assessing the safety of an anti‐diabetic agent

Tuesday, December 8

10:00 am ‐ 11:00 am

387657 Alexis Dancy 2‐151 Evaluation of oral and intravenous vitamin K for warfarin reversal in hospitalized patients

Monday, December 7

10:45 am ‐11:45 am

389549 Diana Dang 5B‐294 Evaluation of pharmacist‐managed heparin anticoagulation protocol in patients with left ventricular assist devices

Tuesday, December 8

11:30 am ‐ 12:30 pm

389223 Huyen Dang 3‐319 Pharmacy students' perception of content delivered by non‐native English‐speaking professors (NNESP) on proper interpretation of educational material

Monday, December 7

12:00 pm ‐ 1:00 pm

388021 Judy Dang 5A‐013 Arizona pharmacists: attitudes regarding pharmacist‐based immunizations and requirements to immunize

Tuesday, December 8

10:00 am ‐ 11:00 am

388055 Amanda Daniels 5B‐140 Impact of interprofessional education on dental participants' perceptions of pharmacy student contributions on the Jamaica dental mission trip: a five‐year comparison

Tuesday, December 8

11:30 am ‐ 12:30 pm


40 | P a g e

Submission ID



386924 William Danko 7‐122 Comprehensive assessment of the effect of genetic polymorphisms in drug metabolizing enzymes and transporters on tamoxifen activation to endoxifen


8:30 am ‐ 9:30 am

388628 Danielle Dantuma 5A‐051 National survey of pharmacy services offered in student‐run free clinics

Tuesday, December 8

10:00 am ‐ 11:00 am

388341 Ann Dao 3‐211 Appropriateness of trimethoprim/sulfamethoxazole (TMP/SMX) for treatment of inpatients

Monday, December 7

12:00 pm ‐ 1:00 pm

387357 Kevin Darcy 5B‐018 Treatment of carbapenem resistant enterobacteriaceae pneumonia with a tetracycline and aminoglycoside antibiotic combination: case report

Tuesday, December 8

11:30 am ‐ 12:30 pm

386313 Elmira Darvish 7‐233 The impact of advanced pharmacy practice students completing the best possible medication history for patients admitted at a community hospital


8:30 am ‐ 9:30 am

388065 Viha Dave 3‐212 Unfractionated heparin infusion rates for critically ill versus non‐critically ill obese patients

Monday, December 7

12:00 pm ‐ 1:00 pm

387222 Mary Esper David 3‐163 Evaluation of the use of gastrointestinal prophylaxis in high‐risk patients on dual anti‐platelet therapy

Monday, December 7

12:00 pm ‐ 1:00 pm

389344 Tosin David 3‐136 Edoxaban: a new addition to the novel oral anticoagulant family

Monday, December 7

12:00 pm ‐ 1:00 pm

386103 Adrienne Davis 7‐014 Pharmacists utilization of available aids when counseling visually impaired patients


8:30 am ‐ 9:30 am

386665 Emily Davis 5A‐162 Identifying health disparities in adherence and medication beliefs to aromatase inhibitors among post‐menopausal women with breast cancer

Tuesday, December 8

10:00 am ‐ 11:00 am


41 | P a g e

Submission ID



388510 Nicole Davis 3‐302 Evaluating the financial burden on residency‐bound students and identifying potential cost saving opportunities

Monday, December 7

12:00 pm ‐ 1:00 pm

387344 Tate Davis 7‐182 Exploring the Pharmacist's Role in Assisting Patients in Monitoring Diabetes Mellitus


8:30 am ‐ 9:30 am

389295 John Day 5A‐081 Pharmacokinetics of oral fosfomycin during extended treatment courses

Tuesday, December 8

10:00 am ‐ 11:00 am

388670 Dominique DeBold 5A‐125 Insurance utilization management techniques may impede access to effective medication‐assisted therapy for opioid addiction

Tuesday, December 8

10:00 am ‐ 11:00 am

386556 Jason DeGooyer 5A‐290 Intravenous acetaminophen use in a large healthcare system since implementing formulary restrictions.

Tuesday, December 8

10:00 am ‐ 11:00 am

389595 Alaina DeKerlegand 5A‐112 Utilization of academic detailing to influence prescribing rates of prescription esomeprazole in a clinically integrated network

Tuesday, December 8

10:00 am ‐ 11:00 am

386682 Caitlin Delabar 2‐283 Intra‐aortic balloon pumps and thrombocytopenia: a risk assessment of duration of use

Monday, December 7

10:45 am ‐11:45 am

385822 Andrea DeLaney 5B‐019 Retrospective study of daptomycin use for the treatment of gram‐positive infections at a tri‐campus health system

Tuesday, December 8

11:30 am ‐ 12:30 pm

387459 Genevieve DeLuze 5A‐243 Impact of clinical pharmacy services on diabetes care at a federally qualified health center (FQHC)

Tuesday, December 8

10:00 am ‐ 11:00 am

389388 Ivonne DelValle 3‐065 A retrospective evaluation of the implementation of a patient‐centered approach for acute‐pain assessment and management in a health‐system.

Monday, December 7

12:00 pm ‐ 1:00 pm

386362 Luke Delzer 3‐008 Calcineurin inhibitor ‐ Monday, 12:00 pm ‐ 1:00 pm


42 | P a g e

Submission ID



nonsteroidal anti‐inflammatory drug interactions: outcomes associated with concurrent use

December 7

386389 Hannah DeMeritt 3‐400 Comparison of nephrotoxicity incidence in hospitalized patients exposed to vancomycin alone or vancomycin in combination with piperacillin‐tazobactam

Monday, December 7

12:00 pm ‐ 1:00 pm

388323 Mallory Demonch 5B‐295 Daptomycin use in adult vancomycin‐resistant enterococcus (VRE)‐colonized bone marrow transplant patients with febrile neutropenia

Tuesday, December 8

11:30 am ‐ 12:30 pm

386611 Tori DeMyer 5A‐321 Utilizing prephenate dehydratase on a microsensor to determine phenylalanine levels in an outpatient setting for patients with phenylketonuria

Tuesday, December 8

10:00 am ‐ 11:00 am

389615 Kailynn DeRonde 3‐009 Establishment of a medication acuity rating system at Childrens Hospital Colorado (CHCO): a quality improvement project, phase two

Monday, December 7

12:00 pm ‐ 1:00 pm

388201 Dharati Desai 5B‐097 Safety and tolerability of high dose protease inhibitors (atazanavir/ritonavir and lopinavir/ritonavir) in pregnant women with human immunodeficiency virus

Tuesday, December 8

11:30 am ‐ 12:30 pm

389460 Zankhana Desai 2‐189 Standard 14 day triple therapy vs. 10 day sequential therapy in H. pylori eradication: a systematic review and meta analysis

Monday, December 7

10:45 am ‐11:45 am

387840 Aaron Devanathan 3‐213 Comparative safety analysis of single and combination therapies for pulmonary arterial hypertension in a tertiary healthcare system

Monday, December 7

12:00 pm ‐ 1:00 pm


43 | P a g e

Submission ID



389264 Negin Deyhim 7‐234 Comparison of numeracy skills in pharmacist‐treated patients versus the standard of care


8:30 am ‐ 9:30 am

388058 Evan DeZeeuw 2‐284 Positive Impact of Telephonic Medication Therapy Management on Resolving Drug Therapy Related Problems

Monday, December 7

10:45 am ‐11:45 am

387485 Mehreen Dharsee 3‐214 Development of an HPLC assay for the prodrug tegafur and its parent drug 5‐fluorouracil for use in permeability and uptake studies with adenocarcinoma cells

Monday, December 7

12:00 pm ‐ 1:00 pm

382728 Jayant Dholaria 3‐066 Bending the curve: A three‐point plan to end the AIDS epidemic

Monday, December 7

12:00 pm ‐ 1:00 pm

389480 Matthew Dickson 5A‐230 Predicting CD34+ collection in autologous HCT with pre‐collection CD34+ counts with or without the use of plerixafor.

Tuesday, December 8

10:00 am ‐ 11:00 am

384665 Calvin Diep 2‐065 Assessing the appropriateness of venous thromboembolism prophylaxis and clinical consequences of over‐prophylaxis in low‐risk patients and moderate‐ or high‐risk patients with exceptions to chemical prophylaxis.

Monday, December 7

10:45 am ‐11:45 am

387019 Kimvi Diep 5A‐126 Identification and review of mobile platform applications related to pediatric vaccinations

Tuesday, December 8

10:00 am ‐ 11:00 am

387190 Emily Dionne 5A‐255 Improving discharge prescription workflow from an ambulatory surgical unit to an outpatient pharmacy: a systems‐based approach

Tuesday, December 8

10:00 am ‐ 11:00 am

388159 Allison Dipper 5B‐296 Effects of discontinuation of ACEI/ARB therapy in patients with elevated serum creatinine being treated for acute exacerbation of heart failure

Tuesday, December 8

11:30 am ‐ 12:30 pm


44 | P a g e

Submission ID



with reduced ejection fraction (HFrEF).

388781 Cassandra Dirks 7‐212 Development of a mock residency interview exercise for fourth year pharmacy students: a three year comparison


8:30 am ‐ 9:30 am

385873 Anupama Divakaruni 7‐082 Assessing the Need for Improved Strategies and Medication‐Related Education to Increase Adherence for Oral Anticancer Agents in the Young Adult (YA) Oncology Population


8:30 am ‐ 9:30 am

386697 Ellen Dixon 7‐183 Pain evaluation of blood glucose collection between the distal and proximal interphalangeal joints versus fingertip


8:30 am ‐ 9:30 am

385671 laurence Djatche 7‐083 Hyperkalemia in Hospitalized Patients with Heart Failure with Reduced Ejection Fraction


8:30 am ‐ 9:30 am

388265 Minh Do 3‐335 Impact of postoperative follow‐up visits on weight loss in Roux‐en‐Y gastric bypass surgery patients

Monday, December 7

12:00 pm ‐ 1:00 pm

385145 Thuy Hang Do 3‐067 Does distance determine performance: a comparison of a satellite campus vs. the traditional classroom

Monday, December 7

12:00 pm ‐ 1:00 pm

387694 Lyly Doan 7‐235 Comparison of clinical institute withdrawal assessment of alcohol scale, revised (CIWA‐Ar) plus scheduled tapered benzodiazepines to CIWA‐Ar alone in the treatment of alcohol withdrawal


8:30 am ‐ 9:30 am

384495 Lauren Dombrowski 5B‐376 Evaluation of ipratropium use in pediatric patients <2 years of age in a large academic medical center

Tuesday, December 8

11:30 am ‐ 12:30 pm

388290 Walter Domingo 2‐074 First case of Streptococcus equi bacteremia in Hawaii: a case report

Monday, December 7

10:45 am ‐11:45 am


45 | P a g e

Submission ID



386765 Kristen Dominick 5A‐265 Effects of efavirenz on ABCG2 expression in human carcinoma cell line MCF‐7

Tuesday, December 8

10:00 am ‐ 11:00 am

389143 Chris Donaldson 5B‐109 The role of interleukin‐2 receptor antagonists in maintenance immunosuppression for renal transplant patients: a single‐center experience

Tuesday, December 8

11:30 am ‐ 12:30 pm

388521 Daniel Dong 5B‐020 Evaluation of population pharmacokinetic vancomycin dosing and creatinine clearance among elderly patients

Tuesday, December 8

11:30 am ‐ 12:30 pm

389281 Raymond Dong 3‐336 Retrospective analysis of antimicrobial resistance patterns amongst pathogens isolated from abdominal surgery patients

Monday, December 7

12:00 pm ‐ 1:00 pm

387054 Vanessa Dorado 5A‐172 Improving Spanish language skills of healthcare professionals by implementing medical Spanish workshops

Tuesday, December 8

10:00 am ‐ 11:00 am

387888 Christine Doran 2‐348 Review and update of the electronic health record downtime policy and procedure for central pharmacy services at an academic medical center

Monday, December 7

10:45 am ‐11:45 am

385759 Himani Doshi 3‐215 Determining student pharmacists' perspectives on a geriatric interprofessional education (IPE) workshop

Monday, December 7

12:00 pm ‐ 1:00 pm

386954 Sona Doshi 3‐337 Structure Based Virtual Screening for Identification of Novel Hit Molecules for Sphingosine kinase‐1

Monday, December 7

12:00 pm ‐ 1:00 pm

389347 Amanda D'Ostroph 5A‐200 Preceptor perceptions of early immersion of student pharmacists in health‐system practice

Tuesday, December 8

10:00 am ‐ 11:00 am

388212 Brittany Dougherty 2‐082 Pharmacists role in optimizing medication education and safety in a rural environment

Monday, December 7

10:45 am ‐11:45 am


46 | P a g e

Submission ID



when faced with communication and education barriers

388735 Monica Dougherty 3‐279 Effect of heart failure interventions on heart failure hospitalizations and mortality

Monday, December 7

12:00 pm ‐ 1:00 pm

387003 Stephanie Dougherty 5B‐400 Venous thromboembolism (VTE) in lung transplant patients: Incidence, risk factors, and time to VTE

Tuesday, December 8

11:30 am ‐ 12:30 pm

385258 Bennett Doughty 3‐024 Effects of inpatient pharmacist collaborative practice dosing of warfarin compared to physician driven dosing in patients diagnosed with venous thromboembolism

Monday, December 7

12:00 pm ‐ 1:00 pm

388554 Jennifer Doughty 3‐144 A Cost Comparison of Breast Cancer Chemotherapy: Traditional Therapy vs. Sequencing‐Guided Therapy

Monday, December 7

12:00 pm ‐ 1:00 pm

382627 Andrea Douglas 5B‐021 Evaluation of guideline adherence to hepatitis b screening prior to rituximab therapy initiation

Tuesday, December 8

11:30 am ‐ 12:30 pm

386636 lynn dressler 5B‐362 Pharmacogenomic perceptions and knowledge base in the practice of pharmacy

Tuesday, December 8

11:30 am ‐ 12:30 pm

388486 Aulbrey Drisaldi 7‐236 Evaluation of the use of amikacin and tobramycin in adult cystic fibrosis patients at Virginia Commonwealth University (VCU) Health System


8:30 am ‐ 9:30 am

388413 Brett Driver 7‐015 Appropriate utilization of dual antiplatelet therapy (DAPT) in acute ischemic stroke or transient ischemic attack (TIA)


8:30 am ‐ 9:30 am

386768 Rose Duchane 2‐094 Evaluation of traditional and systemic lupus erythematosus (SLE) specific cardiovascular risk factors in SLE patients without antiphospholipid syndrome

Monday, December 7

10:45 am ‐11:45 am

388404 Kelli Dulaney 7‐184 Comparison of first and fourth‐ Wednesday, 8:30 am ‐ 9:30 am


47 | P a g e

Submission ID



grade student knowledge of pharmacist roles

December 9

389291 Jecedthel Dumpit 5A‐035 Evaluation of a pharmacist managed telephone pain clinic

Tuesday, December 8

10:00 am ‐ 11:00 am

385256 Carly Duncan 5B‐022 Optimizing functionality and efficiency in oncology treatment verification processes

Tuesday, December 8

11:30 am ‐ 12:30 pm

386338 Emily Dunn 7‐084 Evaluating a team‐based approach to improve health‐system navigation and efficiency in the treatment of hepatitis C virus (HCV)


8:30 am ‐ 9:30 am

385885 Leah Dunnells 2‐285 Determination of intravenous compatibility at a freestanding pediatric institution: insight into the decision‐making process

Monday, December 7

10:45 am ‐11:45 am

387034 An Duong 5B‐091 Evaluation of acute myeloid leukemia treatment at a community hospital

Tuesday, December 8

11:30 am ‐ 12:30 pm

386177 Arianne Duong 5A‐322 Incorporation of medication history collection into the IPPE student experience at the University of Washington Medical Center

Tuesday, December 8

10:00 am ‐ 11:00 am

385619 Linh Duong 5B‐297 Risk factors for readmission in patients with chronic obstructive pulmonary disease (COPD) in a large community teaching hospital

Tuesday, December 8

11:30 am ‐ 12:30 pm

389199 Thinh Duong 5B‐151 Compliance with the American Heart Association/American Stroke Association guidelines for management of acute ischemic stroke at Indiana University Health Methodist Hospital: a retrospective chart review

Tuesday, December 8

11:30 am ‐ 12:30 pm

388234 Uyen Duong 2‐046 Evaluating the safety and efficacy of enoxaparin in bridging mechanical circulatory support (MCS) patients from

Monday, December 7

10:45 am ‐11:45 am


48 | P a g e

Submission ID



subtherapeutic to therapeutic INR in an outpatient setting

388094 Mariah Durham 7‐061 Bosentan‐warfarin drug interaction: a series of three case reports


8:30 am ‐ 9:30 am

382618 Brittany Dustman 3‐216 Key program differences between university affiliated and non‐affiliated industry fellowship programs

Monday, December 7

12:00 pm ‐ 1:00 pm

385708 Alissa DuVall 5B‐391 Effects of team based learning on exam performance and overall course evaluation in pharmacotherapy courses at a school of pharmacy

Tuesday, December 8

11:30 am ‐ 12:30 pm

389148 Remington Easo 5B‐152 Medicare drug reimbursement pricing challenges faced by a non 340b satellite pharmacy outpatient infusion center

Tuesday, December 8

11:30 am ‐ 12:30 pm

387214 Jasmine Ebron 7‐085 Translating geriatric emergency department guidelines into practice: obstacles and opportunities


8:30 am ‐ 9:30 am

386020 Emily Eddy 5B‐215 Provider perception of ambulatory blood pressure monitoring: knowledge and barriers to referral

Tuesday, December 8

11:30 am ‐ 12:30 pm

385812 Emily Eddy 5B‐298 Evaluation of pegfilgrastim prescribing practices in outpatient clinic compared to National Comprehensive Cancer Network (NCCN) guidelines

Tuesday, December 8

11:30 am ‐ 12:30 pm

389273 Akesha Edwards 3‐068 Assessment of the role of the pharmacist in adherence to antiretroviral therapy in patients of Caribbean descent in South Florida

Monday, December 7

12:00 pm ‐ 1:00 pm

385157 Lauren Edwards 3‐145 Effectiveness of pre‐chemotherapy iron replacement at decreasing the need for transfusions during chemotherapy in gynecologic oncology patients

Monday, December 7

12:00 pm ‐ 1:00 pm


49 | P a g e

Submission ID



385369 William Edwards 7‐016 Frequency of diabetes screenings conducted during standard family medicine encounters


8:30 am ‐ 9:30 am

384793 Muhammad Effendi 2‐190 Use of intravenous lidocaine for acute pain secondary to renal colic

Monday, December 7

10:45 am ‐11:45 am

387302 Adam Ehalt 5B‐023 Evaluation of first‐year medical student perceptions of interprofessional educational experiences using the student perceptions of physician‐pharmacist interprofessional clinical education (SPICE) instrument

Tuesday, December 8

11:30 am ‐ 12:30 pm

389433 Sarah Eisho 7‐123 Assessment of adjusted body weight dosing of daptomycin in the obese population


8:30 am ‐ 9:30 am

388746 Jennifer Elfman 5B‐216 Evaluation of time to appropriate antibiotic administration in patients with severe sepsis and septic shock treated in an emergency department

Tuesday, December 8

11:30 am ‐ 12:30 pm

385620 Karem Elizondo 3‐338 Perceptions of weight and health choices in a US‐Mexico border community

Monday, December 7

12:00 pm ‐ 1:00 pm

385386 Amy Ellenburg 5B‐299 Impact of acyclovir dosing weight on the incidence of acute kidney injury

Tuesday, December 8

11:30 am ‐ 12:30 pm

386749 Samantha Ellingson 5B‐024 Impact on door‐to‐needle times in administration of alteplase with pharmacist presence on the stroke response team

Tuesday, December 8

11:30 am ‐ 12:30 pm

386151 Saba Emami 3‐321 (GT)n repeats in human genome: bioinformatics analysis and clinical implications

Monday, December 7

12:00 pm ‐ 1:00 pm

386398 Florence Emeka 5B‐110 Pre‐diabetes knowledge, perceptions and prevalence in the urban primary care clinic (PD‐KPP)

Tuesday, December 8

11:30 am ‐ 12:30 pm


50 | P a g e

Submission ID



387972 Samantha Emmons 2‐115 Evaluating the adherence of a high‐intensity heparin protocol in a community‐based hospital

Monday, December 7

10:45 am ‐11:45 am

389147 Nicole Endres 5A‐337 Implementation of a pharmacy department operated medication reconciliation program

Tuesday, December 8

10:00 am ‐ 11:00 am

389620 Taylor Epperson 5A‐113 Evaluation of alcohol consumption and smoking status among student pharmacists throughout the didactic curriculum

Tuesday, December 8

10:00 am ‐ 11:00 am

386409 Kendyll Erickson 7‐124 Benzodiazepine use and falls in the elderly


8:30 am ‐ 9:30 am

388696 Alexandria Ernst 2‐377 Intensive interdisciplinary diabetes intervention in an underserved, multiethnic population

Monday, December 7

10:45 am ‐11:45 am

389237 Haley Ervin 5B‐025 Evaluation of the safety of adjunctive dexmedetomidine in alcohol withdrawal

Tuesday, December 8

11:30 am ‐ 12:30 pm

386367 Erielle Anne Espina 5B‐111 Piperacillin/tazobactam time to redosing at the transition of care between the emergency department and inpatient care

Tuesday, December 8

11:30 am ‐ 12:30 pm

388347 Kristina Esposito 3‐280 Retrospective evaluation of therapeutic activated partial thromboplastin time (aPTT) in obese patients treated with unfractionated heparin (UFH)

Monday, December 7

12:00 pm ‐ 1:00 pm

382612 Mary Estess 5A‐002 Implementation of electronic documentation and wasting to reduce controlled substance drip discrepancies in the pediatric intensive care unit

Tuesday, December 8

10:00 am ‐ 11:00 am

387405 Elana Evans 5B‐300 Evaluation of the financial impact from implementing a LEAN principle to help reduce missing dose rates at a large, academic medical center

Tuesday, December 8

11:30 am ‐ 12:30 pm

389222 Rebecca Evers 7‐125 Pre‐transplantation colonization of clostridium


8:30 am ‐ 9:30 am


51 | P a g e

Submission ID



difficile and rates of graft‐versus‐host‐disease

387735 Kimberly Ezeama 3‐281 Addition of behavioral activation therapy to standard shared medical appointments (SMA) for patients with both depression and type 2 diabetes: a randomized controlled pilot study

Monday, December 7

12:00 pm ‐ 1:00 pm

387352 Elizabeth Ezell 5A‐003 Assessment of physician and medical trainee perceptions toward clinical pharmacy faculty

Tuesday, December 8

10:00 am ‐ 11:00 am

382603 Amanda Faber 5A‐173 Evaluating the efficacy and student perception of residency preparation program activities

Tuesday, December 8

10:00 am ‐ 11:00 am

388392 Rhiannon Facchinei 2‐378 Implementation of 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults (ACC/AHA 2013 Guidelines) in an outpatient setting

Monday, December 7

10:45 am ‐11:45 am

387704 Christopher Fagbote 5A‐127 Obesity overview and management: a comprehensive approach to a complex issue

Tuesday, December 8

10:00 am ‐ 11:00 am

385717 Colin Fahey 5A‐232 Involvement of pharmacy in admission and discharge medication review to improve patient outcomes in the inpatient setting

Tuesday, December 8

10:00 am ‐ 11:00 am

386877 Martin Faidian 2‐013 Pharmacists use and rationale for use of over‐the‐counter and herbal products

Monday, December 7

10:45 am ‐11:45 am

385670 Tara Fallah 2‐272 Effect of a sedation and withdrawal protocol on overall sedative exposure during intubation in the pediatric intensive care unit

Monday, December 7

10:45 am ‐11:45 am

389434 Jenna Fancher 5A‐244 Management of a student‐implemented anticoagulation initiative: an example of

Tuesday, December 8

10:00 am ‐ 11:00 am


52 | P a g e

Submission ID



leadership

386130 Frank Fanizza 5B‐301 Characterization of off‐label use of tocilizumab at an academic medical center

Tuesday, December 8

11:30 am ‐ 12:30 pm

387765 Naima Farah 3‐069 HIV medication adherence Monday, December 7

12:00 pm ‐ 1:00 pm

389330 Reem Farooq 5B‐112 Formulation and Evaluation of Fast Dissolving Film of Metoclopramide

Tuesday, December 8

11:30 am ‐ 12:30 pm

386806 Kristle Farquharson 2‐191 Order‐set changes aimed at improving appropriate prescribing in the elderly

Monday, December 7

10:45 am ‐11:45 am

389365 Stacy Farry 7‐017 Impact of Virtual Acute Care for Elders (ACE) training on high‐risk medication use in older adult inpatients


8:30 am ‐ 9:30 am

388050 Antonia Fawaz 3‐070 Cost savings analysis of a premixed total parenteral nutrition formula compared to customized parenteral nutrition at a large community hospital

Monday, December 7

12:00 pm ‐ 1:00 pm

388742 Rana Fayad 7‐126 Clinical impact of once‐daily versus twice‐daily ceftriaxone for children with pneumonia


8:30 am ‐ 9:30 am

388493 Victoria Felder 3‐339 Impact of increased total body weight on the occurrence of nephrotoxicity in patients with gram‐negative bacteremia

Monday, December 7

12:00 pm ‐ 1:00 pm

385605 Megan Fenney 3‐340 Antidepressant use post‐stroke in a rural home health population

Monday, December 7

12:00 pm ‐ 1:00 pm

386952 Melissa Ferguson 5A‐233 Comparing three eras of hepatic coagulopathy normalization using coagulation factor concentrates

Tuesday, December 8

10:00 am ‐ 11:00 am

388305 Erica Ferreris 7‐200 Safety of complementary alternative medicine in juvenile idiopathic arthritis patients


8:30 am ‐ 9:30 am

389044 Jamie Fery 2‐192 Pharmacy Students' Perspective on Motivational Factors in a Didactic Setting

Monday, December 7

10:45 am ‐11:45 am


53 | P a g e

Submission ID



387880 Andrea Fetea 3‐341 Evaluation of bivalirudin's effect on the international normalized ratio (INR) to determine an appropriate strategy for transitioning to warfarin

Monday, December 7

12:00 pm ‐ 1:00 pm

388665 Charlotte Fielding 5B‐373 Interprofessional education: students from eight healthcare disciplines working together via video conferencing

Tuesday, December 8

11:30 am ‐ 12:30 pm

388583 Amanda Finch 5B‐145 Comparing time to achieve therapeutic tacrolimus levels between once‐daily extended‐release and twice‐daily immediate‐release tacrolimus formulations in de novo kidney transplant recipients.

Tuesday, December 8

11:30 am ‐ 12:30 pm

387460 Brian Fisette 5B‐351 Bleeding and venous thromboembolism outcomes associated with perioperative tranexamic acid use in elective orthopedic surgery

Tuesday, December 8

11:30 am ‐ 12:30 pm

387876 Michelle Fishburn 3‐295 Optimizing subcutaneous anticoagulants for venous thromboembolism prophylaxis in obese patients in a community hospital

Monday, December 7

12:00 pm ‐ 1:00 pm

387931 Douglas Fisher 5B‐153 Electronic nicotine delivery systems: assessing knowledge and perceptions of e‐cigarettes as potential smoking cessation aids

Tuesday, December 8

11:30 am ‐ 12:30 pm

386897 Jonathan Fisher 5A‐257 Reliability of hospital antibiograms for guidance in empiric therapy of hospital‐acquired Pseudmonas aeruginosa infections

Tuesday, December 8

10:00 am ‐ 11:00 am

386038 Bryan Fitzgerald 2‐193 Pain and pain medication use in patients with myotonic dystrophy (DM) and facioscapulohumeral muscular dystrophy (FSHD)

Monday, December 7

10:45 am ‐11:45 am

386629 Sarah Fitzpatrick 5B‐154 Evaluation of risk factors for Tuesday, 11:30 am ‐ 12:30 pm


54 | P a g e

Submission ID



COPD hospital readmission December 8

386044 Andrea Flanagan 7‐213 Impact of the initiation of statistics reviews into student run journal club


8:30 am ‐ 9:30 am

388073 Ryan Fleer 3‐386 Implementation of a medication reconciliation process in an ambulatory oncology clinic

Monday, December 7

12:00 pm ‐ 1:00 pm

387730 Lauren Flieller 3‐342 Herpes simplex encephalitis: an important consideration in patients with persistent altered mental status of unknown etiology

Monday, December 7

12:00 pm ‐ 1:00 pm

384317 Karen Fong 3‐071 Daptomycin medication use evaluation for dosing and administration considerations

Monday, December 7

12:00 pm ‐ 1:00 pm

389151 Dione Foon 7‐237 Outpatient antibiotic prescribing patterns of acute upper respiratory tract infections in children


8:30 am ‐ 9:30 am

385618 Megan Ford 3‐072 Brand versus generic medications: a disease state approach to identify patients' perceptions and concerns

Monday, December 7

12:00 pm ‐ 1:00 pm

386201 Alison Forrest 5A‐144 Retrospective evaluation of glycemic control at a rural community hospital

Tuesday, December 8

10:00 am ‐ 11:00 am

386495 Marisa Fortunato 5B‐026 Evaluating the effects of intravenous ascorbic acid on epoetin alfa use in hemodialysis patients

Tuesday, December 8

11:30 am ‐ 12:30 pm

387494 Hope Foskey 5B‐027 Evaluation of recommendations and criteria for use for palivizumab at Children's Hospital of Georgia

Tuesday, December 8

11:30 am ‐ 12:30 pm

389219 fomanyi fossoh 3‐343 Association of serum creatinine within twenty‐four hours of admission to the intensive care unit and in‐hospital mortality among surgical intensive care unit patients

Monday, December 7

12:00 pm ‐ 1:00 pm


55 | P a g e

Submission ID



387177 Alexandra Foster 5B‐155 Evaluation of systemic lidocaine use for pain at St. Vincent Indianapolis Hospital

Tuesday, December 8

11:30 am ‐ 12:30 pm

384353 Suzanne Fote 5A‐174 Measured benefits of adopting a standardized aminoglycoside protocol

Tuesday, December 8

10:00 am ‐ 11:00 am

386145 Jenna Foyt 7‐018 In vitro effects of herbal supplements and components on aromatase activity


8:30 am ‐ 9:30 am

382529 Ashley Francis 3‐421 Evaluation of diabetic patient care in comparison to american diabetes association (ADA) guideline recommendations

Monday, December 7

12:00 pm ‐ 1:00 pm

384564 Miguel Franquiz 7‐086 Facilitating hospice transitions of care in oncology: evaluation of pharmacists interventions.


8:30 am ‐ 9:30 am

389015 Kimberly Frantz 3‐217 A unique institutional program for evaluation of innovative medication use in a pediatric tertiary care center

Monday, December 7

12:00 pm ‐ 1:00 pm

387934 Stephanie Free 5B‐418 Cytomegalovirus immune globulin use in the solid organ transplant population: a single center's experience

Tuesday, December 8

11:30 am ‐ 12:30 pm

385806 Sari Freedman 5B‐302 Evaluation of the use of granulocyte‐colony stimulating factor (G‐CSF) following allogeneic hematopoietic stem cell transplant (alloHCT): Clinical and economic outcomes

Tuesday, December 8

11:30 am ‐ 12:30 pm

389516 Jocelyn Freimuth 5A‐054 Refining palliative care for chronic obstructive pulmonary disease patients

Tuesday, December 8

10:00 am ‐ 11:00 am

388101 Joellen Friedman 3‐267 Evaluating cultural competence in advanced pharmacy practice experience (APPE) PharmD students on direct patient care rotations

Monday, December 7

12:00 pm ‐ 1:00 pm

386838 Kimberly Friend 5B‐028 Outcomes of bipolar versus unipolar depression patients being treated with antidepressants admitted to a

Tuesday, December 8

11:30 am ‐ 12:30 pm


56 | P a g e

Submission ID



behavioral care unit at a large tertiary care teaching hospital

387914 Jennifer Froomkin 7‐127 Continuity of care in human immunodeficiency virus (HIV) outpatient therapy


8:30 am ‐ 9:30 am

386883 Frances Shuk Kwan

Fu 2‐286 What is the perception of pharmacy students and colleges of pharmacy, regarding the mental health resources available to pharmacy students in the United States?

Monday, December 7

10:45 am ‐11:45 am

387804 Quanhao Fu 5A‐182 Barriers to student pharmacists involvement in advocacy‐related initiatives

Tuesday, December 8

10:00 am ‐ 11:00 am

388480 Katie Fulks 5B‐029 4‐factor prothrombin complex concentrate (4‐PCC) versus fresh frozen plasma (FFP) in treatment of warfarin associated intracranial hemorrhage (ICH)

Tuesday, December 8

11:30 am ‐ 12:30 pm

382555 Katherine Fuller 7‐019 Implementation of a Pharmacy Student‐Driven Inpatient Inhaler Counseling Service for COPD and Asthma Patients


8:30 am ‐ 9:30 am

385170 Nathan Fuller 3‐422 Evaluation of treatment aimed at skin and soft tissue infections in a community hospital

Monday, December 7

12:00 pm ‐ 1:00 pm

383089 Jesse Fulmer 3‐320 Weight‐based levetiracetam dosing for seizure prophylaxis in neurocritical care patients

Monday, December 7

12:00 pm ‐ 1:00 pm

384619 Krissa Funes 3‐218 Topiramate induced nephrolithiasis

Monday, December 7

12:00 pm ‐ 1:00 pm

389506 Daniel Fung 3‐164 Closing the gap: An in‐depth analysis on the impact of electronic interventions on post‐myocardial infarction patient outcomes

Monday, December 7

12:00 pm ‐ 1:00 pm

389418 Gabrielle Furgiuele 3‐303 Twitter evaluation and extension of pharmacy study group (TWEEPS): an evaluation of hydrocodone

Monday, December 7

12:00 pm ‐ 1:00 pm

389427 Mackenzie Gabel 3‐344 Rise of liquid nicotine toxicity Monday, 12:00 pm ‐ 1:00 pm


57 | P a g e

Submission ID



from electronic cigarette solutions in the pediatric population

December 7

387416 Veena Gadepalli 7‐218 Docking studies on Leonotis leonurus and Leonurus cardiaca derived compounds for their potential activity at CB1 and CB2


8:30 am ‐ 9:30 am

387504 Kelly Gaffney 2‐287 Standardized workflow development for a decentralized pharmacy model in a community hospital

Monday, December 7

10:45 am ‐11:45 am

389406 Priyanka Gaitonde 5A‐145 Pharmacy program characteristics influencing post graduate year 1 (PGY1) residency match rates

Tuesday, December 8

10:00 am ‐ 11:00 am

385640 Mineille Gakuu 5A‐146 Medication use evaluation of patient controlled analgesia (PCA)

Tuesday, December 8

10:00 am ‐ 11:00 am

383966 Isabelle Gallagher 3‐073 The Description of Incidence of Hospital Onset Clostridium difficile Infection after Antimicrobial Therapy

Monday, December 7

12:00 pm ‐ 1:00 pm

385218 Carolyn Gallets 3‐345 Case report of an infection caused by Vibrio vulnificus in the Gulf of Mexico

Monday, December 7

12:00 pm ‐ 1:00 pm

387954 Carl Garcia 3‐025 Evaluation of antimicrobial stewardship interventions: are prescribers choosing the optimal indication when prescribing antimicrobials for children?

Monday, December 7

12:00 pm ‐ 1:00 pm

387032 Nancy Garcia 2‐032 Intravenous chlorothiazide use in pediatric patients

Monday, December 7

10:45 am ‐11:45 am

389437 Olga Garcia 5B‐156 Implementation of a community pharmacy back‐to‐school immunization clinic

Tuesday, December 8

11:30 am ‐ 12:30 pm

388173 Michelle Garfunkel 2‐014 Evaluation of newer drug therapies for hepatitis C at a specialty pharmacy

Monday, December 7

10:45 am ‐11:45 am

386016 Steven Garguilo 5B‐217 Probable case of proton pump inhibitor (PPI)‐induced

Tuesday, December 8

11:30 am ‐ 12:30 pm


58 | P a g e

Submission ID



hypomagnesaemia

389425 Carolyn Garland 5B‐352 Analysis of the impact of pharmacy on cardiology readmissions through the UNC transitions of care program

Tuesday, December 8

11:30 am ‐ 12:30 pm

388078 Aleksey Garmaza 5A‐055 Impact of pharmacy students in local community on prescription drug diversion and promotion of proper drug disposal

Tuesday, December 8

10:00 am ‐ 11:00 am

389258 Ryan Garner 7‐238 Comparison of compounding kits with traditional compounding methods for omeprazole suspensions using an educational activity


8:30 am ‐ 9:30 am

384477 Liana Garza 5A‐280 Pharmacy in the hood: a program evaluation of a summer camp promoting the pharmacy profession to high school students

Tuesday, December 8

10:00 am ‐ 11:00 am

389335 Stephanie Garza 3‐346 Interprofessional treatment of synthetic cannabinoid withdrawals

Monday, December 7

12:00 pm ‐ 1:00 pm

389202 Sara Gattis 7‐020 Professional organization involvement in the transition from student pharmacist to new practitioner


8:30 am ‐ 9:30 am

387832 Sarah Gattoline 5B‐218 Anticoagulant utilization for acute venous thromboembolism in younger adult patients

Tuesday, December 8

11:30 am ‐ 12:30 pm

388391 Erin Gaughran 2‐249 Safety profile of haloperidol lactate administered intravenously in hospitalized patients

Monday, December 7

10:45 am ‐11:45 am

388680 Melissa Gaul 2‐135 Evaluation of a pneumococcal vaccine protocol at an urban health system

Monday, December 7

10:45 am ‐11:45 am

386227 Nicholas Gazda 5B‐303 Evaluation for the potential implementation of an inpatient Medication Therapy Management (MTM) pilot

Tuesday, December 8

11:30 am ‐ 12:30 pm


59 | P a g e

Submission ID



program at a community teaching hospital

387361 Nina Gazonas 5A‐323 Transitions from post‐surgical patient controlled epidural analgesia (PCEA) to oral opioids: a comparison of different approaches

Tuesday, December 8

10:00 am ‐ 11:00 am

385422 Dan Ge 7‐075 Dosing of Target‐Specific Oral Anticoagulants in Special Populations


8:30 am ‐ 9:30 am

384568 Lu Ge 2‐341 Efficacy of using plerixafor in an algorithm‐based approach in multiple myeloma or lymphoma patients

Monday, December 7

10:45 am ‐11:45 am

388547 Melanie Geiszler 5B‐219 A review of antidepressant induced sexual dysfunction in females

Tuesday, December 8

11:30 am ‐ 12:30 pm

387292 Andrew Gentry 3‐026 Identification of common risk factors for cefepime‐ and piperacillin/tazobactam resistant gram negative infections

Monday, December 7

12:00 pm ‐ 1:00 pm

388621 Mary Katherine

Gentry 7‐021 Clinical services provided by inpatient pharmacies in Alabama


8:30 am ‐ 9:30 am

387509 Victoria Germinario 2‐379 Magnesium repletion in the emergency department: a description of current practices

Monday, December 7

10:45 am ‐11:45 am

389400 Amanda Gertz 2‐194 Evaluation of the proper administration and counseling by healthcare professions of intranasal mupirocin for methicillin‐resistant Staphylococcus aureus decolonization

Monday, December 7

10:45 am ‐11:45 am

389567 Sandra Ghaly 5A‐056 Concomitant use of amphetamines and alcohol leading to myocardial infarction in minors

Tuesday, December 8

10:00 am ‐ 11:00 am

389598 Patty Ghazvini 3‐074 Over utilization of over the counter medications in college aged students

Monday, December 7

12:00 pm ‐ 1:00 pm


60 | P a g e

Submission ID



388024 Nishi Ghelani 3‐219 Complementary and alternative medicine education in pharmacy schools in the United States

Monday, December 7

12:00 pm ‐ 1:00 pm

389457 Josephine Giang 3‐010 A retrospective analysis of the use of daptomycin

Monday, December 7

12:00 pm ‐ 1:00 pm

389165 Kevin Giang 2‐015 Impact of a pharmacist‐led multidisciplinary versus a pharmacist‐only student smoking cessation clinic on student knowledge and learning.

Monday, December 7

10:45 am ‐11:45 am

389248 Amanda Gibson 3‐220 Student‐led initiative to further develop the pharmacy student as a communicator and educator

Monday, December 7

12:00 pm ‐ 1:00 pm

388108 Jessie Gil 3‐075 Observation of elevated bilirubin in street drug users

Monday, December 7

12:00 pm ‐ 1:00 pm

386694 Jenna Gilbert 5B‐157 Evaluation of environmental aerosolized disinfectant systems versus ultraviolet disinfectant systems as a pharmacy‐directed antimicrobial stewardship initiative

Tuesday, December 8

11:30 am ‐ 12:30 pm

389006 Austin Ginn 5B‐269 Adequacy of cephalexin compared to first‐line recommended antimicrobials for acute uncomplicated cystitis treated in the emergency department

Tuesday, December 8

11:30 am ‐ 12:30 pm

387902 Brianne Giordano 3‐282 Implementation of new antibiotic stewardship recommendations in the long term care setting

Monday, December 7

12:00 pm ‐ 1:00 pm

386692 Natalie Giron 5B‐030 Comparison of outcomes utilizing three different severity scores for Clostridium difficile infections

Tuesday, December 8

11:30 am ‐ 12:30 pm

386975 Brett Glasheen 3‐283 Assessment of prescribing practices and adherence to a guideline for venous

Monday, December 7

12:00 pm ‐ 1:00 pm


61 | P a g e

Submission ID



thromboembolism (VTE) prophylaxis in patients with trauma

387811 Megan Glasheen 2‐136 The role of basiliximab induction in post‐liver transplantation

Monday, December 7

10:45 am ‐11:45 am

382548 Joseph Goble 7‐087 Target‐specific oral anticoagulants (TSOAC): evaluation of prescribing patterns and safety in a Veteran population


8:30 am ‐ 9:30 am

388374 Daphne Goewey 5B‐113 Tirofiban, a glycoprotein IIb/IIIa inhibitor, in percutaneous coronary intervention

Tuesday, December 8

11:30 am ‐ 12:30 pm

386559 Ankit Gohel 5B‐220 Ovarian Cancer Outcomes In Patients With Type 2 Diabetes Mellitus

Tuesday, December 8

11:30 am ‐ 12:30 pm

386499 Charles Golding 2‐333 Evaluation of Neuromuscular Blocker Continuous infusions in Critically Ill Infants and Children

Monday, December 7

10:45 am ‐11:45 am

382724 Joseph Gomez 5B‐114 Impact of a cardiac surgery preoperative medication history program performed by pharmacy students

Tuesday, December 8

11:30 am ‐ 12:30 pm

386939 Sylvia Gomez 2‐154 Impact of blood pressure education and monitoring by student pharmacists on members of an urban American Indian health center in western Montana.

Monday, December 7

10:45 am ‐11:45 am

383011 Andrew Good 5A‐296 Utilizing pharmacy students to change practice in an infusion center administering parenteral bisphosphonates

Tuesday, December 8

10:00 am ‐ 11:00 am

386506 Angela Goodhart 5A‐222 Evaluation of decentralized pharmacists work load through direct observation at a large academic medical institution

Tuesday, December 8

10:00 am ‐ 11:00 am

386256 Jamicia Gordon 3‐076 Pharmacists impact on body mass index through lifestyle fitness and education (PhITLiFE)

Monday, December 7

12:00 pm ‐ 1:00 pm

385233 Sara Gordon 7‐022 Pharmacist interventions Wednesday, 8:30 am ‐ 9:30 am


62 | P a g e

Submission ID



through discharge medication reconciliation

December 9

388515 Jessica Grahl 5B‐031 Evaluation of the incidence of hypoglycemia in critically ill patients receiving insulin therapy at a large academic institution

Tuesday, December 8

11:30 am ‐ 12:30 pm

387912 Brittany Grant 3‐077 Implementation of a comprehensive medication reconciliation process utilizing pharmacy technicians, interns and students

Monday, December 7

12:00 pm ‐ 1:00 pm

385760 Fran Grappe 7‐023 Financial savings through a closed formulary and inventory control in a student‐run free clinic


8:30 am ‐ 9:30 am

385141 Molly Grasberger 5B‐158 Impact of a PCR‐based rapid influenza diagnostic test on concomitant antibiotic utilization in patients with suspected influenza

Tuesday, December 8

11:30 am ‐ 12:30 pm

386470 Erica Grasso 5B‐221 Diabetes complications with organ implications

Tuesday, December 8

11:30 am ‐ 12:30 pm

386424 Alison Gravelin 7‐128 Use of an educational video to improve patient understanding of apixaban


8:30 am ‐ 9:30 am

386711 Kristen Gray 5B‐304 Pre‐post analysis on the impact of optimizing automated dispensing cabinets on nursing satisfaction and efficiency

Tuesday, December 8

11:30 am ‐ 12:30 pm

385426 Amanda Grear 2‐016 Evaluating an APPE assessment tool using electronic surveys to assess preceptor attitudes and implementing improvements to more accurately measure student achievement

Monday, December 7

10:45 am ‐11:45 am

386137 Alexandra Greco 5B‐377 Evaluation of liposomal bupivacaine use at a large rural academic teaching hospital

Tuesday, December 8

11:30 am ‐ 12:30 pm

386036 Chelsea Green 3‐078 Medication use evaluation of vitamin K in the setting of vitamin K antagonist (VKA)

Monday, December 7

12:00 pm ‐ 1:00 pm


63 | P a g e

Submission ID



reversal

385853 Melissa Green 2‐137 Evaluation of proton pump inhibitor use in variceal hemorrhage

Monday, December 7

10:45 am ‐11:45 am

389420 Eric Gregory 5B‐159 Assessing the significance and perception of the medication therapy consultant (MTC) in the Butler University Community Outreach Pharmacy (BUCOP)

Tuesday, December 8

11:30 am ‐ 12:30 pm

387688 Jennifer Gregory 7‐129 Blood pressure management of intracerebral hemorrhagic patients in a community teaching hospital


8:30 am ‐ 9:30 am

388288 Kym Gregory 3‐041 Topical analgesic compound for musculoskeletal pain relief; an observational survey based study

Monday, December 7

12:00 pm ‐ 1:00 pm

387007 Hannah Greivenkamp 3‐221 Health education and recovery together (HEART): implementation of health education classes in substance abuse rehabilitation

Monday, December 7

12:00 pm ‐ 1:00 pm

382528 Cassia Griswold 2‐017 Evaluation of student and hospital administrator perceptions of student involvement in completion of community health needs assessments

Monday, December 7

10:45 am ‐11:45 am

387561 Kye Grooms 5B‐305 Safe and effective use of metformin in type 2 diabetes

Tuesday, December 8

11:30 am ‐ 12:30 pm

385990 Kyle Grose 3‐146 Cost Comparison Of Personalized Genomic Therapy Versus Standard Chemotherapy In Metastatic Breast Cancer Patients

Monday, December 7

12:00 pm ‐ 1:00 pm

385895 Riley Grubbs 2‐155 Enabling clinically relevant drug‐allergy and drug‐drug interaction alerts for physicians

Monday, December 7

10:45 am ‐11:45 am

389368 Kayla Grzybowski 2‐360 Is ezetimibe prescribing keeping up with the evidence?

Monday, December 7

10:45 am ‐11:45 am

388016 Fatima Guadamuz 3‐079 Evaluating the utilization of ertapenem and compliance of

Monday, December 7

12:00 pm ‐ 1:00 pm


64 | P a g e

Submission ID



prescribing restrictions set in place at a community hospital

388360 Ethan Gudger 5B‐032 Thirty‐day readmission rates in patients with acute myocardial infarction and concurrent depression in a tertiary teaching hospital

Tuesday, December 8

11:30 am ‐ 12:30 pm

388917 Marissa Guillen 2‐288 Renal dysfunction associated with piperacillin‐tazobactam

Monday, December 7

10:45 am ‐11:45 am

387290 Alexander Guimaraes 2‐075 A Qualitative Analysis of E‐cigarette Use Among College Students in Hawaii: A Focus on Reduction Strategies

Monday, December 7

10:45 am ‐11:45 am

385851 Savannah Gulley 7‐062 Clonidine use for dexmedetomidine withdrawal in the pediatric intensive care unit


8:30 am ‐ 9:30 am

387173 Ilios Guma 2‐250 Evaluation of hydrocortisone dose and duration in the treatment of septic surgical intensive care patients

Monday, December 7

10:45 am ‐11:45 am

386612 Vidhi Gupta 5A‐014 Comparing the efficiency and accuracy of health information exchange to the traditional process of medication reconciliation during admission at the Pima County adult detention complex

Tuesday, December 8

10:00 am ‐ 11:00 am

383728 Carmen Gust 5A‐171 Strategy for improvement of monthly hospital unit inspection quality and percent completion

Tuesday, December 8

10:00 am ‐ 11:00 am

386107 Maria Gustafsson 7‐001 Pharmacist intervention significantly reduced the risk of drug‐related readmissions among old people with dementia a randomized controlled trial


8:30 am ‐ 9:30 am

388833 Anne Guthrie 7‐063 Evaluating use of Crotalidae Polyvalent Immune Fab Antivenom for implementation in an enterprise‐wide drug


8:30 am ‐ 9:30 am


65 | P a g e

Submission ID



profile

387002 Alfredo Guzman 3‐002 Clinical pharmacy interventions to reduce morphine equivalent dose in chronic noncancer pain.

Monday, December 7

12:00 pm ‐ 1:00 pm

385558 Lilien Guzman 3‐137 Are practitioners more prone to using the ACC/AHA cholesterol treatment guidelines vs. the ATP III cholesterol treatment guidelines to treat patients with hypercholesterolemia?

Monday, December 7

12:00 pm ‐ 1:00 pm

389635 Mayra Guzman 5A‐015 Unexpected result of asthma education on high‐risk patients

Tuesday, December 8

10:00 am ‐ 11:00 am

388015 Morgan Gwynn 7‐024 Evaluation of guideline compliance when treating patients with febrile neutropenia


8:30 am ‐ 9:30 am

387027 Phu Ha 5A‐147 Evaluating time to therapeutic trough for intravenous vancomycin in hospitalized patients.

Tuesday, December 8

10:00 am ‐ 11:00 am

388140 Bradley Haan 7‐130 Evaluation of a heparin infusion dosing protocol during therapeutic hypothermia


8:30 am ‐ 9:30 am

387179 Meghan Hackerson 2‐289 Patients perception of student pharmacist growth during a 3 year longitudinal patient care project

Monday, December 7

10:45 am ‐11:45 am

385577 Christina Haddad 7‐088 Unique treatment approaches for the treatment of a multidrug resistant Pseudomonas aeruginosa infection


8:30 am ‐ 9:30 am

382524 Cynthia Hager 5A‐341 Daptomycin use at an academic medical center

Tuesday, December 8

10:00 am ‐ 11:00 am

387136 Robert Hakim 5B‐401 Evaluation of a warfarin drug interaction reporting system in an anticoagulation clinic setting and outcomes on supratherapeutic international normalized ratios (INRs)

Tuesday, December 8

11:30 am ‐ 12:30 pm

389106 Ashley Hall 3‐001 Treatment experience with triple negative breast cancer at

Monday, December 7

12:00 pm ‐ 1:00 pm


66 | P a g e

Submission ID



a comprehensive cancer center

388052 Kevin Hall 5B‐033 Prevalence and predictors of factors associated with reduced mortality after administration of 4‐factor prothrombin complex concentrate at a large academic institution

Tuesday, December 8

11:30 am ‐ 12:30 pm

386123 Jared Ham 3‐304 Effect of continuous versus intermittent nafcillin on clinical outcomes in patients with methicillin‐susceptible Staphylococcus aureus (MSSA) infective endocarditis (IE)

Monday, December 7

12:00 pm ‐ 1:00 pm

388667 Stephanie Hamel 7‐131 Comparing the effect of day 6 vs day 8 granulocyte colony‐stimulating factor on engraftment following autologous and allogeneic bone marrow transplantation


8:30 am ‐ 9:30 am

385956 David Hamill 5B‐034 Overutilization patterns of antipsychotics: effects on patient outcomes seen from the setting of an acute care psychiatric facility

Tuesday, December 8

11:30 am ‐ 12:30 pm

387666 Shetha Hamoud 5A‐082 Analysis of antiretroviral regimens and reported method of contraception for HIV+ women

Tuesday, December 8

10:00 am ‐ 11:00 am

385916 Kasey Hamrick 5B‐306 Predictors of CYP2C19 genotype testing and anti‐platelet therapy selection in patients undergoing percutaneous coronary intervention

Tuesday, December 8

11:30 am ‐ 12:30 pm

387977 Chang Woo Han 3‐165 Analyzing the impact of a mentorship program on students' interests in pharmaceutical industry

Monday, December 7

12:00 pm ‐ 1:00 pm

387428 Brian Hancock 5A‐332 Evaluation of the effectiveness and safety of low dose (100 mg/day) oral amiodarone for prevention of recurrence of

Tuesday, December 8

10:00 am ‐ 11:00 am


67 | P a g e

Submission ID



atrial fibrillation

388072 Eileen Hang 5A‐083 Comparison of previous and current cholesterol and diabetes guidelines to assess impact of new therapeutic recommendations on an underserved Chinese American population

Tuesday, December 8

10:00 am ‐ 11:00 am

388005 Claudia Hanni 7‐172 Learning from religious speakers to improve cultural sensitivity


8:30 am ‐ 9:30 am

385648 Benjamin Hansen 5B‐307 Common teaching activities and self‐perceived teaching proficiency in PGY2 residencies

Tuesday, December 8

11:30 am ‐ 12:30 pm

388095 Jacob Hansen 2‐290 Impact of an admission medication reconciliation program in a large academic medical center

Monday, December 7

10:45 am ‐11:45 am

387927 Brittany Hardek 5A‐248 Developing a sustainable nursing unit service line delivery model in a large academic medical center

Tuesday, December 8

10:00 am ‐ 11:00 am

382639 Sarah Hardeman 2‐380 Ciprofloxacin release rates from various novel pH neutral delivery vehicles

Monday, December 7

10:45 am ‐11:45 am

389384 Heather Harnvanich 5B‐160 Focus group study to explore how attitudes towards the future affects stress in second‐year and third‐year professional pharmacy students

Tuesday, December 8

11:30 am ‐ 12:30 pm

385610 Heidi Harper 2‐291 Evaluating use and incidence of adverse effects of proton pump inhibitors in patients with cystic fibrosis

Monday, December 7

10:45 am ‐11:45 am

388031 Brooke Harrington 5A‐076 Use of Fidaxomicin for Treatment of Clostridium Difficile Infection (CDI) in a Community Hospital Setting

Tuesday, December 8

10:00 am ‐ 11:00 am

389429 Danelle Harris 3‐347 Implementation of a medication adherence program in senior public housing facilities utilizing pharmacists

Monday, December 7

12:00 pm ‐ 1:00 pm


68 | P a g e

Submission ID



and health educators

389476 Crystal Harrison 5A‐276 Evaluation of renal function in liver transplant patients initiated on sirolimus based maintenance immunosuppression

Tuesday, December 8

10:00 am ‐ 11:00 am

387475 Holly Harrison 5A‐078 Evaluation of treating asymptomatic bacteriuria in a large academic medical center: a retrospective study

Tuesday, December 8

10:00 am ‐ 11:00 am

385687 April Hartford 5A‐148 Medication use evaluation of proton pump inhibitors following prescriber education

Tuesday, December 8

10:00 am ‐ 11:00 am

385994 Kara Hartman 5B‐378 Evaluation of methylene blue and hydroxocobalamin for the treatment of refractory vasoplegia in cardiac and vascular surgery patients

Tuesday, December 8

11:30 am ‐ 12:30 pm

385697 Lynn Hassoun 5B‐222 The short‐term effects of mandating indication documentation on levofloxacin and vancomycin orders

Tuesday, December 8

11:30 am ‐ 12:30 pm

387736 Rachel Hasty 5A‐104 Perspectives of Indiana healthcare providers on Medicaid coverage and expansion

Tuesday, December 8

10:00 am ‐ 11:00 am

386774 Stephanie Hatten 2‐096 Evaluation and assessment of attention deficit disorder/attention deficit hyperactivity disorder (ADD/ADHD) medication use among student pharmacists

Monday, December 7

10:45 am ‐11:45 am

387959 Brittany Hawke 3‐153 The impact of peer‐led networking and professionalism workshops on the professional presence of students at the University of Minnesota College of Pharmacy

Monday, December 7

12:00 pm ‐ 1:00 pm

383311 Kevin Hawkins 2‐018 Grapefruit‐statin interactions: patient awareness, knowledge and contributing factors

Monday, December 7

10:45 am ‐11:45 am


69 | P a g e

Submission ID



389189 Zuri Hawkins 5B‐035 Impact of pharmacists interventions within a collaborative practice in an indigent clinic: a retrospective review

Tuesday, December 8

11:30 am ‐ 12:30 pm

386750 Jaclyn Hawn 2‐292 Evaluation of patient barriers accessing cystic fibrosis specialty pharmacy medications and staff documentation practices in an outpatient setting

Monday, December 7

10:45 am ‐11:45 am

389079 Christine Hayden 7‐195 Deep vein thrombosis (DVT) in patient taking clomiphene citrate (CC) for hypogonadotropic hypogonadism (HH): a case report


8:30 am ‐ 9:30 am

384797 Lisa Hayes 2‐381 Evaluation of expansion of pharmacist coverage in a community hospital emergency department

Monday, December 7

10:45 am ‐11:45 am

388807 William Hays 2‐293 A drug‐use evaluation of perampanel in a pediatric medical center

Monday, December 7

10:45 am ‐11:45 am

385826 Amy Haywood 5B‐115 Impact of a Pharmacy‐Student Led HIV Educational Program at Milwaukee Public Schools

Tuesday, December 8

11:30 am ‐ 12:30 pm

387497 Harvey He 5A‐249 Measuring the Impact of Computerized Provider Order Entry Rules on Formulary Compliance, Prescriber Action, and Economics

Tuesday, December 8

10:00 am ‐ 11:00 am

383721 Brett Healy 3‐222 Valproic acid induced hyperammonemia: a case report

Monday, December 7

12:00 pm ‐ 1:00 pm

389228 Ashley Heard 7‐207 Investigational correctors for cystic fibrosis have different chaperone dependence


8:30 am ‐ 9:30 am

387171 Megan Heath 7‐064 Unique multidisciplinary group clinic partnered with primary care for education and treatment of a Veterans Affairs


8:30 am ‐ 9:30 am


70 | P a g e

Submission ID



(VA) population with chronic hepatitis C virus (HCV) infection

389410 Taylor Hebenstreit 5A‐105 Development of an intravenous to oral sequential therapy conversion initiative in the largest not‐for‐profit health‐system in the United States

Tuesday, December 8

10:00 am ‐ 11:00 am

387311 Stephanie Heeney 5A‐324 Impact of pharmacy interns on medication review response rates following patient falls

Tuesday, December 8

10:00 am ‐ 11:00 am

389164 Jared Heiles 2‐382 Fludrocortisone‐induced Metabolic Alkalosis Secondary to Mineralocorticoid Excess: A Case Report

Monday, December 7

10:45 am ‐11:45 am

388068 Maggie Hein 2‐157 Knowledge of a therapeutic indication influences the clinical pharmacy decision to dispense a prescription

Monday, December 7

10:45 am ‐11:45 am

389329 Mika Heister 5A‐057 Systematic analysis for sources of missing medications in a decentralized hospital

Tuesday, December 8

10:00 am ‐ 11:00 am

388284 Amanda Helmann 3‐401 Angioedema associated with vilazodone in a patient with systemic lupus erythematosus

Monday, December 7

12:00 pm ‐ 1:00 pm

385971 James Henderson 2‐383 Antimicrobial surgical prophylaxis in obese patients

Monday, December 7

10:45 am ‐11:45 am

387439 Sarah Hendrick 2‐116 Evaluation of meropenem prescribing practices at a large academic teaching facility

Monday, December 7

10:45 am ‐11:45 am

387780 Anthony Hennes 5B‐419 Pharmacist‐to‐Pharmacist communication handoff: improving community pharmacist medication reconciliation and confidence

Tuesday, December 8

11:30 am ‐ 12:30 pm

387335 Erik Henricksen 2‐294 Evaluation of adverse effects associated with pneumocystis carinii pneumonia (PCP) prophylaxis in liver transplant recipients

Monday, December 7

10:45 am ‐11:45 am

384364 Julia Henson 5B‐379 Evaluation of caspofungin use at a large academic medical center

Tuesday, December 8

11:30 am ‐ 12:30 pm


71 | P a g e

Submission ID



388853 Min Ji Her 2‐047 Medication adherence and persistence to brand versus generic levothyroxine among managed‐care beneficiaries within an integrated health system

Monday, December 7

10:45 am ‐11:45 am

386771 Adrienne Herman 7‐089 Evaluation of a nurse‐managed heparin nomogram versus provider‐managed heparin dosing in hospitalized patients with cardiovascular disease


8:30 am ‐ 9:30 am

388204 Beatriz Hernandez 3‐080 Evaluation of glucose gel, intravenous dextrose and glucagon use at a small community hospital

Monday, December 7

12:00 pm ‐ 1:00 pm

386095 Sheila Hernandez 3‐081 Pharmacogenetic Testing for Methotrexate Treatment in Leukemia Patients

Monday, December 7

12:00 pm ‐ 1:00 pm

388103 Catherine Herren 7‐065 Effects of Metformin in Heart Failure Patients


8:30 am ‐ 9:30 am

384357 Elisa Herrera 5A‐074 Evaluating web based employee scheduling solutions

Tuesday, December 8

10:00 am ‐ 11:00 am

388489 Glenn Herrington 5B‐308 Prospective cohort study evaluating the accuracy of medication reconciliation in the ambulatory care setting

Tuesday, December 8

11:30 am ‐ 12:30 pm

389265 Chelsey Hess 3‐011 Evaluation of patients with a diagnosis of antiphospholipid syndrome (APS) within the integrative health care system of a safety net institution

Monday, December 7

12:00 pm ‐ 1:00 pm

383193 William Heuser 2‐261 Heparin‐induced thrombocytopenia (HIT): a retrospective analysis of the true incidence and evaluation of the appropriateness of sending heparin antibody immunoassays in patients over 2 years

Monday, December 7

10:45 am ‐11:45 am

382941 Austin Hewlett 3‐082 Implementation of a refill‐reminder system in an independent community

Monday, December 7

12:00 pm ‐ 1:00 pm


72 | P a g e

Submission ID



pharmacy: before and after

387270 Erin Hickey 5A‐315 Pre‐health students' perceptions of the role of pharmacists on health care teams

Tuesday, December 8

10:00 am ‐ 11:00 am

386575 Joshua Hicks 5A‐316 Evaluation of formulary switch from 3‐factor to 4‐factor prothrombin complex concentrate (PCC) on the usage of factor VIIa at an academic medical center

Tuesday, December 8

10:00 am ‐ 11:00 am

386379 Taylor Hightower 7‐025 Characteristics of pharmacist‐based prescribing in 2013 under CMS


8:30 am ‐ 9:30 am

384649 Brandon Hill 5B‐309 Tumor lysis syndrome: incidence and subsequent management in acute adult myeloid leukemia patients

Tuesday, December 8

11:30 am ‐ 12:30 pm

387747 Marilyn Hill 7‐239 Prescribing patterns of new oral anticoagulants in an outpatient setting


8:30 am ‐ 9:30 am

385251 Sierra Hill 3‐003 Analyzing distribution of intern time within an academic medical center inpatient pharmacy intern program to assess strengths, weaknesses, opportunities, and threats

Monday, December 7

12:00 pm ‐ 1:00 pm

387814 Zac Hill 5B‐098 The value of a psychiatric pharmacist within an integrated treatment team model of care

Tuesday, December 8

11:30 am ‐ 12:30 pm

387052 Alyssa Hinchman 2‐019 Implementation of health information exchange (HIE) at an Arizona detention center: lessons learned

Monday, December 7

10:45 am ‐11:45 am

386031 Ryan Hines 5A‐149 Evaluation of glucagon use in the emergency department and inpatient setting of a metropolitan hospital

Tuesday, December 8

10:00 am ‐ 11:00 am

388664 Gabriel Hinojosa 7‐185 Evaluating the association between age, education level and functional health literacy in Mississippi


8:30 am ‐ 9:30 am


73 | P a g e

Submission ID



388061 Stephanie Hipp 3‐152 Patient satisfaction and adherence following implementation of pharmacy services in a geriatric ambulatory clinic

Monday, December 7

12:00 pm ‐ 1:00 pm

388442 Venus Ho 2‐417 Anticoagulation patient outcomes of a pharmacy managed community hospital based anticoagulation clinic in comparison to the standard warfarin management

Monday, December 7

10:45 am ‐11:45 am

389531 Karen Hoang 3‐223 Development of an inhaler technique assessment tool for pharmacist incorporation into primary care

Monday, December 7

12:00 pm ‐ 1:00 pm

387158 Peter Hoang 2‐195 Interprofessional education within the curriculum of US schools of pharmacy: a 5‐year review

Monday, December 7

10:45 am ‐11:45 am

389116 Hang Hoang‐Nguyen 5A‐325 The quality‐assurance project reviewing the time and appropriateness of antibiotic de‐escalation for patients with methicillin susceptible Staphylococcus aureus (MSSA) bacteremia at an academic hospital institution

Tuesday, December 8

10:00 am ‐ 11:00 am

386024 Nicole Hodgdon 3‐036 Association between weekend admission and in‐hospital outcomes for patients with atrial fibrillation or flutter: a retrospective cohort analysis

Monday, December 7

12:00 pm ‐ 1:00 pm

385557 Lindsey Hodgen 5B‐142 Clinical outcomes based on antibiotic prescribing for healthcare‐associated and community acquired pneumonia

Tuesday, December 8

11:30 am ‐ 12:30 pm

387798 Jennifer Hodges 2‐117 Filgrastim‐sndz: new drug review and cost‐minimization analysis of the first US‐approved biosimilar

Monday, December 7

10:45 am ‐11:45 am

384493 Bryce Hodgson 5A‐297 Chemotherapy order second‐ Tuesday, 10:00 am ‐ 11:00 am


74 | P a g e

Submission ID



check and error discovery rates by pharmacists and pharmacy technicians.

December 8

388238 Hayley Hodgson 5B‐036 Role of pharmacist interventions in the safe administration of anti‐cd20 monoclonal antibodies

Tuesday, December 8

11:30 am ‐ 12:30 pm

387652 Molly Hoff 5A‐234 Ketamine for intractable cancer pain: a case report and policy development

Tuesday, December 8

10:00 am ‐ 11:00 am

388137 Joy Hoffman 2‐295 Assessing knowledge and perceptions of organ donation among students and university employees

Monday, December 7

10:45 am ‐11:45 am

389213 Rachel Hoffman 5B‐161 Evaluation of the safety, efficacy, and pharmacoeconomics of two valganciclovir prophylaxis regimens following renal transplantation

Tuesday, December 8

11:30 am ‐ 12:30 pm

384405 Daniel Holland 3‐027 Medication use evaluation of dextrose 50 percent use following hypoglycemia according to insulin protocol at a community teaching hospital

Monday, December 7

12:00 pm ‐ 1:00 pm

387904 Matthew Hollifield 5B‐310 Comparing adherence to prescribing and management recommendations for direct oral anticoagulants (DOACs) by primary care providers vs. a pharmacist‐managed anticoagulation clinic

Tuesday, December 8

11:30 am ‐ 12:30 pm

386554 Morgan Holmes 7‐240 Incidence and effects of the continuation of stress ulcer prophylaxis medications after discharge


8:30 am ‐ 9:30 am

389478 Brendan Homanick 3‐224 Evaluation of inpatient neurokinin‐1 antagonist utilization as antiemetic prophylaxis for highly emetogenic chemotherapy in a tertiary‐care hospital

Monday, December 7

12:00 pm ‐ 1:00 pm


75 | P a g e

Submission ID



389492 Sukmin Hong 3‐225 Population pharmacokinetic analysis of hydroxychloroquine from a phase I/II study in patients with advanced refractory renal cell carcinoma

Monday, December 7

12:00 pm ‐ 1:00 pm

387886 Adam Hood 5B‐116 Technology in the pharmacy classroom: the relationship between the use of lecture capture technology and participation in student organizations

Tuesday, December 8

11:30 am ‐ 12:30 pm

385857 Michele Hook 2‐072 A retrospective study of pediatric pneumococcal vaccination rates at a county health department

Monday, December 7

10:45 am ‐11:45 am

389565 Gabrielle Horne 3‐083 Advancing the clinical approach of medication reconciliation in the emergency department at South Florida Baptist Hospital (SFBH)

Monday, December 7

12:00 pm ‐ 1:00 pm

388730 Maurice Horton 2‐048 Developing a reversible, broad‐spectrum beta‐lactamase inhibitor to combat bacterial drug resistance.

Monday, December 7

10:45 am ‐11:45 am

387795 Courtney Horvat 5B‐402 Impact of a pharmacy intervention to improve turnaround time for organ donor medications

Tuesday, December 8

11:30 am ‐ 12:30 pm

388725 Audrey Hou 3‐166 Healthcare news consumption patterns among future pharmacy professionals

Monday, December 7

12:00 pm ‐ 1:00 pm

389243 Gary Houchard 7‐132 Comparing student and faculty preferences for course evaluations


8:30 am ‐ 9:30 am

388512 Cora Housley 2‐004 Exposing students to the triple aim: description and evaluation of an introductory interprofessional workshop

Monday, December 7

10:45 am ‐11:45 am

389078 Cameron Howell 7‐026 The Utilization of Oritavancin in a Community Hospital


8:30 am ‐ 9:30 am

387691 Kristin Howell 2‐109 Evaluating the management of patients with prediabetes in a

Monday, December 7

10:45 am ‐11:45 am


76 | P a g e

Submission ID



family medicine clinic

386906 Rachel Howland 2‐138 Effectiveness of intravenous magnesium for the treatment of migraines

Monday, December 7

10:45 am ‐11:45 am

387633 CHIA‐CHI HSU 5B‐162 Impact of a pharmacy orientation course on confidence of first‐year pre‐pharmacy students

Tuesday, December 8

11:30 am ‐ 12:30 pm

388440 Ching‐Ling Hsu 5A‐033 Impact of a pharmacy student on pharmacist clinical documentation in a hospital system

Tuesday, December 8

10:00 am ‐ 11:00 am

387048 Jackie Hu 5A‐016 Standardization of data coding to improve quality and utilization of data in a poison and drug information center

Tuesday, December 8

10:00 am ‐ 11:00 am

385905 Suzan Hua 7‐090 Comparison of vitamin B12 prescribing patterns and response between metformin users and non‐users


8:30 am ‐ 9:30 am

384401 Victoria Huang 3‐167 Reanalysis of the utility of the 2012 Beers Criteria for predicting outcomes in hospitalized older adults in an Acute Care for the Elderly unit

Monday, December 7

12:00 pm ‐ 1:00 pm

388047 Melissa Hubbard 3‐084 Euglycemic diabetic ketoacidosis and its association with SGLT inhibitors

Monday, December 7

12:00 pm ‐ 1:00 pm

389507 Suzanne Huber 3‐085 Popularity of complementary and alternative medicine in adults ages 18 to 85 living in Florida

Monday, December 7

12:00 pm ‐ 1:00 pm

389157 Alex Hughes 2‐005 Impact of an educational intervention on the choice of treatment in Clostridium difficile infections

Monday, December 7

10:45 am ‐11:45 am

386473 Elizabeth Hughes 5B‐223 Changing the approach to prescription drug awareness: creating positive peer influences

Tuesday, December 8

11:30 am ‐ 12:30 pm

386696 Kaitlyn Hughes 2‐196 Evaluation of the effectiveness of liposomal bupivacaine in

Monday, December 7

10:45 am ‐11:45 am


77 | P a g e

Submission ID



controlling post‐operative pain

385418 Sara Huh 7‐091 Use of artesunate for the treatment of plasmodium falciparum cerebral malaria


8:30 am ‐ 9:30 am

383285 Alison Hunter 5B‐037 Impact of pilot medication education student rotation on hospital consumer assessment of healthcare providers and systems (HCAHPS) survey scores

Tuesday, December 8

11:30 am ‐ 12:30 pm

386561 Whitney Hurt 5B‐267 Evaluation of Dexmedetomidine use in a Community Hospital Setting

Tuesday, December 8

11:30 am ‐ 12:30 pm

387120 Lindsey Hutnick 5B‐163 Evaluation of an unfractionated heparin pharmacy dosing protocol for the treatment of venous thromboembolism in non‐obese, obese and morbidly obese patients

Tuesday, December 8

11:30 am ‐ 12:30 pm

387947 Christopher Hutson 5B‐117 Safety and efficacy of protocolized care and neostigmine continuous infusion for colonic ileus

Tuesday, December 8

11:30 am ‐ 12:30 pm

388027 Alexander Huynh 5A‐058 Anti‐factor Xa (anti‐Xa) assay clinical outcomes for monitoring unfractionated heparin (UFH)

Tuesday, December 8

10:00 am ‐ 11:00 am

386573 Jennifer Huynh 5A‐004 Evaluation of adherence to the American Diabetes Association standards of medical care in HIV‐infected patients

Tuesday, December 8

10:00 am ‐ 11:00 am

387753 Qua Kim Huynh 5A‐036 The awareness, perception, and likelihood to continue using Vial of Life (VOL) following Vial of Life presentation

Tuesday, December 8

10:00 am ‐ 11:00 am

386391 Sarah Huynh 5A‐017 Linezolid utilization at a rural community teaching hospital in Arizona

Tuesday, December 8

10:00 am ‐ 11:00 am

388866 Christopher Hvisdas 3‐276 Evaluation of adherence to a neonatal morphine weaning protocol for the treatment of neonatal abstinence syndrome

Monday, December 7

12:00 pm ‐ 1:00 pm


78 | P a g e

Submission ID



(NAS) and its effect on length of stay

388185 Christine Hwang 2‐296 Risk factors for recurrent pneumonia in the surgical intensive care unit

Monday, December 7

10:45 am ‐11:45 am

386397 Eunjeong Hwang 5A‐018 Pilot intervention to evaluate acid suppression therapy in critically ill adult patients

Tuesday, December 8

10:00 am ‐ 11:00 am

385161 Joy Hwang 3‐154 Minnesota pharmacists and medical cannabis: a survey of knowledge, concerns, and interest prior to launch of the state's program

Monday, December 7

12:00 pm ‐ 1:00 pm

386922 Michael Hwang 2‐049 Population pharmacokinetics of efavirenz in HIV infected infants and young children with and without tuberculosis infection

Monday, December 7

10:45 am ‐11:45 am

388951 Stephanie Hymel 5A‐114 Utility of probiotics in gastrointestinal disease states

Tuesday, December 8

10:00 am ‐ 11:00 am

388904 Adam Ingram 2‐297 Identification of factors associated with achieving and maintaining glycemic goals in patients with newly diagnosed type 2 diabetes

Monday, December 7

10:45 am ‐11:45 am

385850 Fanette Iosevich 2‐197 Examination of medication reconciliation process during transition of care from the hospital to a long term care facility

Monday, December 7

10:45 am ‐11:45 am

388209 Benjamin Iredell 7‐241 Antibiotic use trends in U.S. academic medical centers


8:30 am ‐ 9:30 am

384805 Danielle Ishihara 2‐050 Door to diuretic time and length of stay in veterans hospitalized with acute decompensated heart failure

Monday, December 7

10:45 am ‐11:45 am

384646 marcelle issa 3‐086 Evaluation of Phentermine and Topiramate Combination Extended Release on Weight Loss and Waist Circumference in Overweight and Obese Adults

Monday, December 7

12:00 pm ‐ 1:00 pm

388085 Sarah Issa 2‐198 Evaluation of the need for Monday, 10:45 am ‐11:45 am


79 | P a g e

Submission ID



pharmacologic venous thromboembolism (VTE) prophylaxis in patients with cirrhotic coagulopathy

December 7

388645 Emilie Ito 5A‐235 Utilizing pharmacy students to achieve state‐funded health insurance incentives in a federally qualified health center (FQHC)

Tuesday, December 8

10:00 am ‐ 11:00 am

388820 Maria Laura Ituah 5B‐118 The Relationship between Mindfulness, Cultural Background and GPA in Pharmacy Students

Tuesday, December 8

11:30 am ‐ 12:30 pm

387451 Lindsey Jachim 5A‐250 Dosing of diltiazem in patients with atrial fibrillation and rapid ventricular response

Tuesday, December 8

10:00 am ‐ 11:00 am

387151 Laurie Jackson 5B‐038 In‐patient medication management and outcomes in chronic obstructive pulmonary disease (COPD) patients

Tuesday, December 8

11:30 am ‐ 12:30 pm

388559 Peter Jackson 5B‐403 Evaluation of heparin dose required to achieve a therapeutic activated clotting time for patients undergoing extracorporeal membrane oxygenation therapy

Tuesday, December 8

11:30 am ‐ 12:30 pm

388727 Manu Jacob 7‐051 Cost‐minimization Associated with Reducing Inappropriate Enoxaparin Use


8:30 am ‐ 9:30 am

387906 Sherin Jacob 5B‐265 Lyme disease flares post vaccination of human papillomavirus vaccine: a case series

Tuesday, December 8

11:30 am ‐ 12:30 pm

385896 Joshua Jacobs 2‐298 Evaluation of patient preference of heart failure education material at a community teaching hospital

Monday, December 7

10:45 am ‐11:45 am

387903 Alina Jaeger 2‐020 Effect of an information intervention on prescribers' use of aspirin and clopidogrel as dual antiplatelet therapy

Monday, December 7

10:45 am ‐11:45 am

389352 Husain Jafferji 2‐118 Secukinumab: new drug review Monday, 10:45 am ‐11:45 am


80 | P a g e

Submission ID



and cost‐minimization analysis for treatment of moderate‐to‐severe plaque psoriasis

December 7

386974 Daniel James 2‐299 Assessment of critical thinking skills progression in a pre‐pharmacy curriculum

Monday, December 7

10:45 am ‐11:45 am

389443 Devinne James 2‐006 Evaluating the use of guideline driven pharmacotherapy in the management of uncontrolled type 2 diabetes mellitus at four primary care clinics

Monday, December 7

10:45 am ‐11:45 am

387659 Sara James 2‐262 Development of a pharmacy team to improve patient follow‐up care post‐discharge

Monday, December 7

10:45 am ‐11:45 am

387766 Stephanie James 3‐297 Connectivity: Next Level Development Through Teaching and Learning

Monday, December 7

12:00 pm ‐ 1:00 pm

388932 Rachel Jamieson 2‐407 Clinical characteristics of patients with chronic obstructive pulmonary disease (COPD) within a rural family medicine clinic

Monday, December 7

10:45 am ‐11:45 am

387014 Vanessa Jamison 3‐012 Impact of pharmacist‐run anticoagulation clinics on improving non‐warfarin related patient outcomes

Monday, December 7

12:00 pm ‐ 1:00 pm

388060 Nadya Jammal 5B‐039 Title: Retrospective evaluation of inpatients with suspected clostridium difficile infection (CDI) at a community hospital

Tuesday, December 8

11:30 am ‐ 12:30 pm

386270 Maria Janda 2‐257 Increasing the quality of medication reconciliation with pharmacy interns

Monday, December 7

10:45 am ‐11:45 am

384345 Heewon Jang 3‐322 Empowering head start families to improve the quality and safety of their health: resource tool development and assessment

Monday, December 7

12:00 pm ‐ 1:00 pm

388581 Mika Jankowski 5A‐019 Assessment of an intervention to improve patient satisfaction at a community pharmacy

Tuesday, December 8

10:00 am ‐ 11:00 am

388889 Megan Januszewski 5B‐424 Electronic cigarettes: Tuesday, 11:30 am ‐ 12:30 pm


81 | P a g e

Submission ID



perception amongst teens December 8

386102 Kelsey Japs 5A‐050 Efforts to improve prescription delivery time in a discharge prescription bedside delivery service: a pneumatic tube delivery pilot

Tuesday, December 8

10:00 am ‐ 11:00 am

386663 Courtney Jarka 5A‐186 Pharmacy interventions, student satisfaction, and educational value while participating in an international medical brigade in Ecuador

Tuesday, December 8

10:00 am ‐ 11:00 am

385265 Mary Claire Jarrell 7‐186 HPV: Are College Age Females Getting Vaccinated? If not, Why?


8:30 am ‐ 9:30 am

385910 Neda Javan 5B‐040 Evaluation of dexmedetomidine utilization in the intensive care units of a community hospital

Tuesday, December 8

11:30 am ‐ 12:30 pm

383290 Caitlin Jenkins 5B‐041 Description and impact of outpatient clinical pharmacy interventions in patients with hypertension at an academic medical center: a two year retrospective review

Tuesday, December 8

11:30 am ‐ 12:30 pm

388639 Rebecca Jett 5A‐084 Impact of cefepime exposure on outcomes of extended‐spectrum beta‐lactamase producing Enterobacteriaceae infections

Tuesday, December 8

10:00 am ‐ 11:00 am

384508 Christine Jiang 5A‐266 Adequacy of annual antibiograms to inform empiric prescribing

Tuesday, December 8

10:00 am ‐ 11:00 am

388860 Tessa Jimenez 5B‐380 Pharmacist and student pharmacist administered immunizations: patient and provider perspectives

Tuesday, December 8

11:30 am ‐ 12:30 pm

386337 Bonnie Jiron 2‐349 Evaluation of the clinical impact and appropriateness of prior authorization policy for biological agents in the Oregon Medicaid program

Monday, December 7

10:45 am ‐11:45 am

386373 Satta Jivagunchainan 2‐350 Evaluation of clinical efficacy and safety of generic compared

Monday, December 7

10:45 am ‐11:45 am


82 | P a g e

Submission ID



to innovator tacrolimus in kidney transplant recipients: a single‐center retrospective study

385556 Beth Jobson 5A‐005 Assessing the Impact of an Early Pharmacy Practice Experience through Progress Note Review

Tuesday, December 8

10:00 am ‐ 11:00 am

389623 Blake Johnson 2‐076 Evaluation of vancomycin therapy in patients with cellulitis at a not‐for‐profit medical center in Hawaii

Monday, December 7

10:45 am ‐11:45 am

384727 Brittney Johnson 3‐087 Systematic review of pharmacy compounding of pain medication

Monday, December 7

12:00 pm ‐ 1:00 pm

382974 Karissa Johnson 2‐199 Immunoglobulin G levels: common renal transplant infectious complications

Monday, December 7

10:45 am ‐11:45 am

385877 Katie Johnson 7‐133 Pre‐ and post‐intervention analysis of antimicrobial smart infusion pump alerts at an academic medical center


8:30 am ‐ 9:30 am

386633 Sarah Johnson 5B‐042 Inhibition of neurotrophin receptor; p75NTR on mesenchymal stem cells potentiates angiogenic response in retinal endothelial cells

Tuesday, December 8

11:30 am ‐ 12:30 pm

389146 Tiffany Johnson 3‐088 Efficacy of Incretin Mimetics on Obesity: A Meta‐Analysis of Randomized Double‐Blinded Clinical Trials

Monday, December 7

12:00 pm ‐ 1:00 pm

386732 Emily Johnston 5A‐115 Association of serum magnesium on hypertensive crises patient: a case‐control study

Tuesday, December 8

10:00 am ‐ 11:00 am

386029 Heather Johnston 5A‐298 A model review for identifying and managing polypharmacy in the military at fort hood, texas

Tuesday, December 8

10:00 am ‐ 11:00 am

389316 Jayme Johnston 3‐348 Retrospective analysis of hospital‐acquired venous thromboembolism: effect of appropriate pharmacologic and

Monday, December 7

12:00 pm ‐ 1:00 pm


83 | P a g e

Submission ID



mechanical thromboprophylaxis on time to development in high‐risk patients

387771 Aubrey Jones 2‐334 Prevalence of unrounded medication doses and associated factors among hospitalized pediatric patients

Monday, December 7

10:45 am ‐11:45 am

385700 Rodjsyne Jones 5A‐059 Comparison of traditional and novel laxatives in the treatment of opioid‐induced constipation (OIC)

Tuesday, December 8

10:00 am ‐ 11:00 am

389076 Sarah Jones 2‐300 An examination of student pharmacist psychological capital

Monday, December 7

10:45 am ‐11:45 am

384622 Brittany Jordan 5A‐245 Predictors of Adherence Profiles in Older Adults

Tuesday, December 8

10:00 am ‐ 11:00 am

385175 Lukose Joseph 3‐089 Comparison of standard fluoroquinolone (FQ) prophylaxis versus rectal swab targeted prophylaxis in men undergoing trans rectal ultrasound guided prostate biopsy (TRUSBx)

Monday, December 7

12:00 pm ‐ 1:00 pm

388357 Harrison Jozefczyk 5B‐043 Effect of maintenance intravenous fluids on survival in critically ill adult patients

Tuesday, December 8

11:30 am ‐ 12:30 pm

382523 Rebecca Juhl 7‐066 Assessment of Phosphorus Management in Patients Receiving Parenteral Nutrition (PN) Support in a Community Hospital Inpatient Setting


8:30 am ‐ 9:30 am

386390 Olson Julia 2‐021 Development of site specific antibiograms: an antimicrobial stewardship initiative in a rural hospital

Monday, December 7

10:45 am ‐11:45 am

387038 Jiyeon Jung 7‐050 Evaluation of rivaroxaban use in Daegu Catholic University Medical Center


8:30 am ‐ 9:30 am

388851 Yu Na Jung 3‐168 Pharmacist assisted self‐management goal setting: impact of specific,

Monday, December 7

12:00 pm ‐ 1:00 pm


84 | P a g e

Submission ID



measureable, attainable, relevant, and time‐bound (SMART) criteria on goal attainment in patients with type 2 diabetes mellitus

387854 Peter Kaiser 7‐092 Evaluation of antimicrobial medication adherence in the neutropenic oncology patient


8:30 am ‐ 9:30 am

386037 Payal Kakadiya 5B‐044 Adherence to The Joint Commission standards by avoiding duplicate as needed pain medication orders through educational methods

Tuesday, December 8

11:30 am ‐ 12:30 pm

387662 Paria Kalantari 5A‐111 Interprofessional education to pharmacy students through presentations from medical and dietetic students

Tuesday, December 8

10:00 am ‐ 11:00 am

387547 David Kalina 5B‐119 Evaluation of the relationship between pharmacy student leadership positions, academic performance, and career goals

Tuesday, December 8

11:30 am ‐ 12:30 pm

387483 James Kallander 2‐258 Increasing pharmacy practice model initiative hospital self‐assessment completion rates in North Dakota and analysis of services provided by North Dakota Health‐System Pharmacies

Monday, December 7

10:45 am ‐11:45 am

385559 Julian Kam 3‐268 Evaluation of the interprofessional healthcare professionals' perception of roles of pharmacists in the rural setting of a medical mission to Jamaica

Monday, December 7

12:00 pm ‐ 1:00 pm

387060 Marissa Kamaryt 5B‐120 Over‐the‐counter progestin‐only contraception: a comparison of knowledge and readiness for practice change between student pharmacists and experienced practitioners.

Tuesday, December 8

11:30 am ‐ 12:30 pm

385849 Christine Kane 5B‐164 Impact of an adult cystic fibrosis non‐surgical pain

Tuesday, December 8

11:30 am ‐ 12:30 pm


85 | P a g e

Submission ID



algorithm on opioid prescribing

382947 Amy Kang 2‐051 Clinical outcomes associated with utilizing midodrine in patients with subarachnoid hemorrhages

Monday, December 7

10:45 am ‐11:45 am

385430 Min Jung Kang 5A‐258 Unintended trace element contamination in commercially available parenteral nutrition products

Tuesday, December 8

10:00 am ‐ 11:00 am

385859 TaeHi Kang 5B‐224 Associated risk of metronidazole and neutropenia: case report

Tuesday, December 8

11:30 am ‐ 12:30 pm

389610 Shivani Kapadia 2‐270 A case of a near miss medication error due to deviation from protocol‐driven insulin infusion treatment of hyperosmolar hyperglycemia

Monday, December 7

10:45 am ‐11:45 am

387241 Marcus Kaplan 5A‐201 Retrospective analysis of the adherence of prescription medications at the Student Health Action Coalition (SHAC) free clinic

Tuesday, December 8

10:00 am ‐ 11:00 am

389029 Aisha Karim 5B‐099 Role of pharmacy students on an Infectious Diseases Center Quality Committee

Tuesday, December 8

11:30 am ‐ 12:30 pm

389313 Sushmita Karki 3‐090 Initiating antihypertensive agents in adults 60 and older: Is 150/90 mm Hg too high of a starting point?

Monday, December 7

12:00 pm ‐ 1:00 pm

388181 Scott Karpowicz 3‐349 Case report of ceftazidime‐avibactam used in the treatment of multidrug‐resistant pneumonia caused by Citrobacter freundii and Klebsiella pneumoniae

Monday, December 7

12:00 pm ‐ 1:00 pm

386116 Rupal Kasbekar 5B‐311 Assessment of antibiotic prescribing practices and outcomes for acute bacterial skin and skin structure infections at a large, academic medical center

Tuesday, December 8

11:30 am ‐ 12:30 pm


86 | P a g e

Submission ID



389028 Sejada Kastrati 5A‐060 Identifying the Role and Utilization of Pharmacists in Pediatric Resuscitation Teams

Tuesday, December 8

10:00 am ‐ 11:00 am

388162 Vivek Kataria 3‐226 FilmArray blood culture identification (BCID) panel reduces hospital length of stay, hospital costs, and pharmacy costs

Monday, December 7

12:00 pm ‐ 1:00 pm

388876 Georgia Katsoulis 5A‐100 Impact of procalcitonin testing on reducing antimicrobial use in lower respiratory tract infection patients in a community hospital

Tuesday, December 8

10:00 am ‐ 11:00 am

388908 Jasmeet Kaur 3‐387 Outcomes of a post‐discharge patient counseling project at a community hospital

Monday, December 7

12:00 pm ‐ 1:00 pm

385707 Lovdeep Kaur 2‐256 Drug use evaluation of oral vancomycin in the treatment of recurrent Clostridium difficile‐associated diarrhea (CDAD) at Long Island Jewish (LIJ) Hospital

Monday, December 7

10:45 am ‐11:45 am

386393 Sharanjit Kaur 5A‐236 Current and potential outcomes of recycling medications: An economical, environmental, and clinical analysis

Tuesday, December 8

10:00 am ‐ 11:00 am

388744 Sarah Kean 7‐134 Interprofessional approach to improve safe opioid utilization at Bronson Methodist Hospital: a retrospective study


8:30 am ‐ 9:30 am

386836 Kristine Keller 7‐093 Incidence of drug‐drug interactions in patients receiving tyrosine kinase inhibitors


8:30 am ‐ 9:30 am

384802 Jordan Kelley 5A‐165 CASE REPORT SERIES: EFFECT OF SGLT2 INHIBITORS ON INDUCING DIABETIC KETOACIDOSIS IN THREE PATIENTS WITH LATENT AUTOIMMUNE DISEASE

Tuesday, December 8

10:00 am ‐ 11:00 am

386878 Gregory Kelly 3‐389 Assessing Anticholinergic Medication Burden among Older Adults Receiving Care in a

Monday, December 7

12:00 pm ‐ 1:00 pm


87 | P a g e

Submission ID



Family Medicine and an Internal Medicine Clinic.

387860 Priyanka Kelshikar 3‐269 Inappropriate use of lorazepam in the elderly: pharmacist's impact on reduction of adverse events

Monday, December 7

12:00 pm ‐ 1:00 pm

389561 Nalinoe Kernizan 3‐169 Acute renal colic pain management in the presence of opioid dependence rehabilitation

Monday, December 7

12:00 pm ‐ 1:00 pm

383190 John Kesler 7‐242 The Effect of High‐Dose N‐Acetylcysteine on Chronic Obstructive Pulmonary Disease


8:30 am ‐ 9:30 am

386997 Jason Keung 7‐094 Impact of Medication Synchronization on Mail Order Pharmacies


8:30 am ‐ 9:30 am

388984 Kaitlin Keyworth 3‐155 Impact of including a pharmacist in transitional care management: the patients' perspective of a new clinical service

Monday, December 7

12:00 pm ‐ 1:00 pm

389307 Alesia Khafizova 2‐200 Preserving culture in dietary choices while implementing lifestyle modifications in South Asian patients with type 2 diabetes: a recipe exchange plan

Monday, December 7

10:45 am ‐11:45 am

385839 Bushra Khan 5A‐287 Comparing Vancomycin Oral Solution and Capsule for Treatment of Clostridium Difficile Infection (CDI)

Tuesday, December 8

10:00 am ‐ 11:00 am

387016 John Khoan 2‐052 Complexity and adherence of patients referred to the pharmacist‐led Diabetes Intense Medical Management (DIMM) clinic versus patients treated by primary care provider (PCP) clinics

Monday, December 7

10:45 am ‐11:45 am

385997 Shadi Khosravi 2‐361 Creating and sustaining practices for handling hazardous drugs based on the United States Pharmacopeia

Monday, December 7

10:45 am ‐11:45 am


88 | P a g e

Submission ID



(USP) 800 guidelines

389182 Steven Khov 5B‐225 Identification of mobile apps on iPhones and iPads for travel medicine practitioners and patients

Tuesday, December 8

11:30 am ‐ 12:30 pm

387009 Alexandra Kibler 3‐227 Evaluation of the accuracy of sixty day medication expiration reports for automated medication dispensing machines (AMDM) at a large academic teaching hospital

Monday, December 7

12:00 pm ‐ 1:00 pm

387467 Christin Kilcrease 2‐384 Identification of the top cited articles in pharmacy education

Monday, December 7

10:45 am ‐11:45 am

388987 Christine Kim 2‐083 Multidisciplinary intervention to improve concordance with American College of Cardiology/American Heart Association (ACC/AHA) cholesterol guidelines in a family medicine clinic

Monday, December 7

10:45 am ‐11:45 am

388215 ChungYun Kim 5A‐085 Comparison of community and hospital pharmacists' attitudes and behaviors on medication error disclosure

Tuesday, December 8

10:00 am ‐ 11:00 am

387036 Deborah Kim 2‐413 Generation Rx on education and awareness of prescription drug abuse for San Diego youth

Monday, December 7

10:45 am ‐11:45 am

384618 Eun Jung Stella

Kim 7‐204 Rate of Antibiotic Prescription in Smoking Population in Comparison to Nonsmoking Population and its Consequences


8:30 am ‐ 9:30 am

388897 Gee Youn Kim 3‐170 Front‐line use of clofarabine in multisystem Langerhans cell histiocytosis in an adult: a case report

Monday, December 7

12:00 pm ‐ 1:00 pm

385773 Hye Jin Kim 5B‐045 Improving provider evidence‐based decision‐making using an electronic drug information service

Tuesday, December 8

11:30 am ‐ 12:30 pm

385803 Hyesun Kim 3‐228 Describing Clostridium difficile infections in patients with a

Monday, December 7

12:00 pm ‐ 1:00 pm


89 | P a g e

Submission ID



ventricular assist device

387799 Junga Kim 5A‐183 Antipsychotic adherence in patients with schizophrenia: variability and outcomes in best practices

Tuesday, December 8

10:00 am ‐ 11:00 am

386312 Sara Kim 2‐419 Evaluation of barriers to asthma control for patients

Monday, December 7

10:45 am ‐11:45 am

387818 Soomin Kim 7‐135 Comparison Between Clopidogrel 600mg versus 300mg in the Cardiac Catheterization Lab for Improving Outcomes in Acute Myocardial Infarction Patients Who Received Percutaneous Coronary Intervention


8:30 am ‐ 9:30 am

384334 Melissa Kincaid 2‐301 Comparison of haloperidol and quetiapine use for delirium and agitation in hospitalized medical patients

Monday, December 7

10:45 am ‐11:45 am

386938 Alexander King 5A‐299 2013 Medicare Part D claims data VS. 2012 American Geriatrics Society updated Beers criteria: are the recommendations being followed?

Tuesday, December 8

10:00 am ‐ 11:00 am

386704 Eric Kinney 5A‐333 Evaluation of urinary tract infection (UTI) management in hematopoietic stem cell transplant recipients receiving pneumocystis prophylaxis with sulfamethoxazole/trimethoprim

Tuesday, December 8

10:00 am ‐ 11:00 am

386272 Brittany Kiracofe 2‐302 Evaluation of compliance with guideline‐concordant therapy for empiric atypical bacterial coverage in critical community‐acquired pneumonia patients

Monday, December 7

10:45 am ‐11:45 am

385673 Loren Kirk 2‐385 Validated chromatographic method for application toward the beyond‐use date determination of two lidocaine containing mouthwash preparations

Monday, December 7

10:45 am ‐11:45 am


90 | P a g e

Submission ID



388180 Jenelle Kitasoe 5A‐237 Cerebral venous thrombosis, to treat or not to treat as ischemic stroke?

Tuesday, December 8

10:00 am ‐ 11:00 am

383172 Jonathan Kline 3‐229 Impact of providing patient awareness regarding ambulatory pharmacy services in a community hospital

Monday, December 7

12:00 pm ‐ 1:00 pm

385755 Keesha Kline 5A‐150 Pharmacist management of inpatient warfarin therapy: time to first therapeutic international normalized ratio (INR).

Tuesday, December 8

10:00 am ‐ 11:00 am

389532 Andrew Kluemper 5B‐165 Hospital‐acquired clostridium difficile infections: a retrospective chart review and quality improvement project

Tuesday, December 8

11:30 am ‐ 12:30 pm

386778 Alyssa Kmet 5B‐166 Accuracy of electronic health records one year post medication reconciliation and the impact on patient safety

Tuesday, December 8

11:30 am ‐ 12:30 pm

386203 Benjamin Knapp 5B‐420 Improving core measure compliance for hospital‐based psychiatric services through pharmacist intervention

Tuesday, December 8

11:30 am ‐ 12:30 pm

385284 Josephine Kochou 5B‐121 Factors that influence adoption of anticoagulation self‐monitoring in a minority population

Tuesday, December 8

11:30 am ‐ 12:30 pm

388370 Abigail Kojetin 5A‐300 Efficacy of pharmacist‐managed versus non‐pharmacist managed vancomycin therapy at a tertiary care medical center

Tuesday, December 8

10:00 am ‐ 11:00 am

387445 Meghan Kolf 3‐423 Practicality of insulin double check use and application in an inpatient setting

Monday, December 7

12:00 pm ‐ 1:00 pm

383310 Sammy Kolofske 5B‐046 Retrospective assessment of the management of patients with Parkinson's disease admitted to a community hospital

Tuesday, December 8

11:30 am ‐ 12:30 pm

386914 Devraj Kothari 5B‐226 Carbapenem‐resistant enterobacteriaceae (CRE): the

Tuesday, December 8

11:30 am ‐ 12:30 pm


91 | P a g e

Submission ID



concerning expansion of modern medicine's new superbug

386233 Sonia Kothari 3‐171 Association of previous limb injury and chronic pain with side of onset in Parkinson's disease and the potential role of pharmacists in delaying onset of the disease

Monday, December 7

12:00 pm ‐ 1:00 pm

385399 Andrew Kowalski 5A‐061 Chemotherapy‐induced peripheral neuropathy: analyzing treatment strategies in patients receiving bortezomib for multiple myeloma

Tuesday, December 8

10:00 am ‐ 11:00 am

387656 Sefa Kploanyi 5A‐187 How low can you go: is there a safe lower limit of low‐density lipoprotein (LDL)?

Tuesday, December 8

10:00 am ‐ 11:00 am

385151 Ann Kraatz 2‐158 Evaluating pharmacists confidence to screen for diabetes and prediabetes with CLIA‐waived point‐of‐care devices

Monday, December 7

10:45 am ‐11:45 am

386476 Antonia Kraljevic 5B‐122 Evaluation of therapeutic enoxaparin anti‐Xa level monitoring in the obese patient population: a retrospective chart review

Tuesday, December 8

11:30 am ‐ 12:30 pm

389166 Brittany Kramer 2‐351 Effects of regional anesthetic pain pumps plus opioid patient controlled analgesia compared to patient controlled analgesia: a retrospective chart review

Monday, December 7

10:45 am ‐11:45 am

385817 Anne Krasniak 5B‐167 Safety of pharmacologic venous thromboembolism (VTE) prophylaxis in non‐traumatic hemorrhagic stroke

Tuesday, December 8

11:30 am ‐ 12:30 pm

386090 Shannon Kraus 5A‐223 Analysis of 2015 ASHP PGY1 initial matching data

Tuesday, December 8

10:00 am ‐ 11:00 am

388509 Alex Kravetz 7‐095 Patients' perspectives on innovative randomization approaches


8:30 am ‐ 9:30 am


92 | P a g e

Submission ID



388677 Kelly Kreuter 3‐013 Assessment for the need of a nurse‐initiated ED sepsis bundle strategy to improve patient outcomes

Monday, December 7

12:00 pm ‐ 1:00 pm

386552 Judith Kristeller 3‐193 Importance of pharmacist or pharmacy student involvement in the medication reconciliation process to improve medication safety

Monday, December 7

12:00 pm ‐ 1:00 pm

386731 Zachary Kristoff 3‐172 Assessment of horizontal and vertical integration of top pharmacy programs based upon online curricula

Monday, December 7

12:00 pm ‐ 1:00 pm

387111 Zachary Kritzer 5B‐312 Evaluation of a transitions of care pharmacy service and its effect on 30‐day hospital readmission rates

Tuesday, December 8

11:30 am ‐ 12:30 pm

388067 Chelsea Krueger 3‐350 Systematic literature review of low molecular weight heparin compared with warfarin in cancer patients

Monday, December 7

12:00 pm ‐ 1:00 pm

387890 Lance Kruger 5B‐168 Comparison of empathy between 1st year and 4th year pharmacy students.

Tuesday, December 8

11:30 am ‐ 12:30 pm

385809 Jennifer Ku 5A‐202 Factors affecting interprofessional communication and teamwork skills in a simulation‐based course

Tuesday, December 8

10:00 am ‐ 11:00 am

386265 Tara Kuhn 3‐042 Interim analysis of pitavastatin and pitavastatin‐lactone pharmacokinetics in ClinSeq participants with genetic variants in solute carrier organic anion transporter family (SLCO/OATP), members 1B1 and 1B3

Monday, December 7

12:00 pm ‐ 1:00 pm

389592 Neha Kumar 2‐201 Electronic cigarette use, awareness and knowledge in collegiate students

Monday, December 7

10:45 am ‐11:45 am

388623 Sabina Kurian 5B‐047 Evaluation of clinical management services on

Tuesday, December 8

11:30 am ‐ 12:30 pm


93 | P a g e

Submission ID



adherence and quality of life in patients enrolled in a pharmacist‐run specialty clinic

385721 Brian Kurish 5A‐203 Characterization of the patient population for a health screening clinic at a North Carolina homeless shelter

Tuesday, December 8

10:00 am ‐ 11:00 am

388217 Rachel LaBianca 5B‐313 Medication use evaluation of treatment strategies for patients with post‐coronary artery bypass grafting (CABG) atrial fibrillation (AF) at a community health system

Tuesday, December 8

11:30 am ‐ 12:30 pm

387971 Miranda Lackie 2‐303 Medication therapy management in a pediatric pharmacy

Monday, December 7

10:45 am ‐11:45 am

385248 Michelle LaFever 5B‐404 Characterization of an emergency department management of alcohol withdrawal

Tuesday, December 8

11:30 am ‐ 12:30 pm

388524 Naureen Lalani 5B‐048 Evaluation of treatment of alcohol withdrawal at a tertiary care hospital

Tuesday, December 8

11:30 am ‐ 12:30 pm

388980 Nathan Laliberte 5A‐142 Evaluation of the in vitro activity of azithromycin, ceftriaxone, chloramphenicol, ciprofloxacin, fosfomycin, levofloxacin, and moxifloxacin against Salmonella enterica serovar Typhi

Tuesday, December 8

10:00 am ‐ 11:00 am

389645 Bao Lam 5A‐062 Integrating pharmacy services through medication reconciliation in a student‐run free medical clinic

Tuesday, December 8

10:00 am ‐ 11:00 am

386415 Cynthia Lam 2‐139 Evidence based review of probiotic efficacy in the treatment of antibiotic associated diarrhea to ensure appropriate product selection for hospital formulary

Monday, December 7

10:45 am ‐11:45 am

386900 Laura Lambeth 5B‐353 Medication use evaluation of an unactivated 4 factor

Tuesday, December 8

11:30 am ‐ 12:30 pm


94 | P a g e

Submission ID



prothrombin complex concentrate at a large, community hospital

387215 Jessica Lampley 2‐386 Assessing the impact of direct community involvement when designing self‐help materials, and the effectiveness of those materials in increasing medication adherence and health awareness

Monday, December 7

10:45 am ‐11:45 am

386786 Alen Landup 5B‐007 Evaluation of ceftriaxone, cefepime, piperacillin/tazobactam, and carbapenem susceptibilities and antimicrobial utilization pre‐ and post‐implementation of laboratory cessation of extended‐spectrum beta‐lactamase (ESBL) phenotypic testing

Tuesday, December 8

11:30 am ‐ 12:30 pm

389240 Tia Lane 3‐091 Depression trends in pharmacy school students

Monday, December 7

12:00 pm ‐ 1:00 pm

386558 Courtney Lanehart 5A‐151 Evaluation of clinical pharmacist‐led medicare annual wellness visits

Tuesday, December 8

10:00 am ‐ 11:00 am

387004 Lynsee Lanners 7‐214 Implementation of tranexamic acid (TXA) for trauma protocol at a rural trauma center


8:30 am ‐ 9:30 am

389489 Nick Larned 5A‐326 Impact of a student‐led shadowing program on professional and career development

Tuesday, December 8

10:00 am ‐ 11:00 am

382946 Melissa Laub 3‐014 Impact of clinical pharmacy services in a federally qualified health center (FQHC) primary care setting.

Monday, December 7

12:00 pm ‐ 1:00 pm

385222 Prutha Lavani 5A‐204 Optimization of institutional patient assistance programs at an academic medical center

Tuesday, December 8

10:00 am ‐ 11:00 am

385918 Adrian Lawrence 5B‐049 Impact of malnutrition in patients with heart failure on hospital length of stay and

Tuesday, December 8

11:30 am ‐ 12:30 pm


95 | P a g e

Submission ID



readmission rate

386328 Allen Le 5A‐301 Time and cost‐savings of implementing an automatic renal dosing protocol per pharmacy

Tuesday, December 8

10:00 am ‐ 11:00 am

387725 Binh Le 5B‐381 Clinical utility of methicillin‐resistant Staphylococcus aureus nasal polymerase chain reaction (PCR) in intensive care unit patients with pneumonia

Tuesday, December 8

11:30 am ‐ 12:30 pm

385669 Hannah Le 5B‐169 Health Plan Coverage Of Drugs Approved by the Food and Drug Administration (FDA) With Breakthrough Therapy Designation

Tuesday, December 8

11:30 am ‐ 12:30 pm

388277 James Le 5A‐302 Current HIV treatment knowledge and confidence within clinical pharmacy practice

Tuesday, December 8

10:00 am ‐ 11:00 am

386830 Nam Phuong

Le 5A‐291 Multimodal analgesic management report: focus on controlling pain in hip fracture and hip orthopedic patients within 48 hours of admission

Tuesday, December 8

10:00 am ‐ 11:00 am

387063 Thao Le 2‐077 Four factor prothombin complex concentrate for urgent reversal of new oral anticoagulants: a case series

Monday, December 7

10:45 am ‐11:45 am

388211 Mary‐Haston

Leary 7‐187 Potential impact of revised quinolone clinical breakpoints on susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa


8:30 am ‐ 9:30 am

383296 Andrew Lee 5B‐270 Evaluation of Immunosuppression in the Combined Liver‐Kidney Transplant Recipient

Tuesday, December 8

11:30 am ‐ 12:30 pm

386351 Clarice Lee 2‐202 Evaluation of granulocyte‐colony stimulating factor use in patients at an academic medical center

Monday, December 7

10:45 am ‐11:45 am


96 | P a g e

Submission ID



385371 Cynthia Lee 5B‐314 Evaluation of health care professional students' perspectives on interprofessional collaborative practice

Tuesday, December 8

11:30 am ‐ 12:30 pm

387234 David Lee 3‐402 Medication utilization evaluation of four‐factor prothrombin complex concentrate and adherence to restrictions at University of Washington Medical Center and Harborview Medical Center

Monday, December 7

12:00 pm ‐ 1:00 pm

386840 Grace Lee 5B‐050 Validation of the Drug Abuse Screening Test (DAST): a potential screening tool for pharmacists in hospital settings

Tuesday, December 8

11:30 am ‐ 12:30 pm

385763 Hye Jin Lee 2‐203 Calciphylaxis, an unusual adverse drug reaction to warfarin therapy.

Monday, December 7

10:45 am ‐11:45 am

386388 Jacky Lee 2‐164 Diabetic ketoacidosis secondary to intolerance with inhaled insulin

Monday, December 7

10:45 am ‐11:45 am

388299 Jade Lee 7‐136 Persistence of metabolic monitoring for psychiatry inpatients treated with second‐generation antipsychotics


8:30 am ‐ 9:30 am

387274 Jane Lee 2‐119 Evaluation of empiric and definitive therapy for febrile neutropenia

Monday, December 7

10:45 am ‐11:45 am

389100 Jane Lee 5A‐086 Novel urinary biomarkers in the detection of vancomycin associated renal injury

Tuesday, December 8

10:00 am ‐ 11:00 am

388371 Justine Lee 3‐092 Adjunctive therapy of statin and ezetimibe: dwindling fad or robust future?

Monday, December 7

12:00 pm ‐ 1:00 pm

389315 Kyulim Lee 3‐034 Enoxaparin Administration Times and Hospital Length of Stay in Venous Thromboembolism Treatment

Monday, December 7

12:00 pm ‐ 1:00 pm

388576 Margaret Lee 5A‐101 Antifungal prophylaxis consideration in patients being treated with blinatumomab for

Tuesday, December 8

10:00 am ‐ 11:00 am


97 | P a g e

Submission ID



Philadelphia chromosome‐negative relapsed or refractory b‐cell acute lymphoblastic leukemia: a case report.

385528 Megan Lee 2‐204 Evaluation of warfarin interactions and frequency of international normalized ratio (INR) monitoring with chemotherapy at Queens Cancer Center

Monday, December 7

10:45 am ‐11:45 am

384408 Michelle Lee 5B‐005 Description and educational outcomes of a pre‐APPE student delivered patient counseling service, a model for early experiential education

Tuesday, December 8

11:30 am ‐ 12:30 pm

387820 Soyoon Lee 3‐351 Evaluation of national hospital inpatient quality measures sepsis bundle project compliance at a community hospital

Monday, December 7

12:00 pm ‐ 1:00 pm

383196 Susan Lee 5A‐037 Evaluating the accuracy of creatinine clearance estimations by Cockcroft‐Gault equation based on serum creatinine rounding in elderly patients as part of the vancomycin dosing protocol

Tuesday, December 8

10:00 am ‐ 11:00 am

387845 Sue Lee‐Chuu 2‐022 Evaluation of adherence to empiric antibiotic recommendations in treatment of diabetic foot infections

Monday, December 7

10:45 am ‐11:45 am

389349 Alyson Leonard 3‐305 Ipilimumab‐induced colitis with perforation following treatment of metastatic melanoma

Monday, December 7

12:00 pm ‐ 1:00 pm

382598 Nicholas Leung 3‐284 Liposomal bupivacaine in total knee arthroplasty

Monday, December 7

12:00 pm ‐ 1:00 pm

385711 Ashley Lewis 2‐097 Implementation of 2D barcode scanned medication administration

Monday, December 7

10:45 am ‐11:45 am

388953 Demetria Lewis 5B‐382 Growth inhibition and penetration ability of anionic fluoroquinolone derivatives

Tuesday, December 8

11:30 am ‐ 12:30 pm


98 | P a g e

Submission ID



against mucoid Pseudomonas aeruginosa

387331 AARON LEYBA 2‐023 Intent to provide the influenza vaccine to children ages 6‐18: an analysis of law implementation by Tucson community pharmacies

Monday, December 7

10:45 am ‐11:45 am

388940 Christine Li 2‐387 Evaluation of venous thromboembolism (VTE) incidence and characterization of patients with VTE in a level one trauma center

Monday, December 7

10:45 am ‐11:45 am

388855 Curtis Li 3‐173 Impact of Student Exposure to Managed Care Courses in Pharmacy School on Attainment of Managed Care Post‐Graduate Year 1 Residencies

Monday, December 7

12:00 pm ‐ 1:00 pm

388580 Irene Li 2‐205 Evaluation of the vancomycin pharmacokinetic calculator for empiric dosing and attainment of goal trough levels at a community hospital

Monday, December 7

10:45 am ‐11:45 am

389474 Mary Li 7‐096 Review of IV workflow managers in preventing errors in the IV compounding room


8:30 am ‐ 9:30 am

385782 Yinyin Li 5A‐152 Pregnancy‐related constipation and commonly prescribed bowel regimens

Tuesday, December 8

10:00 am ‐ 11:00 am

385761 Nadia Lian 5A‐303 Warfarin dose adjustments for patients starting and stopping tube feeds. Is there an average dose adjustment in warfarin that can be determined and a time frame that this will occur in?

Tuesday, December 8

10:00 am ‐ 11:00 am

388687 Jenny Liang 5A‐038 Pharmacy services impact on diabetes outcomes in an ambulatory care setting

Tuesday, December 8

10:00 am ‐ 11:00 am

389104 Vivian Liang 5B‐123 Impact of early versus late initiation of angiotensin‐converting enzyme inhibitor or

Tuesday, December 8

11:30 am ‐ 12:30 pm


99 | P a g e

Submission ID



angiotensin II receptor blocker on long‐term kidney allograft outcomes: a 10 year follow‐up

385966 Holly Lien 5B‐354 Optimization and purification of essential reagents involved in the large‐scale production of synthetic heparin

Tuesday, December 8

11:30 am ‐ 12:30 pm

389438 Jihae Lim 3‐230 Evaluation of appropriateness of intravenous immunoglobulin (IVIG) at a large urban medical center

Monday, December 7

12:00 pm ‐ 1:00 pm

387670 Sin Yin Lim 2‐335 Comparisons of fentanyl pharmacokinetics and dose‐determining factors in obese and non‐obese children

Monday, December 7

10:45 am ‐11:45 am

386835 Wai in Lim 2‐206 Prevalence and risk factors for potential drug‐drug interactions in a inner‐city HIV clinic with electronic medical health care record

Monday, December 7

10:45 am ‐11:45 am

387388 Grace Lin 5A‐020 Comparison of frequencies and patterns of cardiopulmonary arrests inside versus outside of the intensive care unit at a tertiary teaching hospital

Tuesday, December 8

10:00 am ‐ 11:00 am

388280 Justin Lin 5A‐039 Physicochemical stability and lot variance of colistimethate sodium in aqueous solution

Tuesday, December 8

10:00 am ‐ 11:00 am

386155 Michelle Lin 5A‐021 Hydrocodone combination prescriptions filled at community pharmacy before and after reschedule

Tuesday, December 8

10:00 am ‐ 11:00 am

389299 Mingyang Lin 3‐174 A Regression Analysis of Factors Affecting Hospital Quality in Acute Care Hospitals in NJ

Monday, December 7

12:00 pm ‐ 1:00 pm

387837 Pei Lin 3‐352 Evaluation of the use of 4‐factor prothrombin complex concentrate in the reversal of target specific oral anticoagulants

Monday, December 7

12:00 pm ‐ 1:00 pm

383286 Swan Lin 7‐114 Pharmacometabolomics of pulmonary delivered tissue


8:30 am ‐ 9:30 am


100 | P a g e

Submission ID



plasminogen activator in a plastic bronchitis murine model

387259 Brian Lindner 5A‐153 Evaluation of current self‐report adherence scales used in transplant patients

Tuesday, December 8

10:00 am ‐ 11:00 am

387051 Sarah Lindstrom 2‐362 Assessing QT prolongation and risk of torsaudes de pointes (TdP) with selected tyrosine kinase inhibitors (TKIs)

Monday, December 7

10:45 am ‐11:45 am

384640 Tara Lines 2‐086 Tolvaptan use for hypervolemic hyponatremia in left ventricular assist device patients: a retrospective investigation

Monday, December 7

10:45 am ‐11:45 am

388187 Lauren Linna 7‐027 Incidence of neutropenia associated with clozapine use in African Americans in an outpatient clinic in Alabama


8:30 am ‐ 9:30 am

383483 Ivy Lio 5B‐315 Evaluation of Drug Therapy Problems for North Carolina Medicaid Patients within Community Care Plan of Eastern Carolina

Tuesday, December 8

11:30 am ‐ 12:30 pm

387323 Caleb Little 5B‐316 Assessment of an outpatient‐driven weight loss management clinic

Tuesday, December 8

11:30 am ‐ 12:30 pm

387800 Catherine Liu 3‐285 Impact of peer mentor involvement in professionalism day on first year professional pharmacy students

Monday, December 7

12:00 pm ‐ 1:00 pm

386978 Jennifer Liu 3‐175 Comparison of medical information websites: value assessments

Monday, December 7

12:00 pm ‐ 1:00 pm

388149 Jiajun Liu 5B‐100 Multicenter evaluation of clinical outcomes among patients with Gram negative bloodstream infections (GNBSI) due to Enterobacteriaceae and non‐Enterobacteriaceae according to cefepime SDD MIC determination

Tuesday, December 8

11:30 am ‐ 12:30 pm

386419 Parker Liu 7‐137 Is dual Psuedomonas coverage necessary? A retrospective


8:30 am ‐ 9:30 am


101 | P a g e

Submission ID



cohort of adult ICU patients treated for healthcare‐associated pneumonia

386363 Wendy Liu 5B‐002 Nutrition Requirements in Patients with Acute Brain Injury Undergoing Pentobarbital Infusion

Tuesday, December 8

11:30 am ‐ 12:30 pm

386144 Lauren Lockus 3‐231 Utilization review of Saccharomyces boulardii in an academic medical center

Monday, December 7

12:00 pm ‐ 1:00 pm

385210 Kathryn Loeser 5B‐170 Efficacy of rivaroxaban in non‐low risk pulmonary embolism

Tuesday, December 8

11:30 am ‐ 12:30 pm

388960 Brittany Logston 5B‐271 Pilot study evaluating a new vancomycin dosing algorithm in pediatric patients

Tuesday, December 8

11:30 am ‐ 12:30 pm

385875 Tara Longman 7‐173 Analysis of pathogens responsible for health care associated or community acquired pneumonia in the intensive care unit (ICU)


8:30 am ‐ 9:30 am

386371 Christopher Loos 5B‐124 Anticoagulant use in suspected heparin induced thrombocytopenia

Tuesday, December 8

11:30 am ‐ 12:30 pm

385788 Alicia Lopez 7‐243 Assessing interprofessional education (IPE) activities to determine if activity duration impacts amount of change in individual interprofessional perceptions.


8:30 am ‐ 9:30 am

389652 William Lopez 2‐053 Retrospective review of pharmacist's interventions, monitoring, and documentation of insulin dosing at a teaching community hospital

Monday, December 7

10:45 am ‐11:45 am

389512 Yartiza Lopez 5B‐125 High (150mg twice daily) versus standard (75mg twice daily) oseltamivir dosing in critically ill patients with influenza

Tuesday, December 8

11:30 am ‐ 12:30 pm

386263 Michael Lorenzo 5B‐227 Evaluation of cardiac rehabilitation directed medication education services

Tuesday, December 8

11:30 am ‐ 12:30 pm

387232 Susan Lowrie 5A‐281 Evaluation of liposomal Tuesday, 10:00 am ‐ 11:00 am


102 | P a g e

Submission ID



bupivacaine for post‐surgical analgesia following joint replacement procedures

December 8

388244 Ashley Loy 5A‐022 Comparison of a comprehensive, telephone‐based medication therapy management (MTM) service to standard MTM programs on centers for medicare and medicaid services (CMS) star ratings

Tuesday, December 8

10:00 am ‐ 11:00 am

387057 Andy Lu 2‐054 Management of psychiatric conditions in a congestive heart failure clinic at an academic medical center

Monday, December 7

10:45 am ‐11:45 am

384778 Jennifer Lu 5A‐128 Assessment of prescribing practices of four‐factor prothrombin complex concentrate at an urban teaching hospital

Tuesday, December 8

10:00 am ‐ 11:00 am

386598 Stanley Luc 3‐093 Pharmacy students' impact on inpatient medication errors in human immunodeficiency virus (HIV) infected patients

Monday, December 7

12:00 pm ‐ 1:00 pm

389253 Christina Luisi 3‐270 Implementation of an innovative influenza and pneumococcal immunization screening model to increase vaccination rates in hospitalized pediatric patients

Monday, December 7

12:00 pm ‐ 1:00 pm

386627 William Lukkes 5B‐051 Therapeutic management of a liver hydatid cyst: case report

Tuesday, December 8

11:30 am ‐ 12:30 pm

386940 Chuyi Luliang 5B‐228 Common high risk medications for G6PD deficiency patients

Tuesday, December 8

11:30 am ‐ 12:30 pm

389345 Miriam Lulusa 5B‐052 Gestational diabetes clinic for indigent Latinos

Tuesday, December 8

11:30 am ‐ 12:30 pm

385208 Kristine Luong 3‐015 Students perception of Team‐based Learning (TBL) as a teaching pedagogy in a fully integrated doctor of pharmacy curriculum

Monday, December 7

12:00 pm ‐ 1:00 pm

385585 VINCENT LUONG 5B‐229 Endocarditis caused by Gemella Tuesday, 11:30 am ‐ 12:30 pm


103 | P a g e

Submission ID



morbillorum December 8

388443 Erin Lupton 2‐304 Impact of a shared medication list in an outpatient pharmacy at a pediatric institution: Potential barriers to medication access

Monday, December 7

10:45 am ‐11:45 am

386862 Katherine Lutek 3‐353 Adherence to oral chemotherapy: a study on dasatinib

Monday, December 7

12:00 pm ‐ 1:00 pm

385253 Yao Luu 2‐408 Stability of sildenafil in combination with heparin and dopamine

Monday, December 7

10:45 am ‐11:45 am

389269 Alexandrea Lux 5A‐219 Implementation of process improvements to decrease dispensing defects produced by an automated unit‐dose dispensing system

Tuesday, December 8

10:00 am ‐ 11:00 am

384782 Eric Ly 2‐024 Development of a standardized total parenteral nutrition (TPN) protocol for the obese population

Monday, December 7

10:45 am ‐11:45 am

388660 Tony Ly 2‐120 Edoxaban: new drug review and cost‐minimization analysis

Monday, December 7

10:45 am ‐11:45 am

388028 Rachel Lynch 3‐176 Pharmacists and physicians unite: an analysis of the interdisciplinary approach to healthcare at the Promise Clinic

Monday, December 7

12:00 pm ‐ 1:00 pm

388958 Owen Lyons 5A‐304 Does implementing a pharmacy driven counseling program lead to improved hospital consumer assessment of healthcare providers and systems (HCAHPS) scores?

Tuesday, December 8

10:00 am ‐ 11:00 am

387924 Sheng Da Ma 5B‐383 Evaluation of antibiotic bone cement at a large academic teaching hospital

Tuesday, December 8

11:30 am ‐ 12:30 pm

388702 Casey Mabus 3‐306 Examining the pharmacokinetic parameters of procalcitonin and determining factors associated with a delayed rise in levels

Monday, December 7

12:00 pm ‐ 1:00 pm


104 | P a g e

Submission ID



388432 Bragan Mace 3‐307 Effect of pre‐existing beta‐blocker and/or statin therapy on outcomes for patients with septic shock

Monday, December 7

12:00 pm ‐ 1:00 pm

387206 Travis Macek 2‐305 Implementation of a pharmacy managed medication reconciliation program in an emergency department

Monday, December 7

10:45 am ‐11:45 am

387958 Christine Machtemes 5B‐230 Treatment of obesity Tuesday, December 8

11:30 am ‐ 12:30 pm

386030 Chelsea Macias 5B‐425 Evaluation of piperacillin/tazobactam use before and after the implementation of a best practice advisory alert for 72 hours of use

Tuesday, December 8

11:30 am ‐ 12:30 pm

387087 Mia Magliazzo 2‐207 Evaluation of meropenem use at a childrens hospital

Monday, December 7

10:45 am ‐11:45 am

386831 Maximilian Magun 2‐208 Providing pharmacy services to help improve pharmaceutical care in an underserved community in Antigua, Guatemala

Monday, December 7

10:45 am ‐11:45 am

386943 Ashley Maharana 3‐308 Characterizing drug classes likely to cause adverse events based on frequency of prescribing

Monday, December 7

12:00 pm ‐ 1:00 pm

388915 Shanti Maheshwari 5B‐231 Exploring cost reduction strategies when using alteplase to clear occluded central venous catheters: a GPO perspective

Tuesday, December 8

11:30 am ‐ 12:30 pm

388979 Mehwish Mahmood 2‐209 Benzocaine induced methemoglobinemia

Monday, December 7

10:45 am ‐11:45 am

386617 Syeda Mahmood 7‐138 Effect of hyponatremia in heart failure patients on cognitive function and gait


8:30 am ‐ 9:30 am

386292 Zeshan Mahmood 7‐244 Impact of computerized physician order entry (CPOE) treatment recommendations on influencing antibiotic prescribing patterns for


8:30 am ‐ 9:30 am


105 | P a g e

Submission ID



community acquired pneumonia

386368 Mahta Mahmoudieh 7‐245 Black currant (Ribes nigrum L) anthocyanins' (BCA) effect on expression of EZH2 in a rat hepatocellular carcinoma model and HepG2 cell line


8:30 am ‐ 9:30 am

386776 Jairus Mahoe 2‐078 Impact of The A.L.O.H.A. (A Life of Health and Awareness) Project on Knowledge, Confidence, and Empathy of Students Enrolled in the Doctor of Pharmacy Program

Monday, December 7

10:45 am ‐11:45 am

385370 Ashlynn Mahoney 2‐098 Administration of tamsulosin via nasogastric tube, gastrostomy tube, jejunostomy tube, or pureed mix and effects on blood pressure

Monday, December 7

10:45 am ‐11:45 am

387995 Ahmad Mahrous 5B‐232 Evaluation of phone call reminders to improve medication adherence in a medication assistance program (MAP)

Tuesday, December 8

11:30 am ‐ 12:30 pm

387578 Kiet Mai 2‐210 Evaluation of unfractionated heparin in surgical intensive care unit patients with low body mass index.

Monday, December 7

10:45 am ‐11:45 am

389235 Kyle Malhotra 2‐025 Inpatient multidisciplinary educational approach to reduce 30‐day heart failure readmissions

Monday, December 7

10:45 am ‐11:45 am

386825 Evan Mallory 5A‐023 Effects of introducing standardized instructions into a computerized physician order entry (CPOE) at a community health center

Tuesday, December 8

10:00 am ‐ 11:00 am

388885 Mallory Moore

389239 Josh Maloney 2‐007 Student pharmacists' social distancing towards people with mental health

Monday, December 7

10:45 am ‐11:45 am

389660 Ericka Malow 5B‐317 Outcomes for Patients Receiving Pharmacist Dosed

Tuesday, December 8

11:30 am ‐ 12:30 pm


106 | P a g e

Submission ID



Vancomycin and/or Aminoglycoside Antibiotics

386394 Monica Manandik 5A‐175 Risk of vancomycin nephrotoxicity in obese and morbidly obese patients

Tuesday, December 8

10:00 am ‐ 11:00 am

386105 Sarah Manasen 5B‐053 Case report of sulfamethoxazole‐trimethoprim‐induced rhabdomyolysis in an immunocompetent patient

Tuesday, December 8

11:30 am ‐ 12:30 pm

389018 Kyle Mangan 7‐139 Sustained low‐efficiency daily dialysis (SLEDD): evaluation of antimicrobial dose adjustment at an academic medical center


8:30 am ‐ 9:30 am

386280 Bejoy Maniara 2‐211 Using pharmacy informatics in the acute care setting to optimize antimicrobial prescribing and stewardship program process measures

Monday, December 7

10:45 am ‐11:45 am

385269 Kayihura Manigaba 2‐403 Evaluation of accuracy of home medication lists as part of a nonpharmacy‐based medication reconciliation program

Monday, December 7

10:45 am ‐11:45 am

386374 Melanie Manis 2‐420 Improving the use of tolvaptan in a community hospital through periodic medication use evaluations (MUE)

Monday, December 7

10:45 am ‐11:45 am

387006 Deepa Manivannan 2‐212 Efficacy of intravenous tranexamic acid in minimizing blood loss following total knee replacement

Monday, December 7

10:45 am ‐11:45 am

388527 Dana Manning 5A‐251 Choosing wisely with PPIs: An interprofessional quality project at Regional Hospital.

Tuesday, December 8

10:00 am ‐ 11:00 am

387363 Tharit Manoi 5A‐305 Identification of Drug Interaction of Pirfenidone with Various Pharmaceutical Drugs

Tuesday, December 8

10:00 am ‐ 11:00 am

389458 Heba Mansour 3‐094 Adverse drug events related to canagliflozin: a meta‐analysis of randomized, placebo‐controlled trials

Monday, December 7

12:00 pm ‐ 1:00 pm


107 | P a g e

Submission ID



385992 Andrea Manteuffel 7‐246 Effect of Pharmacy School Curriculum on Critical Thinking Using the HSRT and CCTDI


8:30 am ‐ 9:30 am

387910 Yan Mao 5B‐421 Evaluation and comparison of basal‐bolus protocol versus non‐basal bolus protocol to control blood glucose in hospitalized patients

Tuesday, December 8

11:30 am ‐ 12:30 pm

384763 John Rafael Marasigan 3‐232 Acute hepatitis Induced by fertility medications and phytoestrogenic dietary supplements: a case report

Monday, December 7

12:00 pm ‐ 1:00 pm

382615 Jacob Maready 5B‐318 Dofetilide usage and effects on QTc interval prolongation in patients taking selective serotonin reuptake inhibitors

Tuesday, December 8

11:30 am ‐ 12:30 pm

387452 Robert Marquis 2‐213 Creating a productivity model for a bedside delivery pharmacy through a student‐observed time study

Monday, December 7

10:45 am ‐11:45 am

388406 Legacy Marsolek 5A‐205 Retrospective assessment of vancomycin management in a pediatric hospital

Tuesday, December 8

10:00 am ‐ 11:00 am

384669 Christina Martin 3‐095 Remodeling systolic heart failure treatment with angiotensin receptor blocker‐neprilysin inhibition

Monday, December 7

12:00 pm ‐ 1:00 pm

389462 Jacob Martin 5A‐106 Pharmacists' experiences reviewing a self‐administered brief screening tool for medication‐related problems with patients in a community pharmacy setting

Tuesday, December 8

10:00 am ‐ 11:00 am

389533 Elena Martinez 5B‐101 Clostridium difficile infection (CDI) in bone marrow transplant recipients

Tuesday, December 8

11:30 am ‐ 12:30 pm

384475 Laurence Martinez 3‐233 Linagliptin induced pancreatitis: a case report

Monday, December 7

12:00 pm ‐ 1:00 pm

384335 Daraoun Mashrah 5B‐171 Comparison of students and patients perceptions on reasons for medication non‐adherence

Tuesday, December 8

11:30 am ‐ 12:30 pm

386104 Dalila Masic 5A‐087 Analysis of descriptive themes Tuesday, 10:00 am ‐ 11:00 am


108 | P a g e

Submission ID



and errors in letters of recommendation for postgraduate year one (PGY‐1) pharmacy residency candidates

December 8

385842 Inela Masic 5A‐088 Appropriateness of nucleoside reverse transcriptase inhibitor dosing during continuous veno‐venous hemofiltration at a large academic center

Tuesday, December 8

10:00 am ‐ 11:00 am

385973 Anne Masich 7‐247 Evaluation of the concurrent use of dolutegravir (DTG) and metformin in human immunodeficiency virus (HIV)‐positive patients


8:30 am ‐ 9:30 am

388164 Mathew Mason 3‐177 Evaluation of patient and emergency department (ED) characteristics associated with inpatient sepsis mortality: a comparative analysis between sepsis and severe sepsis

Monday, December 7

12:00 pm ‐ 1:00 pm

388549 Kayleigh Matesic 5A‐218 Hypertension Awareness Event at the Rochester Public Market

Tuesday, December 8

10:00 am ‐ 11:00 am

387448 Daniel Mathan 2‐214 Trends in polymyxin b use and resistance at an academic medical center

Monday, December 7

10:45 am ‐11:45 am

385270 Justin Mathew 2‐251 Assessment of postoperative glycemic control in orthotopic heart transplant recipients

Monday, December 7

10:45 am ‐11:45 am

386977 Sharon Mathew 5B‐233 Medication use evaluation of IV levothyroxine in a tertiary care academic facility

Tuesday, December 8

11:30 am ‐ 12:30 pm

386162 Sheryl Mathew 3‐178 Antibiotic prophylaxis in oncology patients at Capital Health Medical Center

Monday, December 7

12:00 pm ‐ 1:00 pm

385135 Janna Matson 5B‐054 Subtherapeutic vancomycin trough levels in elderly or malnourished cancer patients: the impact of rounding serum creatinine

Tuesday, December 8

11:30 am ‐ 12:30 pm

388844 Michael Mauri 2‐215 Pharmacoeconomic evaluation of treating multi‐drug resistant gram negative infections

Monday, December 7

10:45 am ‐11:45 am


109 | P a g e

Submission ID



386626 Meshell Maxam 5A‐267 Analysis of financial impact on unnecessary extension of antibiotic therapy in patients diagnosed with community‐acquired pneumonia

Tuesday, December 8

10:00 am ‐ 11:00 am

387727 Andrew May 5B‐055 Identification of risk factors for higher than expected incidence of Clostridium difficle infections at an academic medical center

Tuesday, December 8

11:30 am ‐ 12:30 pm

388736 Julianne Mazzola 2‐328 Infections in a severely immunocompromised hematopoietic stem cell transplant (HSCT) patient

Monday, December 7

10:45 am ‐11:45 am

386777 Kristina McAtee 5B‐172 Assessment of postoperative blood transfusion requirements in elective orthopedic surgery patients

Tuesday, December 8

11:30 am ‐ 12:30 pm

384775 Kathryn McAvoy 5A‐129 Assessment of time to reversal of international normalized ratio and adverse events associated with the use of four‐factor prothrombin complex concentrate

Tuesday, December 8

10:00 am ‐ 11:00 am

385388 Patrick McBride 5B‐234 Fertility preservation in females undergoing chemotherapy

Tuesday, December 8

11:30 am ‐ 12:30 pm

387990 Melissa McCarty 7‐097 Evaluation of pharmacist involvement in a post‐discharge transitions of care clinic


8:30 am ‐ 9:30 am

388511 Meredith McCauley 2‐329 Quality improvement initiative to guide appropriate use of intravenous acetaminophen in pediatric patients

Monday, December 7

10:45 am ‐11:45 am

384788 Logan McConnell 2‐216 Antibiogram of Double Antibiotic Coverage for P. aeruginosa

Monday, December 7

10:45 am ‐11:45 am

386342 Zachary McConnell 7‐248 Comparison of acute kidney injury incidence of piperacillin‐tazobactam monotherapy to piperacillin‐tazobactam and vancomycin combination therapy in patients with chronic kidney disease


8:30 am ‐ 9:30 am


110 | P a g e

Submission ID



386175 Ryan McCoy 2‐159 Aripiprazole‐induced diabetic ketoacidosis

Monday, December 7

10:45 am ‐11:45 am

383010 Danielle McDonald 3‐179 Adherence to parenteral nutrition guidelines in a single‐center multidisciplinary intensive care setting

Monday, December 7

12:00 pm ‐ 1:00 pm

388947 Marissa McDonald 2‐306 Development of a transition of care medication education program for hematopoietic stem‐cell transplantation patients: importance of pharmacist interventions and education on patient outcomes at discharge

Monday, December 7

10:45 am ‐11:45 am

387922 Melanie McDonald 3‐309 Evaluation of appropriate statin therapy in HIV‐infected patients in the southeast

Monday, December 7

12:00 pm ‐ 1:00 pm

389168 Leann McDowell 2‐033 Bedside delivery of discharge medication decreases medication‐related issues post‐discharge

Monday, December 7

10:45 am ‐11:45 am

386331 Teri McElheny 5B‐319 Impact of administration times of metolazone and furosemide on the efficacy and safety of the diuretic effect in patients with acute decompensated heart failure

Tuesday, December 8

11:30 am ‐ 12:30 pm

389381 Katelin McGory 5A‐268 Monte Carlo analysis of ceftolozane‐tazobactam and ceftazidime‐avibactam against common Gram‐negative pathogens

Tuesday, December 8

10:00 am ‐ 11:00 am

385785 Erin McGurty 5B‐395 Risk factors for colonization with multidrug‐resistant organisms in patients undergoing pancreaticoduodenectomy

Tuesday, December 8

11:30 am ‐ 12:30 pm

384791 Kelsey McIntyre 3‐180 Evaluation of the efficacy of alteplase for catheter occlusion in an urban hospital‐based outpatient hemodialysis unit

Monday, December 7

12:00 pm ‐ 1:00 pm

387413 Danielle Mckimmy 5B‐405 Safety and efficacy of linezolid Tuesday, 11:30 am ‐ 12:30 pm


111 | P a g e

Submission ID



for the treatment of cholangitis in liver transplant recipients

December 8

387295 Amanda McKinney 7‐028 Antibiotic de‐escalation using target enriched multiplex polymerase chain reaction (TEM‐PCR): analysis in patients with hospital‐acquired pneumonia (HAP), healthcare‐associated pneumonia (HCAP), and ventilator‐associated pneumonia (VAP)


8:30 am ‐ 9:30 am

389334 Lindsey McKinney 5B‐384 Assessment of predictors involved in successful discontinuation of buprenorphine therapy and maintenance of sobriety post withdrawal from buprenorphine in opiate addicted patients.

Tuesday, December 8

11:30 am ‐ 12:30 pm

389548 Ellen McKnight 5A‐116 Effect of asthma guideline adherence on clinical outcomes of pediatric asthma patients

Tuesday, December 8

10:00 am ‐ 11:00 am

383082 Jean McLaughlin 7‐249 Needs assessment for the implementation of a pharmacist‐run oral chemotherapy clinic


8:30 am ‐ 9:30 am

386628 Clare McMahon 2‐307 Mosquito bites: from itching to intubation

Monday, December 7

10:45 am ‐11:45 am

387216 Bliss McMichael 5B‐056 Percentage of patients with hematocrit less than 32 percent using point‐of‐care international normalized ratio testing in anticoagulation clinic

Tuesday, December 8

11:30 am ‐ 12:30 pm

389473 Zackary McMullan 7‐029 Prescribing practices of sildenafil in pediatric patients diagnosed with pulmonary hypertension at Children's of Alabama


8:30 am ‐ 9:30 am

389103 Christine McNamara 3‐354 Demonstration of how to use pilot data to estimate sample size to test the association of age and health literacy among

Monday, December 7

12:00 pm ‐ 1:00 pm


112 | P a g e

Submission ID



geriatric surgical patients

386180 Krista Mecadon 5B‐235 Impact of pharmacist‐initiated home blood pressure monitoring (HBPM) and telephonic interventions

Tuesday, December 8

11:30 am ‐ 12:30 pm

387937 Patricia Medina 3‐096 Vitamin D deficiency and the effect of supplementation in critically ill patients

Monday, December 7

12:00 pm ‐ 1:00 pm

387984 Sarah Mehringer 2‐389 Penicillin allergy testing: a novel role for pharmacists in antimicrobial stewardship

Monday, December 7

10:45 am ‐11:45 am

386921 Caroline Mejias‐De Jesus

7‐098 Sex differences in antibody profiles and adverse reactions to 2009 H1N1 influenza virus immunization in a mouse model


8:30 am ‐ 9:30 am

387355 Gladys Mekenye 2‐336 Evaluating relapse rates in allogeneic hematopoietic stem cell transplant (HSCT) patients receiving fludarabine, intravenous busulfan, and antithymocyte globulin equine reduced intensity conditioning (FB2 RIC) regimen

Monday, December 7

10:45 am ‐11:45 am

387834 Krystal Memmer 3‐286 Improvement of postoperative pain management following orthopedic surgery through pharmacist‐led interdisciplinary education.

Monday, December 7

12:00 pm ‐ 1:00 pm

389577 Christopher Mendoza 2‐217 Hypothermia protocol and the role of the clinical pharmacist in the coronary care unit

Monday, December 7

10:45 am ‐11:45 am

384761 Randy Meng 3‐234 Valganciclovir‐induced pancytopenia: a case report

Monday, December 7

12:00 pm ‐ 1:00 pm

389167 Kody Merwine 2‐140 Evaluation of treatment for angiotensin‐converting enzyme (ACE) inhibitor induced angioedema and practicality of implicating icatibant in a community hospital emergency room

Monday, December 7

10:45 am ‐11:45 am

382721 Jeremiah Metzdorf 5A‐272 Relationship between receiving pneumococcal vaccination in

Tuesday, December 8

10:00 am ‐ 11:00 am


113 | P a g e

Submission ID



COPD patients with health‐related quality of life: analysis using a nationally representative dataset.

386357 Brendan Meyer 7‐030 Impact of an interdisciplinary geriatric clinic on cognition, depression, and anxiety in geriatric patients.


8:30 am ‐ 9:30 am

389303 Andrea Mezentsef 5A‐063 The Right to Dispense: Survey of practicing Florida pharmacists regarding obtaining the right to dispense self‐administered hormonal contraceptives in the community setting

Tuesday, December 8

10:00 am ‐ 11:00 am

389254 Leah Michael 7‐067 Analysis of rejection rates and adverse effects associated with the use of belatacept in kidney transplant patients compared to traditional treatment regimens.


8:30 am ‐ 9:30 am

387554 Jamie Micheletto 5B‐057 Correlation of statin intensity and clinical outcomes following coronary artery bypass grafting surgery

Tuesday, December 8

11:30 am ‐ 12:30 pm

388224 Lisa Michener 5A‐089 Attitude Assessment of a Longitudinal Advanced Pharmacy Practice Experience at Health‐Systems

Tuesday, December 8

10:00 am ‐ 11:00 am

389534 Mina Mikhaeil 3‐097 Impact of community involvement, through e‐summits and health screening events, on increasing the knowledge and awareness of prostate cancer among men in Florida

Monday, December 7

12:00 pm ‐ 1:00 pm

386976 Valerie Milazzo 3‐159 Improving the Minnesota community measurement of optimal vascular care in a primary care clinic

Monday, December 7

12:00 pm ‐ 1:00 pm

385649 Mia Miles 7‐140 Mood stabilizer, antipsychotic, antidepressant, and antianxiety


8:30 am ‐ 9:30 am


114 | P a g e

Submission ID



medication use changes after bariatric surgery

386199 Nataliya Milikhiker 5A‐090 Prevention of preterm labor with hydroxyprogesterone caproate (17OHP): are there differences in adverse reaction rates between the compounded and commercial formulation?

Tuesday, December 8

10:00 am ‐ 11:00 am

385150 Amber Miller 7‐031 Medication use evaluation: a retrospective review evaluating appropriate piperacillin‐tazobactam usage in a community hospital setting


8:30 am ‐ 9:30 am

387425 Cassandra Miller 2‐308 Patient medication education preferences: a survey of patients in the community hospital setting

Monday, December 7

10:45 am ‐11:45 am

385552 Emily Miller 2‐309 Retrospective review of carbapenem use to determine impact of an antimicrobial stewardship program educational intervention

Monday, December 7

10:45 am ‐11:45 am

389206 Erin Miller 5B‐320 Evaluation of a pharmacy‐driven medication reconciliation program in a 49‐bed, rural community hospital

Tuesday, December 8

11:30 am ‐ 12:30 pm

389310 Heather Miller 2‐218 Evaluation of collaborative drug therapy management pharmacist in an interdisciplinary model for the treatment of patients with uncontrolled diabetes

Monday, December 7

10:45 am ‐11:45 am

386465 Paige Miller 7‐250 Diabetic numeracy: do pharmacists make a difference?


8:30 am ‐ 9:30 am

389268 Patrik Miller 5A‐225 Concomitant use of rifamycins and azole antifungals in cystic fibrosis patients

Tuesday, December 8

10:00 am ‐ 11:00 am

385228 William Miller 5A‐289 Comparison of protocol‐driven and guideline‐based management of warfarin: frequency, management, and

Tuesday, December 8

10:00 am ‐ 11:00 am


115 | P a g e

Submission ID



cost of critical values

387759 Alexander Milligan 2‐141 Retrospective drug use evaluation of dornase alfa in a pediatric teaching hospital

Monday, December 7

10:45 am ‐11:45 am

386829 Sarah Mills 7‐032 Evaluation of a pharmacist‐led patient‐counseling program on nutrition among patients with diabetes in an outpatient setting


8:30 am ‐ 9:30 am

385565 Kate Mislan 7‐217 Comparison of independent, hospital, and chain pharmacists: quality of life and job satisfaction


8:30 am ‐ 9:30 am

389286 Bhavik Mistry 2‐219 Evaluation of the appropriateness of antibiotic use in patients with a primary diagnosis of chronic obstructive pulmonary disorder (COPD) exacerbations in a small suburban hospital

Monday, December 7

10:45 am ‐11:45 am

387130 Bryan Mogle 2‐220 Medication‐use‐evaluation of rivaroxaban and coagulation monitoring in hospitalized patients

Monday, December 7

10:45 am ‐11:45 am

389201 Thayra Molinary 3‐098 Health‐system pharmacy partners with high‐risk teens to promote healthy living and appreciation of pharmacy practice

Monday, December 7

12:00 pm ‐ 1:00 pm

384663 Maryam Molki 5B‐126 Evaluation of anticoagulant utilization in patients receiving percutaneous coronary intervention

Tuesday, December 8

11:30 am ‐ 12:30 pm

388946 Peter Montgomery 5A‐226 Evaluation of antithrombotic agent influence on PTT‐anti‐Xa concordance for establishment of institutional heparin therapeutic PTT range

Tuesday, December 8

10:00 am ‐ 11:00 am

388632 Tyler Moody 2‐121 Evaluation of antiretroviral therapy: identifying problems with current formulary

Monday, December 7

10:45 am ‐11:45 am


116 | P a g e

Submission ID



386429 Jennifer Moon 3‐235 Development of communication: a study of the differences in communication skills between healthcare students in an interprofessional education program

Monday, December 7

12:00 pm ‐ 1:00 pm

386346 Zachary Moon 5B‐173 Pharmacists role in the resuscitation of acute burn patients in the emergency department

Tuesday, December 8

11:30 am ‐ 12:30 pm

388631 Emanuela Mooney 5B‐092 What demographic factors influence late pickup of antibiotics used to treat chlamydia and/or gonorrhea?

Tuesday, December 8

11:30 am ‐ 12:30 pm

389654 Breyon Moore 5A‐064 Does promediation at midterm serve as a positive reinforcement in improving pharmacy students grades?

Tuesday, December 8

10:00 am ‐ 11:00 am

389432 Heather Moore 5B‐321 The rise in prescription of multiple non‐antiretroviral medications in persons living with HIV (PLWH) versus non‐PLWH

Tuesday, December 8

11:30 am ‐ 12:30 pm

386157 Kerry Moore 5A‐227 Analysis of chemotherapy compounding times in an outpatient chemotherapy infusion center at a large academic medical center

Tuesday, December 8

10:00 am ‐ 11:00 am

388668 R. Joel Moore 3‐355 Trends in antibiotic use before and during a piperacillin/tazobactam shortage in a large academic teaching hospital

Monday, December 7

12:00 pm ‐ 1:00 pm

386879 John Moorman 2‐310 Evaluation of an insulin infusion protocol for patients undergoing cardiothoracic surgery

Monday, December 7

10:45 am ‐11:45 am

388296 Deo Mopera 2‐026 Effect of pneumatic tubing system on regular insulin concentration

Monday, December 7

10:45 am ‐11:45 am

387530 Lori Mor 3‐099 Assessing the appropriateness of phytonadione use for vitamin

Monday, December 7

12:00 pm ‐ 1:00 pm


117 | P a g e

Submission ID



k antagonist (VKA) reversal in adult inpatients at Memorial Hospital Pembroke

387434 James Moran 2‐263 Impact of a pharmacy led in‐service on hospital readmission rates

Monday, December 7

10:45 am ‐11:45 am

388671 Taj Morgan 3‐100 Pharmacists perceptions of their relative worth in the health care professional spectrum.

Monday, December 7

12:00 pm ‐ 1:00 pm

388930 Melissa Moriarty 5B‐127 Does depleting vs. non‐depleting induction therapy impact outcomes of elderly kidney transplant recipients?

Tuesday, December 8

11:30 am ‐ 12:30 pm

388106 Jaclyn Morris 5B‐174 Dosing body weight versus actual body weight for vancomycin dosing in obese patients: a retrospective analysis of trough concentrations

Tuesday, December 8

11:30 am ‐ 12:30 pm

388911 Joseph Morris 5B‐008 Comparison of atracurium and cisatracurium in patients with acute respiratory distress syndrome

Tuesday, December 8

11:30 am ‐ 12:30 pm

389032 Chelsie Morrison 3‐040 Innovative pharmacy student‐managed care organization collaborative practice model: impact of pharmacy student coordinated asthma education on patient and health system outcomes

Monday, December 7

12:00 pm ‐ 1:00 pm

388763 Elizabeth Morton 2‐330 Underrepresented minority (URM) student perception of seminar impact on application to pharmacy residency programs

Monday, December 7

10:45 am ‐11:45 am

387897 Marissa Moseley 5B‐322 Impact of guideline implementation on postoperative albumin utilization in cardiothoracic surgery patients

Tuesday, December 8

11:30 am ‐ 12:30 pm

386998 Michael Moser 3‐356 Clinical outcomes among Monday, 12:00 pm ‐ 1:00 pm


118 | P a g e

Submission ID



Clostridium difficile infection patients with and without cancer: A Veterans Health Administration national cohort study

December 7

386321 Abigail Mott 3‐147 Institution wide evaluation of medication overrides from automated medication dispensing cabinets after process improvement changes

Monday, December 7

12:00 pm ‐ 1:00 pm

385212 Karim Mouabbi 7‐141 Evaluation of a Clinically Focused Student Pharmacist Internship Program


8:30 am ‐ 9:30 am

385855 Suhaib Muflih 3‐101 Knowledge and attitudes towards pharmacogenetic testing among a cohort of patients and prescribers: diffusion of innovation theory

Monday, December 7

12:00 pm ‐ 1:00 pm

389158 Lesley Ann Mukai 5A‐077 Analyzing the impact of instructional resources on improving immunization administration and delivery

Tuesday, December 8

10:00 am ‐ 11:00 am

384479 Tyler Mullen 2‐221 Designing and implementing an international advanced pharmacy practice experience (APPE) rotation in a resource‐limited setting with a focus on HIV/AIDS treatment and education: Harare, Zimbabwe.

Monday, December 7

10:45 am ‐11:45 am

389255 Surafel Mulugeta 5B‐128 Difference in Clostridium difficile infection outcomes between guideline concordant and discordant therapy

Tuesday, December 8

11:30 am ‐ 12:30 pm

385802 Amy Munekiyo 3‐403 Evaluation of intravenous immunoglobulin (IVIG) utilization in patients receiving care at Seattle Cancer Care Alliance

Monday, December 7

12:00 pm ‐ 1:00 pm

385129 Alyssa Munns 3‐102 Intern pharmacists immunizing: the views of pharmacists on intern pharmacists being permitted to immunize

Monday, December 7

12:00 pm ‐ 1:00 pm


119 | P a g e

Submission ID



according to the CS/HB 279 act

389187 Myranda Munoz 3‐148 The impact on preventive medication use after distribution of a medication guide to patients admitted to hospice

Monday, December 7

12:00 pm ‐ 1:00 pm

388171 Rachel Murdock 7‐073 Clinical outcomes of the high‐dose influenza vaccination compared to standard‐dose vaccination in veterans over 65 years of age


8:30 am ‐ 9:30 am

386377 Joshua Murray 5A‐238 Model for sustainable recycling of surplus medications: A joint effort by Pacific University School of Pharmacy, SIRUM and Central City Concern (CCC) Pharmacy

Tuesday, December 8

10:00 am ‐ 11:00 am

389101 Matthew Murray 7‐251 Evaluation of filgrastim use in a community acute care hospital to establish a pharmacy monitoring protocol


8:30 am ‐ 9:30 am

388541 Mursal Mursal 7‐252 Assessing the effect of student pharmacist on reducing drug related problems in high risk patients


8:30 am ‐ 9:30 am

389373 Andrea Murzello 3‐103 A descriptive evaluation of biosimilar regulations of the FDA, EMA, and Health Canada

Monday, December 7

12:00 pm ‐ 1:00 pm

389366 Greta Musaraj 5A‐091 Exploration of cefepime associated neurotoxicity (CAN) and downstream clinical outcomes

Tuesday, December 8

10:00 am ‐ 11:00 am

385158 Tasnima Nabi 2‐264 Midodrine as adjuvant therapy for weaning intravenous vasopressors in septic shock

Monday, December 7

10:45 am ‐11:45 am

383295 Victoria Nachar 2‐265 National survey of treatment strategies for cystic fibrosis‐related diabetes

Monday, December 7

10:45 am ‐11:45 am

388160 Mandana Naderi 3‐404 Investigating student pharmacists' interest in pursuing residency training

Monday, December 7

12:00 pm ‐ 1:00 pm


120 | P a g e

Submission ID



386339 Reema Naeem 5B‐365 Rounding pharmacists' impact on reducing written medication order errors

Tuesday, December 8

11:30 am ‐ 12:30 pm

386548 Tara Nagaraj 2‐415 Quality improvement project to decrease digoxin, amitriptyline, cyclobenzaprine, promethazine, and glyburide prescribed to the elderly

Monday, December 7

10:45 am ‐11:45 am

382549 Vishnu Nagaraj 2‐222 Proton Pump Inhibitor Approved Indications: Appropriateness of Use Study

Monday, December 7

10:45 am ‐11:45 am

389493 Joseph Naggar 5B‐236 Analysis of optimal scaling techniques used for identifying the risk benefit of anticholinergic use in older adults

Tuesday, December 8

11:30 am ‐ 12:30 pm

388542 Rakia Nasir 5B‐058 Novel oral anticoagulants compared to the standard of care for the chronic management of recurrent venous thromboembolism in oncology patients: a retrospective observational analysis

Tuesday, December 8

11:30 am ‐ 12:30 pm

388810 Kayla Natali 5B‐237 Allergy to insulin aspart and insulin lispro: a case report

Tuesday, December 8

11:30 am ‐ 12:30 pm

388110 Jennifer Navar 3‐357 Impact of University of Texas at El Paso‐ University of Texas at Austin (UTEP‐ UT Austin) cooperative pharmacy program on pharmacist shortage in the borderland

Monday, December 7

12:00 pm ‐ 1:00 pm

386360 Emily Neddermeyer 3‐287 Proton pump inhibitor prescribing across transitions of care

Monday, December 7

12:00 pm ‐ 1:00 pm

388905 Kristen Nelson 5A‐092 Evaluation of patient outcomes for daptomycin treated bloodstream infections using fixed dose, weight adjusted and standard dosing approaches.

Tuesday, December 8

10:00 am ‐ 11:00 am

387963 Nichole Neville 7‐068 Predictors of outcomes after liver transplantation in the


8:30 am ‐ 9:30 am


121 | P a g e

Submission ID



setting of chronic opiate use

384979 Courtney Newby 7‐074 Impact of a pharmacist‐physician collaborative care agreement on number of patients receiving HIV pre‐exposure prophylaxis.


8:30 am ‐ 9:30 am

385423 Katherine Newman 5A‐231 Examining the relationship of glycemic control and depression severity in an African‐American patient population with type II diabetes

Tuesday, December 8

10:00 am ‐ 11:00 am

385613 Kylie Newman 7‐069 Medication Use Evaluation of Micafungin


8:30 am ‐ 9:30 am

387674 Brittany Newton 2‐066 Evaluating acetazolamide use in critically ill patients with metabolic alkalosis

Monday, December 7

10:45 am ‐11:45 am

385630 Kenny Ng 5A‐188 Pharmaceutical Industry Fellowship Program Satisfaction of 2014 and 2015 PharmD Alumni

Tuesday, December 8

10:00 am ‐ 11:00 am

386514 Robert Ng 2‐055 Evaluation of antipsychotic use on alcohol‐related readmissions in schizophrenic patients with comorbid alcohol use disorders

Monday, December 7

10:45 am ‐11:45 am

388161 Van Ngo 3‐358 Colonization of Clostridium difficile in zoo animal feces after exposure to broad‐spectrum antibiotics

Monday, December 7

12:00 pm ‐ 1:00 pm

388183 Danielle Nguyen 5A‐306 National investigation into point‐of‐care testing‐ clinical laboratory improvement amendments (CLIA) waivers

Tuesday, December 8

10:00 am ‐ 11:00 am

386416 Hoa‐Hong Nguyen 7‐209 Genetic variations of GRIK1, a subunit of ionotropic kainate glutamate receptor, in a bipolar population


8:30 am ‐ 9:30 am

387196 Hoang Nguyen 2‐223 Pilot mentorship program for student pharmacists in a student society chapter at a new college of pharmacy

Monday, December 7

10:45 am ‐11:45 am

385167 Hugh Nguyen 7‐142 Pharmacokinetic prediction of paclitaxel induced peripheral


8:30 am ‐ 9:30 am


122 | P a g e

Submission ID



neuropathy

386381 Jennifer Nguyen 3‐004 Corticosteroid use prior to cardiopulmonary bypass and risk of surgical site infections and complications in neonates

Monday, December 7

12:00 pm ‐ 1:00 pm

386681 Khiet Nguyen 3‐359 Evaluation of compounding errors pre and post implementation of a compounding workflow technology (CWT) system

Monday, December 7

12:00 pm ‐ 1:00 pm

389220 Kristy Nguyen 5A‐130 Impact of a structured electronic capture and assessment tool on the acuity of reported pharmacist interventions

Tuesday, December 8

10:00 am ‐ 11:00 am

382948 Linda Nguyen 7‐253 Analysis of Statin Therapy Prescribing Practices for Patients with Diabetes in a Primary Care Setting


8:30 am ‐ 9:30 am

385931 Matthew Nguyen 3‐016 A novel use of ethiodized oil for embolization and lymphangiogram in the pediatric patient population

Monday, December 7

12:00 pm ‐ 1:00 pm

389575 Michelle Nguyen 2‐034 Evaluation of pediatric chemotherapy‐related errors at UC Davis Health System

Monday, December 7

10:45 am ‐11:45 am

389023 Michelle Nguyen 5B‐129 Mycophenolate dosing ‐ does it affect kidney transplant outcomes?

Tuesday, December 8

11:30 am ‐ 12:30 pm

384407 Nghia Nguyen 7‐099 Accessibility of insurance coverage policies for pharmacogenomics testing


8:30 am ‐ 9:30 am

388230 Nhu Nguyen 5A‐040 Impact of subsidy status on the frequency of medication related problems (MRPs) identified among ambulatory Medicare beneficiaries

Tuesday, December 8

10:00 am ‐ 11:00 am

387567 Peter Nguyen 5A‐093 Dyslipidemia guideline comparison: a retrospective chart review

Tuesday, December 8

10:00 am ‐ 11:00 am

386757 Phuc Nguyen 5A‐094 Utilization of pharmacy student telephone outreach to facilitate

Tuesday, December 8

10:00 am ‐ 11:00 am


123 | P a g e

Submission ID



goal attainment in type 2 diabetes mellitus patients: a retrospective pilot study

387955 Rosie Nguyen 5A‐095 Unavailability of outpatient medications: trends and management

Tuesday, December 8

10:00 am ‐ 11:00 am

388344 Tammy Nguyen 5B‐059 Impact of rapid diagnostics with multiplex PCR and pharmacist driven physician reporting program on clinical, economical, and antimicrobial therapy‐related outcomes in patients with bloodstream infections

Tuesday, December 8

11:30 am ‐ 12:30 pm

388154 Thai‐Hang Nguyen 5A‐307 Establishment and implementation of a chemotherapy competency program for clinical pharmacists at Intermountain Medical Center

Tuesday, December 8

10:00 am ‐ 11:00 am

385706 Thi Nguyen 5A‐239 Impact of pharmacy student involvement in medication review on outpatient clinic medication list accuracy

Tuesday, December 8

10:00 am ‐ 11:00 am

387565 Thuy Tien Nguyen 5A‐096 Expression of mucin 3 in human rheumatoid arthritis cell lines associated with resistance to the disease‐modifying antirheumatic drugs hydroxychloroquine, methotrexate hydrate, sulfasalazine, and teriflunomide

Tuesday, December 8

10:00 am ‐ 11:00 am

388267 Tien Nguyen 3‐405 To assess the frequency and type of medication related problems after discharge from an acute rehabilitation facility

Monday, December 7

12:00 pm ‐ 1:00 pm

384556 Tina Nguyen 3‐360 Impact of pharmacist intern‐led discharge counseling in a community hospital

Monday, December 7

12:00 pm ‐ 1:00 pm

388084 Tinh An (April)

Nguyen 5A‐041 Evaluation of Tpeak‐Tend and QT/QTc intervals in patients on combination Class III

Tuesday, December 8

10:00 am ‐ 11:00 am


124 | P a g e

Submission ID



antiarrhythmics: a retrospective study

384491 Trang Nguyen 2‐337 Assessing administration technique of insulin pen devices: a vital step in successful diabetes management

Monday, December 7

10:45 am ‐11:45 am

388226 Vivian Nguyen 2‐342 Impact of the quantity of chronic medications on International Normalized Ratio stability of patients with atrial fibrillation using warfarin therapy

Monday, December 7

10:45 am ‐11:45 am

386839 Vy Nguyen 7‐100 The use of dexmedetomidine for sedation in mechanically ventilated patients in the pediatric intensive care unit


8:30 am ‐ 9:30 am

384557 Weiyi Ni 2‐035 IMPACT OF A COMMUNITY PHARMACY‐BASED TRANSITION OF CARE PROGRAM ON HOSPITAL READMISSIONS AT 30 AND 180 DAYS

Monday, December 7

10:45 am ‐11:45 am

388146 Drita Nicaj 7‐143 Complexity of medication regimens by people with intellectual and developmental disabilities within the University of Michigan health system clinic


8:30 am ‐ 9:30 am

389362 Dan Nichols 7‐254 Tacrolimus levels in patients who developed post‐transplant lymphoproliferative disease after kidney transplantation


8:30 am ‐ 9:30 am

383205 Frances Nicholson 5A‐228 Hospital pharmacy unscheduled computer downtime protocol

Tuesday, December 8

10:00 am ‐ 11:00 am

386023 Jennee Nickleson 2‐390 Documented penicillin and cephalosporin allergies and their effect on antibiotic prescribing

Monday, December 7

10:45 am ‐11:45 am

385955 Jaclyn Niggemyer 7‐101 Justification of a pharmacist‐run renal dosing program on active medication orders in patients with fluctuating renal function


8:30 am ‐ 9:30 am


125 | P a g e

Submission ID



386231 Cameron Ninos 3‐236 A description of the etiologies of liver cirrhosis and the use of Vitamin K in a hospitalized cohort at an academic medical center.

Monday, December 7

12:00 pm ‐ 1:00 pm

382722 Stephanie Nitz 2‐071 Online depression training module for health professional students participating at a student‐run free clinic

Monday, December 7

10:45 am ‐11:45 am

389585 Daryl Nnani 2‐252 Role of phosphate binders on cardiovascular biomarkers in nondialysis‐dependent chronic kidney disease patients

Monday, December 7

10:45 am ‐11:45 am

388003 Hannah Noh 7‐102 Short term use of ascorbic acid to improve magnesium supplementation absorption in the setting of long‐term proton pump inhibitor use


8:30 am ‐ 9:30 am

388148 Krista Noll 5B‐175 Incidence of symptomatic venous thromboembolism after hospital discharge of critically ill patients receiving enoxaparin prophylaxis

Tuesday, December 8

11:30 am ‐ 12:30 pm

389128 Nadia Noormohamed 5A‐131 Glucagon‐Like Peptide‐1 (GLP‐1) receptor expression on Human Umbilical Vein Endothelial Cells (HUVEC) in response to cellular activation

Tuesday, December 8

10:00 am ‐ 11:00 am

389411 Kelsey Norman 3‐288 Evaluation of student perceptions of an early interprofessional educational course

Monday, December 7

12:00 pm ‐ 1:00 pm

389114 olena northrup 5B‐361 Characterization of antiepileptic drug therapy for achieving seizure cessation in patients with benzodiazepine‐resistant status epilepticus

Tuesday, December 8

11:30 am ‐ 12:30 pm

386117 Ryan Nottingham 3‐406 Pharmacy services in an outpatient palliative care clinic: a quality improvement project

Monday, December 7

12:00 pm ‐ 1:00 pm

386854 Maryam Noureldin 5B‐176 Medication collection events: an emerging role for pharmacy

Tuesday, December 8

11:30 am ‐ 12:30 pm


126 | P a g e

Submission ID



386041 Kathie Nowicki 3‐407 Evaluation of paliperidone long‐acting injection criteria for use at two academic medical centers

Monday, December 7

12:00 pm ‐ 1:00 pm

387960 Ozioma Nwaobia 5B‐130 Administration of pancreatic enzyme replacement therapy via enteral tubes

Tuesday, December 8

11:30 am ‐ 12:30 pm

386864 Lily‐Ann Nyangau 5A‐216 Safety and efficacy of aztreonam in nosocomial pneumonia in patients with a reported beta‐lactam allergy: a retrospective study

Tuesday, December 8

10:00 am ‐ 11:00 am

385987 Jaeau Obcemea 7‐255 Evaluation of diabetic test strip utilization in a Medicare population


8:30 am ‐ 9:30 am

383087 Bailey O'Brien 3‐104 Evaluation of four factor prothrombin complex concentrate (PCC) at a large teaching institution

Monday, December 7

12:00 pm ‐ 1:00 pm

388994 Stephanie O'Brien 5B‐177 Assesment of pharyngitis treatment at a university student health services clinic

Tuesday, December 8

11:30 am ‐ 12:30 pm

386932 Gevette Ocasio 3‐105 Pharmacy student perception of an elective clinical research course

Monday, December 7

12:00 pm ‐ 1:00 pm

387049 Andrew Occiano 5A‐042 Impact of energy drinks and ingredients within on heart rhythm: a pilot project

Tuesday, December 8

10:00 am ‐ 11:00 am

388914 Hannah Oh 5A‐189 Impact of pharmacy involvement in the heart failure care transition program

Tuesday, December 8

10:00 am ‐ 11:00 am

387850 Janet Oh 5B‐323 Evaluation of adherence to prophylaxis recommendations with minocycline/doxycycline for prevention of rash in lung cancer patients receiving erlotinib and/or afatinib at Duke Cancer Center

Tuesday, December 8

11:30 am ‐ 12:30 pm

387257 Jillian O'Keefe 5B‐238 Characteristics and demographics of patients with ESBL‐producing Enterobacteriaceae infections:

Tuesday, December 8

11:30 am ‐ 12:30 pm


127 | P a g e

Submission ID



a retrospective review of community hospital patients.

384480 Benedicta Okoroafor 7‐256 Effect of combination of tea tree oil and coconut oil dental gel on psoriatic arthritis induced periodontal disease: case study


8:30 am ‐ 9:30 am

389485 Christopher Okoye 7‐257 Impact of the implementation of Friday night flu clinics into the local community


8:30 am ‐ 9:30 am

389440 Elizabeth Olafson 2‐160 Student knowledge, attitudes, and beliefs (KAB) towards pain management

Monday, December 7

10:45 am ‐11:45 am

385967 Misty O''Lexey 3‐424 Wyoming Community Members Storage Habits and Safety Beliefs Regarding Prescription Pain Medications

Monday, December 7

12:00 pm ‐ 1:00 pm

385142 Brittany Oliver 5B‐178 Impact of an expansion of pharmacist management of warfarin using an evidence‐based dosing protocol at a tertiary care center

Tuesday, December 8

11:30 am ‐ 12:30 pm

386915 Amber Olson 7‐215 Completion of rabies post exposure prophylaxis after presentation to the emergency department at Avera McKennan Hospital


8:30 am ‐ 9:30 am

385867 Mijung Om 5B‐060 Timing of pegfilgrastim administration and impact on duration and severity of neutropenia

Tuesday, December 8

11:30 am ‐ 12:30 pm

389054 D.J. Onuaguluchi 5A‐117 Cell‐extrinsic effects of metformin in the breast cancer microenvironment.

Tuesday, December 8

10:00 am ‐ 11:00 am

386890 Shwe Yamin Oo 5A‐132 Impact of pharmacy interns driven intervention for process improvement and medication safety in discharged patients at a community hospital

Tuesday, December 8

10:00 am ‐ 11:00 am

383207 Kristin O'Reilly 5B‐406 Rural pharmacy residency training environmental scan and program design

Tuesday, December 8

11:30 am ‐ 12:30 pm


128 | P a g e

Submission ID



388465 Evangeline Oriakhi 5B‐131 Intravenous diphenhydramine in the treatment of acute migraine.

Tuesday, December 8

11:30 am ‐ 12:30 pm

386477 Nosarieme Osagiede 3‐237 Evaluation of outpatient treatment for acute venous thromboembolism (VTE) in patients presenting to an emergency department (ED)

Monday, December 7

12:00 pm ‐ 1:00 pm

387847 Kyle Osborne 3‐310 Outcomes of student‐driven independent research and impact on postgraduate training and career selection

Monday, December 7

12:00 pm ‐ 1:00 pm

388845 Sarah Osellame 2‐080 Prevalence of sport supplement use in gyms across hawaii island

Monday, December 7

10:45 am ‐11:45 am

386804 Kimberly Overman 3‐156 Medication error reporting after the implementation of an electronic event reporting system

Monday, December 7

12:00 pm ‐ 1:00 pm

388948 James Paciotti 5B‐239 Pharmacy student involvement in interprofessional education collaboration exercise

Tuesday, December 8

11:30 am ‐ 12:30 pm

389503 Cristina Pagan‐Montalvo

7‐201 Is Iodine excess related to thyroid disease?


8:30 am ‐ 9:30 am

385985 Diana Pak 3‐238 Poppers‐induced hemolytic anemia in patients with glucose‐6‐phosphate dehydrogenase (G6PD) deficiency

Monday, December 7

12:00 pm ‐ 1:00 pm

389244 Terry Pak 3‐239 Comparison of empathy scores in pharmacy students before and after completion of advanced pharmacy practice experiential (APPE) Rotations

Monday, December 7

12:00 pm ‐ 1:00 pm

383288 Nicole Palazzolo 5B‐355 Examination of QTc values in critically ill patients prescribed atypical antipsychotics and diagnosed with delirium

Tuesday, December 8

11:30 am ‐ 12:30 pm

387160 Nicholas Palm 3‐106 Small group learning communities: The impact of small group communities and authentic learning in pharmacy curriculum

Monday, December 7

12:00 pm ‐ 1:00 pm


129 | P a g e

Submission ID



384672 Katelyn Palmer 5B‐356 Evaluating health literacy in the inpatient setting using the shortened rapid estimate of adult literacy in medicine (REALM) model: a descriptive study

Tuesday, December 8

11:30 am ‐ 12:30 pm

387300 Ingrid Pan 5A‐254 Medication reconciliation of HCV genotype 1 patient candidates for ledipasvir/sofosbuvir (LED/SOF) and ombitasvir, paritaprevir, ritonavir, plus dasabuvir

Tuesday, December 8

10:00 am ‐ 11:00 am

388642 Irene Pan 5B‐366 Statins in diabetic elderly for primary prevention of cardiovascular disease ‐ a retrospective cohort study

Tuesday, December 8

11:30 am ‐ 12:30 pm

385703 Rebekah Panak 2‐338 Tramadol withdrawal and migraines: a case of medical mimics?

Monday, December 7

10:45 am ‐11:45 am

386361 Priya Panchal 3‐240 Efficacy and Safety Comparing Novel to Conservative Starter Parenteral Nutrition Management in Very Low Birth Weight Infants

Monday, December 7

12:00 pm ‐ 1:00 pm

388115 Martha Panselinos 7‐258 Use of antidepressants in patients with bipolar depression


8:30 am ‐ 9:30 am

386511 Pawvana Pansiri 3‐039 Survey of preference and utilization of drug information resources by senior doctor of pharmacy students

Monday, December 7

12:00 pm ‐ 1:00 pm

385674 Talia Papiro 3‐028 Renal dose adjustments of antifungal and antiviral agents in pediatric patients: implementing updated pediatric data

Monday, December 7

12:00 pm ‐ 1:00 pm

385980 paulo pardi 5A‐259 CHAMOMILE APPLICATION IN THE TREATMENT OF PHLEBITIS IN HOSPITALIZED PATIENTS

Tuesday, December 8

10:00 am ‐ 11:00 am

386205 Nehali Parikh 2‐224 Medication use evaluation of the novel oral anticoagulants at Long Island Jewish Hospital

Monday, December 7

10:45 am ‐11:45 am


130 | P a g e

Submission ID



386583 Nisha Parikh 3‐241 Cross‐sectional survey of veteran homelessness and medication adherence

Monday, December 7

12:00 pm ‐ 1:00 pm

388591 Parth Parikh 5A‐269 Retrospective analysis of the inappropriate use of concomitant warfarin and heparin therapy

Tuesday, December 8

10:00 am ‐ 11:00 am

388301 Meaghan Paris 5B‐240 Longitudinal Impact of a Pharmacist on Diabetes Care

Tuesday, December 8

11:30 am ‐ 12:30 pm

388255 Clara Park 3‐408 Lurasidone medication utilization review

Monday, December 7

12:00 pm ‐ 1:00 pm

388091 Grace Park 3‐194 Comparison of the utilization of available medications on a medical mission trip in rural Jamaica to US guideline recommendations

Monday, December 7

12:00 pm ‐ 1:00 pm

384338 Jeong Eun Park 5A‐133 Characterization of pharmaceutical care issues for patients seen at a community health center pharmacy clinic

Tuesday, December 8

10:00 am ‐ 11:00 am

389445 Sunmin Park 5B‐241 Evaluation of the first "pink viagra" in its efficacy and safety profile for females with HSDD.

Tuesday, December 8

11:30 am ‐ 12:30 pm

389606 Brittany Parker 5A‐118 Evaluation of perceived versus actual level of physical activity of student pharmacists

Tuesday, December 8

10:00 am ‐ 11:00 am

386307 James Parrett 7‐188 Do married couples do it cheaper? A comparison of health care costs based on marital status


8:30 am ‐ 9:30 am

388198 Marissa Pasquini 5A‐097 Non‐conventional, topical treatment modalities for dry eye disease

Tuesday, December 8

10:00 am ‐ 11:00 am

384758 Kiersten Pasternak 2‐311 Assessing mental health and wellness in pharmacy students: results from a survey that initiated change

Monday, December 7

10:45 am ‐11:45 am

384648 Ammie Patel 3‐181 An evaluation of the appropriateness of documentation regarding the use of multiple antipsychotic medications in an inpatient

Monday, December 7

12:00 pm ‐ 1:00 pm


131 | P a g e

Submission ID



psychiatric facility

387848 Ankit Patel 5B‐061 Evaluation of cefotaxime dosing for neonatal sepsis or meningitis at an academic childrens medical center

Tuesday, December 8

11:30 am ‐ 12:30 pm

386225 Avni Patel 2‐165 A breakthrough seizure associated with the initiation of an energy drink containing herbal extracts: a case report

Monday, December 7

10:45 am ‐11:45 am

387805 Bhakti Patel 5B‐242 Design and implementation of a cardiovascular risk assessment program for patients with diabetes in a patient‐centered medical home.

Tuesday, December 8

11:30 am ‐ 12:30 pm

387569 Chirag Patel 5B‐243 Medication complexity, medication number, and their relationships to medication discrepancies

Tuesday, December 8

11:30 am ‐ 12:30 pm

387370 Dhaval Patel 3‐242 Evaluation of inpatient sepsis mortality and associated risk factors in the emergency department

Monday, December 7

12:00 pm ‐ 1:00 pm

387380 Disa Patel 5B‐062 Evaluation of the use of liposomal bupivacaine in patients undergoing total knee arthroplasty at a community hospital

Tuesday, December 8

11:30 am ‐ 12:30 pm

388250 Ekta Patel 5B‐244 Systematic review of self‐monitoring blood glucose devices and their relative accuracies and features

Tuesday, December 8

11:30 am ‐ 12:30 pm

384406 Hima Patel 7‐206 Characteristics Related to Opioid Prescribing for Migraine Headache in an Academic Versus Community‐Based Emergency Department (CHROME)


8:30 am ‐ 9:30 am

386192 Hina Patel 2‐404 DEPAKOTE AS AN ALTERNATIVE TREATMENT FOR BENZODIAZEPINE WITHDRAWAL AND ANXIETY IN AN ELDERLY PATIENT WITH A

Monday, December 7

10:45 am ‐11:45 am


132 | P a g e

Submission ID



HISTORY OF CHRONIC BENZODIAZEPINE USE

386526 Hiten Patel 5A‐282 Retained symptomatic control following discontinuation of proton pump inhibitors after extended use: a pharmacist‐led medication use evaluation

Tuesday, December 8

10:00 am ‐ 11:00 am

389414 Jalak Patel 3‐035 Enhanced process for patient‐supplied medication use in the inpatient setting

Monday, December 7

12:00 pm ‐ 1:00 pm

387790 Jessica Patel 5B‐245 Associated risk of radiocontrast media and nephrotoxicity: case report

Tuesday, December 8

11:30 am ‐ 12:30 pm

385728 Juhi Patel 5B‐324 Effectiveness of clinical pharmacist service primarily in diabetes management at a rural family practice: a retrospective chart review.

Tuesday, December 8

11:30 am ‐ 12:30 pm

385899 Julie Patel 5B‐063 Characterization of the duration of antipsychotic therapy for treatment of intensive care unit delirium

Tuesday, December 8

11:30 am ‐ 12:30 pm

385954 Kapil Patel 5A‐154 Medication use evaluation of ertapenem at a small university‐owned community hospital

Tuesday, December 8

10:00 am ‐ 11:00 am

388253 Ketul Patel 7‐259 Evaluation of preceptors confidence in student pharmacists ability to dose antibiotics using pharmacokinetics following implementation of a computer‐assisted module


8:30 am ‐ 9:30 am

388565 Manali Patel 5B‐357 Impact of in‐service on use of long‐term proton pump inhibitors in the geriatric population at a long term care facility

Tuesday, December 8

11:30 am ‐ 12:30 pm

385981 Megha Patel 7‐189 Medication misinformation in college students: a survey on medication false beliefs and non‐adherence


8:30 am ‐ 9:30 am


133 | P a g e

Submission ID



388033 Mehul Patel 5B‐064 Evaluation of current empiric antibiotic therapy guidelines based on an updated institutional antibiogram

Tuesday, December 8

11:30 am ‐ 12:30 pm

388134 Neal Patel 5B‐065 Management of Heart Mate II and Heartware left ventricular assist device (LVAD) thrombus with tirofiban: a success and failure

Tuesday, December 8

11:30 am ‐ 12:30 pm

389484 Neil Patel 3‐182 Student assessment of the value of the Doctor of Pharmacy degree based on academic and non‐academic factors

Monday, December 7

12:00 pm ‐ 1:00 pm

386985 Niketa Patel 5B‐102 Reasons for use of atovaquone in a kidney transplant population

Tuesday, December 8

11:30 am ‐ 12:30 pm

385947 Nishika Patel 5A‐308 Potential bromocriptine induced mania in a patient being treated for a pituitary tumor

Tuesday, December 8

10:00 am ‐ 11:00 am

386154 Parin Patel 3‐190 Effect of protocol initiation on adherence to surgical prophylaxis guidelines at a community hospital

Monday, December 7

12:00 pm ‐ 1:00 pm

386269 Priyanka Patel 5A‐049 Evaluation of adverse drug effects associated with Pneumocystitis carinii pneumonia prophylaxis and the need to switch therapy

Tuesday, December 8

10:00 am ‐ 11:00 am

383308 Reema Patel 5A‐024 Impact of procalcitonin levels on antibiotic utilization in a community hospital

Tuesday, December 8

10:00 am ‐ 11:00 am

385262 Risha Patel 5B‐132 Effects of providing medication reconciliation services on pharmacy student knowledge and attitudes at a large academic medical center

Tuesday, December 8

11:30 am ‐ 12:30 pm

386923 Risha Patel 5B‐179 Scope, completeness, ease of use, and consistency of drug information resources for assessing interactions

Tuesday, December 8

11:30 am ‐ 12:30 pm


134 | P a g e

Submission ID



389470 Roshni Patel 5B‐141 Evaluation of medications that mimic acute stroke causing stroke code activation: a retrospective cohort study

Tuesday, December 8

11:30 am ‐ 12:30 pm

387346 Shaili Patel 2‐225 Evaluation of factors influencing a student's choice of pharmacy school

Monday, December 7

10:45 am ‐11:45 am

388614 Sunnybhai Patel 5B‐066 Evaluation of appropriate specimen collection as defined by the contamination rate at Midtown Medical Center

Tuesday, December 8

11:30 am ‐ 12:30 pm

386246 Toral Patel 3‐272 Safety of default electrolyte selection for initial parenteral nutrition order

Monday, December 7

12:00 pm ‐ 1:00 pm

387929 Urvi Patel 3‐273 Comparing consumer preference between two medication adherence applications

Monday, December 7

12:00 pm ‐ 1:00 pm

389490 zarna patel 2‐087 Prevalence of hypertension and vaginal symptoms in a selected cohort in rural Haiti

Monday, December 7

10:45 am ‐11:45 am

386296 Sherin Pathickal 2‐364 Role of community pharmacists in the appropriateness of zolpidem prescribing and counseling

Monday, December 7

10:45 am ‐11:45 am

385762 Roshani Patolia 3‐191 Incidence of nephrotoxicity in patients receiving combination vancomycin and piperacillin‐tazobactam

Monday, December 7

12:00 pm ‐ 1:00 pm

385563 Ainsley Paton 5B‐180 Comparing cefazolin & ceftriaxone for the treatment of cystitis

Tuesday, December 8

11:30 am ‐ 12:30 pm

382621 Nicholas Patricia 3‐243 Prospective review of interventions resulting from student pharmacist medication reviews in hemodialysis patients

Monday, December 7

12:00 pm ‐ 1:00 pm

386215 Aimee Patterson 7‐033 Timing of anticoagulation therapy in atrial fibrillation status post cardioembolic stroke


8:30 am ‐ 9:30 am

389051 Ciera Patzke 2‐266 Use of intravenous Monday, 10:45 am ‐11:45 am


135 | P a g e

Submission ID



acetaminophen peri‐operatively does not significantly reduce post‐operative opioid consumption

December 7

387669 Kathleen Paul 5A‐246 Evaluating the efficacy of a simulated sterile products cleanroom for educating new pharmacy interns

Tuesday, December 8

10:00 am ‐ 11:00 am

389060 Erica Paulette 2‐122 Vorapaxar: new drug review and cost‐minimization analysis

Monday, December 7

10:45 am ‐11:45 am

387326 Allison Pavkov 2‐312 Medication errors associated with orders to use nonformulary medications at a community teaching hospital

Monday, December 7

10:45 am ‐11:45 am

386817 Casey Payne 2‐100 Association of serum calcium on hypertensive crises patients: a case‐control study

Monday, December 7

10:45 am ‐11:45 am

388176 Timofey Pchelka 5B‐246 Comparison of the morse fall scale (MFS) versus medication fall risk score (MFRS) as a predictor for actual inpatient falls in a small community hospital

Tuesday, December 8

11:30 am ‐ 12:30 pm

386484 Shatera Peace 3‐107 Evaluation of health literacy among college students

Monday, December 7

12:00 pm ‐ 1:00 pm

388991 Nicole Pearl 7‐144 Analysis of pharmacy student learning from a pilot interprofessional patient safety program


8:30 am ‐ 9:30 am

388437 Aaron Peck 2‐084 Multidisciplinary Quality Improvement to Improve Medicare PQRS Antiplatelet Measures in a Family Medicine Clinic

Monday, December 7

10:45 am ‐11:45 am

387153 Diana Pei 7‐260 Potential solution models for medication access and community response for the barrio of Esfuerzo in Santo Domingo Norte, Dominican Republic.


8:30 am ‐ 9:30 am

387867 Megan Pellett 3‐244 Evaluation of novel oral anticoagulant prescribing in a

Monday, December 7

12:00 pm ‐ 1:00 pm


136 | P a g e

Submission ID



community teaching hospital setting

385983 Janell Penha 2‐418 Ethnic differences in the prevalence of multiple chronic conditions: results from the national health interview survey (NHIS)

Monday, December 7

10:45 am ‐11:45 am

388262 Rose Pennick 2‐008 Impact of targeted educational interventions on the proper use of stress ulcer prophylaxis in critically ill patients

Monday, December 7

10:45 am ‐11:45 am

388809 Stephanie Pennington 5B‐407 Levofloxacin prophylaxis: revisiting the safety and efficacy profile in hematopoietic stem cell transplant patients in an era of Clostridium difficile infection

Tuesday, December 8

11:30 am ‐ 12:30 pm

388369 Gabriella Pepe 5B‐247 Tranexamic acid utilization at an urban level 1 trauma center and implications for improved utilization

Tuesday, December 8

11:30 am ‐ 12:30 pm

385965 Alexa Perales 5A‐310 Antimicrobial resistance in house pets/ livestock and the effects on our public health system: an article review

Tuesday, December 8

10:00 am ‐ 11:00 am

388415 Ernesto Perez 3‐108 Potential impact of a pharmacy led clinical intervention on venous thromboembolism (VTE) prophylaxis

Monday, December 7

12:00 pm ‐ 1:00 pm

388386 Lena Perry 3‐409 Evaluation of appropriate prescribing of proton pump inhibitors (PPI) in patients in a community hospital setting

Monday, December 7

12:00 pm ‐ 1:00 pm

385578 Leslie Perry 5B‐325 Assessing clinical efficacy of SGLT‐2 inhibitors used in diabetics: a retrospective analysis

Tuesday, December 8

11:30 am ‐ 12:30 pm

387532 Rosetta Persaud 3‐037 Analysis of smart infusion pump use in hospitalized patients and the reduction of IV administration errors with decrease usage of basic mode

Monday, December 7

12:00 pm ‐ 1:00 pm


137 | P a g e

Submission ID



389522 Stephanie Persaud 2‐352 Metered dose inhaler versus nebulization in intensive care unit patients

Monday, December 7

10:45 am ‐11:45 am

386812 Daniel Peterson 5B‐143 Forecasting medication procurement and associated costs of therapy duration with fiscal budget consideration at a student‐run, professionals‐advised outreach clinic

Tuesday, December 8

11:30 am ‐ 12:30 pm

387587 Christine Pham 2‐142 Review of Severe Sepsis and Septic Shock Management to Evaluate Impact on Achieving Treatment Benchmarks

Monday, December 7

10:45 am ‐11:45 am

386789 Duyen‐Anh Pham 2‐056 Simulation analysis of using total body weight compared to ideal body weight to estimate creatinine clearance for dosing target‐specific oral anticoagulants in obese patients: When does the method matter?

Monday, December 7

10:45 am ‐11:45 am

385958 Hoang K Pham 2‐161 Retrospective evaluation of triglyceride monitoring with propofol use in critical care patients at an academic medical center

Monday, December 7

10:45 am ‐11:45 am

384668 Huong Pham 5B‐067 Evaluating severity of illness in adult patients with skin and soft tissue infections at a community teaching hospital

Tuesday, December 8

11:30 am ‐ 12:30 pm

389024 Monica Pham 5A‐283 Assessing support and perceived barriers to over‐the‐counter birth control in south Texas

Tuesday, December 8

10:00 am ‐ 11:00 am

386521 Cassandra Phan 5B‐103 Computerized prescription order entry (CPOE) functionality and use among US office‐based physicians, 2007 to 2012

Tuesday, December 8

11:30 am ‐ 12:30 pm

384628 Diep Phan 5B‐326 Outcomes of hepatitis C treatment in an urban clinic setting

Tuesday, December 8

11:30 am ‐ 12:30 pm

388298 Franklin Phan 2‐353 Evaluation and implementation Monday, 10:45 am ‐11:45 am


138 | P a g e

Submission ID



of pre‐packed discharge medications in the emergency department at Oregon Health and Sciences University (OHSU)

December 7

388938 Ha Phan 5A‐155 Palatability of liquid medications used to treat pediatric mental health conditions

Tuesday, December 8

10:00 am ‐ 11:00 am

386995 Julie Phan 5A‐256 Student stress in a three‐year doctor of pharmacy program using a mastery learning educational model ‐ a comparison of studies five years apart

Tuesday, December 8

10:00 am ‐ 11:00 am

388235 Vananh Phan 2‐123 Efinaconazole: new drug review and cost‐minimization analysis

Monday, December 7

10:45 am ‐11:45 am

388847 Kingsavanh Philavong 5A‐270 Targeting cyclin‐dependent kinase 8 (CDK8) to prevent resistance in epidermal growth factor receptor (EGFR) targeted therapy in breast cancer

Tuesday, December 8

10:00 am ‐ 11:00 am

385914 Zipporah Phillips 5B‐133 New antimicrobial chemistry of Udotea looensis against Vibro species and Bacillus specie.

Tuesday, December 8

11:30 am ‐ 12:30 pm

386165 Tina Pho 5A‐317 Correlation of ANG‐II and ET‐1 plasma levels to HIF‐1 alpha urinary expression in Chronic Kidney Disease and Cardio‐Renal Syndrome patients

Tuesday, December 8

10:00 am ‐ 11:00 am

383292 Suzanne Phong 3‐017 Perioperative blood loss and anemia in total hip and knee arthroplasty: outcomes associated with intravenous tranexamic acid

Monday, December 7

12:00 pm ‐ 1:00 pm

386799 Jenny Phung 7‐261 The Effects of Sedative‐Hypnotic Medications on Blood‐Brain Barrier Integrity and Function


8:30 am ‐ 9:30 am

388220 Mary Frances

Picone 5B‐408 Association between cardiovascular medication use and mental health outcomes in older adults: a systematic

Tuesday, December 8

11:30 am ‐ 12:30 pm


139 | P a g e

Submission ID



review

388494 Lionel Picot‐Vierra 3‐289 Appropriateness of analgesics for osteoarthritis in community‐dwelling older adults

Monday, December 7

12:00 pm ‐ 1:00 pm

382633 Jenna Picton 5B‐327 Benzodiazepine use in the elderly: a risk factor for dementia?

Tuesday, December 8

11:30 am ‐ 12:30 pm

388124 Heidi Pigott 3‐245 Impact of new medication education by pharmacists on patient knowledge and adherence within a patient‐centered medical home

Monday, December 7

12:00 pm ‐ 1:00 pm

389090 Arathi Pillay 3‐311 Human papillomavirus 16 integration in cervical lesions associated with cervical intraepithelial neoplasia

Monday, December 7

12:00 pm ‐ 1:00 pm

389486 Fawad Piracha 2‐226 A comparison of online neonatal drug information resources

Monday, December 7

10:45 am ‐11:45 am

387973 Christopher Pitts 5B‐068 Lacosamide for seizure prophylaxis in acute CNS injury

Tuesday, December 8

11:30 am ‐ 12:30 pm

388484 Gabrielle Plaia 2‐253 Comparative assessment of two primary treatment options for hepatitis C virus (HCV) in patients co‐infected with HIV (human immunodeficiency virus): a retrospective chart review

Monday, December 7

10:45 am ‐11:45 am

387084 Christian Polen 5A‐109 Comparing and analyzing traditional warfarin education with newly designed and implemented warfarin video education series at an anticoagulation clinic

Tuesday, December 8

10:00 am ‐ 11:00 am

386748 John Polnak 2‐227 Appropriateness of empiric antibiotic prescribing practices for hospitalized patients with urinary tract infections.

Monday, December 7

10:45 am ‐11:45 am

387915 Keith J. Polovich II 5A‐006 Impact of targeted pharmacotherapy on readmission rates in heart failure with preserved ejection

Tuesday, December 8

10:00 am ‐ 11:00 am


140 | P a g e

Submission ID



fraction (HFpEF)

386607 Teresa Poon 2‐228 Evaluation of the utilization of filgrastim in kidney transplant recipients

Monday, December 7

10:45 am ‐11:45 am

389662 Vladimir Poplavskiy 2‐421 Pharmacy involvement in early delivery of treatment to septic patient: A response to the New York state battle against sepsis.

Monday, December 7

10:45 am ‐11:45 am

387187 Ann Marie Porreca 3‐274 Evaluation of the appropriateness of colistin dosing and resulting nephrotoxicity

Monday, December 7

12:00 pm ‐ 1:00 pm

386487 Timothy Porter 3‐246 Efficacy of oral phosphate replacement: a medication use evaluation

Monday, December 7

12:00 pm ‐ 1:00 pm

387943 Jessica Portlock 5A‐177 Increasing access to hormonal contraception: the pharmacists' expanding role

Tuesday, December 8

10:00 am ‐ 11:00 am

385768 Savannah Poskevich 3‐312 Impact of a bedside medication delivery program on 30‐day readmission in a noncompliant patient population

Monday, December 7

12:00 pm ‐ 1:00 pm

385576 David Poston 3‐109 Comparative analysis of use and cost effectiveness of vancomycin vs. dalbavancin

Monday, December 7

12:00 pm ‐ 1:00 pm

389163 Jacey Potenza 5B‐248 Successful use of fondaparinux via subcutaneous arm injection for the prevention of thrombotic events

Tuesday, December 8

11:30 am ‐ 12:30 pm

383313 Lance Pramann 3‐388 Variability in content and purity of extemporaneously compounded enalapril oral liquid suspensions for pediatric patients

Monday, December 7

12:00 pm ‐ 1:00 pm

385160 Jamal Pratt 2‐101 Evaluating the incidence of concurrent verification of acid lowering agents and oral iron supplements in the inpatient setting.

Monday, December 7

10:45 am ‐11:45 am

389340 Ashley Press 5B‐003 Medication reconciliation upon hospital admission: an evaluation of unintentional

Tuesday, December 8

11:30 am ‐ 12:30 pm


141 | P a g e

Submission ID



medication discrepancies

386908 Mark Priddy 3‐043 Evaluating the utilization of vasopressin within a large academic medical center

Monday, December 7

12:00 pm ‐ 1:00 pm

385398 Dorela Priftanji 5A‐156 Evaluation of patient‐specific insulin pen dispensing patterns during patient transfers following implementation of medication transfer bags

Tuesday, December 8

10:00 am ‐ 11:00 am

386404 Vincent Procopio 7‐145 Evaluation of the etiologies and treatment of hypoglycemic events in critically ill patients in the intensive care unit


8:30 am ‐ 9:30 am

387835 Lisa Puterio 3‐183 Clozapine rechallenge in a patient with neutropenia

Monday, December 7

12:00 pm ‐ 1:00 pm

383480 Courtney Putz 5B‐409 Screening and interrater analysis for an extended interval of INR follow‐up protocol

Tuesday, December 8

11:30 am ‐ 12:30 pm

389513 Sahar Rabbat 2‐229 Evaluation of oxycodone, morphine, and hydromorphone in pain management for patients in the surgical intensive care unit (SICU) with a high risk for dependence

Monday, December 7

10:45 am ‐11:45 am

386237 Rebecca Racz 7‐146 Assessing similarities and differences between student and faculty perceptions of professional electives


8:30 am ‐ 9:30 am

389542 Tyler Raduzycki 5B‐249 Pharmacist Intervention Using Online Resources to Improve Insulin Management in Patients with Type 2 Diabetes in Federally Qualified Community Health Centers: Before and After Study

Tuesday, December 8

11:30 am ‐ 12:30 pm

385948 Michaela Raes 2‐254 Effect of clinical pharmacist monitoring and intervention in patients receiving intravenous heparin

Monday, December 7

10:45 am ‐11:45 am

385893 Farah Raheem 5A‐025 Evaluation of pantoprazole for stress ulcer prophylaxis in a

Tuesday, December 8

10:00 am ‐ 11:00 am


142 | P a g e

Submission ID



rural community hospital

387224 Masseeh Rahman 5A‐240 Transitions of care services: interventions and financial impact for CHF, AMI, CVS patients: an APPE student experience

Tuesday, December 8

10:00 am ‐ 11:00 am

385431 Oishi Rahman 2‐230 Complementary alternative medicine use in an oncology clinic

Monday, December 7

10:45 am ‐11:45 am

385805 Lara Rajic 5B‐328 Pro‐ and anti‐adipogenic effects of phytoestrogens are mediated through PPAR‐gamma

Tuesday, December 8

11:30 am ‐ 12:30 pm

387417 James Raley 7‐034 Antibiotic optimization for the treatment of acute pulmonary exacerbations associated with pediatric cystic fibrosis


8:30 am ‐ 9:30 am

385568 Joyce Camille

Ramano 7‐103 Assessment of health literacy for residents of a federally‐assisted senior facility


8:30 am ‐ 9:30 am

388824 Isha Rana 5A‐190 Major genetic risk signatures associated with paclitaxel and vincristine‐induced peripheral neuropathy: a literature review

Tuesday, December 8

10:00 am ‐ 11:00 am

385964 Emily Rapesak 3‐361 Evaluating various types of clinical pharmacy interventions and their impact on treatment outcomes in a human immunodeficiency virus (HIV) ambulatory care setting

Monday, December 7

12:00 pm ‐ 1:00 pm

384341 Chenzira Raphael 2‐363 Stability of extemporaneously compounded levetiracetam intravenous solution

Monday, December 7

10:45 am ‐11:45 am

387852 Jeff Rasmussen 5B‐093 Evaluation of different vancomycin minimum inhibitory concentrations

Tuesday, December 8

11:30 am ‐ 12:30 pm

386330 Kelsey Rasmussen 3‐410 Medication use evaluation (MUE) of methylnaltrexone utilization at the University of Washington Medical Center

Monday, December 7

12:00 pm ‐ 1:00 pm

386164 Morgan Ratte 3‐290 Effect of the JNC 8 guidelines for the management of

Monday, December 7

12:00 pm ‐ 1:00 pm


143 | P a g e

Submission ID



hypertension on prescribing practices

388223 Zachary Rawn 2‐313 Implementing a dashboard to effectively track and evaluate an independently operated, outpatient, inter‐professional, congestive heart failure clinic

Monday, December 7

10:45 am ‐11:45 am

387678 Stephanie Rawson 5B‐410 Introduction to the inpatient pharmacist: a pharmacotherapy skills lab to prepare students for experiential rotations

Tuesday, December 8

11:30 am ‐ 12:30 pm

386770 Alexandre Raymond 7‐190 Evaluating Hemoglobin A1c Control of Renal Transplant Patients with Diabetes in Mississippi


8:30 am ‐ 9:30 am

388190 Paisley Read 5B‐367 Using pharmacogenetic testing to improve medication therapy management (MTM)

Tuesday, December 8

11:30 am ‐ 12:30 pm

388522 Jessica Reader 7‐070 Measuring the clinical impact and acceptance of antimicrobial stewardship team recommendations at an academic medical center


8:30 am ‐ 9:30 am

389387 Jasmine Reber 2‐057 Evaluation of benzodiazepine prescribing practices and clinical outcomes for post‐traumatic stress disorder (PTSD) within the San Diego Veterans Affairs Healthcare System

Monday, December 7

10:45 am ‐11:45 am

386282 Nastja Rebrin 2‐423 A pilot study of the effects of yoga practice intervention on sleep outcomes and quality‐of‐life in cancer patients undergoing treatment

Monday, December 7

10:45 am ‐11:45 am

383191 Sarah Redmond 5A‐229 Utilization of intensive statin therapy for secondary prevention of ischemic stroke and transient ischemic attack

Tuesday, December 8

10:00 am ‐ 11:00 am

388142 Chelsea Reed 5B‐422 Assessment of appropriate statin use in adults with elevated low‐density

Tuesday, December 8

11:30 am ‐ 12:30 pm


144 | P a g e

Submission ID



lipoprotein cholesterol (LDL‐C)

389170 Patrick Reed 7‐219 Meningococcal Vaccine: Are Freshmen Students Aware and Getting Vaccinated?


8:30 am ‐ 9:30 am

385923 Ashley Reich 2‐143 Disparity of high‐alert medications across St. Louis area hospitals: the collaborative actions taken to standardize and increase medication safety

Monday, December 7

10:45 am ‐11:45 am

389571 Whitney Reid 5A‐134 Assessing the adherence of the local HIV population to the recommended CDC immunizations

Tuesday, December 8

10:00 am ‐ 11:00 am

387412 Tyler Reinsch 5B‐134 Limitations of a voluntary adverse event reporting system: deaths associated with commonly abused opioids

Tuesday, December 8

11:30 am ‐ 12:30 pm

387159 Adam Remick 5A‐065 The educational value of genotyping pharmacy students in a pharmacogenomics course

Tuesday, December 8

10:00 am ‐ 11:00 am

388008 Catherine E. Renna 2‐009 Prognostic significance of stratified elevations of troponin in patients with severe sepsis or septic shock

Monday, December 7

10:45 am ‐11:45 am

388046 Kaitlin Rennie 5A‐178 Laws regulating the access of naloxone and considerations of its use

Tuesday, December 8

10:00 am ‐ 11:00 am

387844 Keila Rentas Centeno

5A‐157 Evaluating knowledge regarding cardiovascular risk factors and its association with exercise and diet behaviors in a geriatric population

Tuesday, December 8

10:00 am ‐ 11:00 am

385295 Cristina Reyes 5B‐329 Implementation of a pharmacy‐led antimicrobial stewardship protocol on appropriate meropenem use in a community hospital

Tuesday, December 8

11:30 am ‐ 12:30 pm

387093 Alexandra Rice 5B‐385 Early onset sepsis treatment patterns at a level III neonatal intensive care unit

Tuesday, December 8

11:30 am ‐ 12:30 pm

386993 Amanda Richards 7‐104 Evaluation the use of the new oral anticoagulation therapies


8:30 am ‐ 9:30 am


145 | P a g e

Submission ID



prior and during hospitalization

387404 Steven Richardson 3‐362 Factors independently associated with all‐cause 30‐day mortality in patients with gram‐negative bacteremia

Monday, December 7

12:00 pm ‐ 1:00 pm

388352 Caroline Riedel 2‐027 Evaluating the relationship between diabetes and beverage intake with patient‐centered clinical intervention by assessing hemoglobin A1C.

Monday, December 7

10:45 am ‐11:45 am

389012 Sheila Riggs 3‐018 Delayed type I and III hypersensitivity reaction to insulin detemir in a 44 year old Native American female

Monday, December 7

12:00 pm ‐ 1:00 pm

387033 Carol Rim 2‐028 Prescription stimulant medication attitudes and beliefs of undergraduate students involved in social fraternities and sororities

Monday, December 7

10:45 am ‐11:45 am

385771 Hannah Rinker 7‐262 Analysis of antiplatelet therapy prescribing practices for primary prevention in diabetic patients in the primary care setting


8:30 am ‐ 9:30 am

388483 John Rinker 7‐035 Wednesday, December 9

8:30 am ‐ 9:30 am

387907 Courtney Ritchey 3‐363 Therapy use and guideline‐concordance among a national cohort of Clostridium difficile infection patients with and without cancer

Monday, December 7

12:00 pm ‐ 1:00 pm

387999 Jodie Ritchie 5B‐423 Inborn errors of metabolism: development of protocols for appropriate initial treatment

Tuesday, December 8

11:30 am ‐ 12:30 pm

387717 Julianna Rivich 5B‐181 Evaluation of critical international normalized ratio (INR) value appropriateness in the ambulatory care setting: a simulation

Tuesday, December 8

11:30 am ‐ 12:30 pm

388207 Mayumi Robbins 3‐411 Evaluation of tranexamic acid use in a variety of indications at an academic medical center

Monday, December 7

12:00 pm ‐ 1:00 pm


146 | P a g e

Submission ID



386347 Megan Robbins 2‐391 Evaluation of argatroban transition to oral anticoagulation

Monday, December 7

10:45 am ‐11:45 am

388272 Morgan Robertson 2‐029 Rattlesnake envenomation demographic and situational statistics: a retrospective database analysis

Monday, December 7

10:45 am ‐11:45 am

384379 Elizabeth Robinette 3‐313 Outcomes of Pseudomonas aeruginosa infections with intermediate susceptibility to piperacillin‐tazobactam at a large academic medical center: analysis of the impact of FDA versus CLSI breakpoints

Monday, December 7

12:00 pm ‐ 1:00 pm

385928 John Robinson 7‐147 Reversal of oral anticoagulant‐associated bleeding: a comparison of three‐factor versus four‐factor prothrombin complex concentrate


8:30 am ‐ 9:30 am

385693 Joshua Robinson 2‐102 Evaluation of the financial impact of student pharmacist interventions at a primary care clinic for HIV/AIDS patients

Monday, December 7

10:45 am ‐11:45 am

387776 Morgann Robinson 3‐110 Morgann Robinson Monday, December 7

12:00 pm ‐ 1:00 pm

388276 Teri Robinson 2‐103 Neuroleptic malignant syndrome versus serotonin syndrome: the challenge of finalizing a diagnosis in the presence of psychiatric polypharmacy

Monday, December 7

10:45 am ‐11:45 am

388804 Sherry Robles 5B‐274 Retrospective, descriptive study to compare patient inspiratory flow rates to inhaler specifications using the In‐Check DIAL device

Tuesday, December 8

11:30 am ‐ 12:30 pm

388468 Lindsay Robusto 2‐124 Olodaterol: new drug review and cost‐minimization analysis

Monday, December 7

10:45 am ‐11:45 am

387163 Cristina Roca Rivera 5A‐066 Utilization of a pediatric age‐based resource in the community pharmacy: a prospective cohort study

Tuesday, December 8

10:00 am ‐ 11:00 am


147 | P a g e

Submission ID



386570 Stacy Roche 5A‐191 The impact of continuity in care between patient visits to achieve hypertension control.

Tuesday, December 8

10:00 am ‐ 11:00 am

388168 Christopher Rochon 7‐197 Development of a mentorship program between pharmacy residents and student pharmacists on their Advanced Pharmacy Practice Experience rotations


8:30 am ‐ 9:30 am

387415 Alex Rock 5A‐135 Effects of clinical and patient exposure on pharmacy students attitudes towards people living with HIV/AIDS (PLWHA).

Tuesday, December 8

10:00 am ‐ 11:00 am

388153 Thomas Roduta 3‐364 Transforming the pharmacy practice model for a long‐term care and skilled nursing facility to one that is patient‐centered and pharmacist facilitated

Monday, December 7

12:00 pm ‐ 1:00 pm

389183 Kayla Rogers 2‐104 Assessing perceptions of student pharmacists before and after pharmacy school boot camp orientation

Monday, December 7

10:45 am ‐11:45 am

388403 Amber Rollins 3‐291 From bivalirudin to warfarin: bridging the knowledge gap with an effective protocol

Monday, December 7

12:00 pm ‐ 1:00 pm

384418 Michael Rollins 5B‐330 Identifying Medication‐Related Problems in High‐Risk Patients to Assess Opportunities for Pharmacist Interventions

Tuesday, December 8

11:30 am ‐ 12:30 pm

386306 Angela Rondon‐Begazo

7‐148 Improving interdisciplinary communications in a clinic‐based transitions of care service


8:30 am ‐ 9:30 am

384342 Jessica Rose 7‐036 Risk factor management with guideline‐based medications for prevention of recurrent ischemic stroke: a retrospective chart review


8:30 am ‐ 9:30 am

386019 Patrick Rose 2‐231 Comparison of 10‐Year Atherosclerotic Cardiovascular Disease Risk Score Reduction following Roux‐en‐Y Gastric Bypass Surgery and Sleeve

Monday, December 7

10:45 am ‐11:45 am


148 | P a g e

Submission ID



Gastrectomy

386528 Audrey Rosene 5B‐182 Observations of the impact of cefazolin skin testing for patients with documented penicillin allergy at a community‐based, regional medical center

Tuesday, December 8

11:30 am ‐ 12:30 pm

386481 Connor Roth 5A‐007 Impact of a quick patient work‐up tool for student pharmacists

Tuesday, December 8

10:00 am ‐ 11:00 am

387184 Christiane Rothenberg 3‐111 Gamification as a learning method in pharmacy education

Monday, December 7

12:00 pm ‐ 1:00 pm

386717 Mary Rothermal 7‐149 Utilizing social network advertising to provide access to guideline‐based assessment of arteriosclerotic cardiovascular disease (ASCVD) risk


8:30 am ‐ 9:30 am

389546 Tony Rudisill 5B‐331 Comprehensive evaluation of the use of darbepoetin alfa in the inpatient hospital setting

Tuesday, December 8

11:30 am ‐ 12:30 pm

385874 Laura Rumschik 2‐232 Characterization of factors affecting student involvement in medical mission trips

Monday, December 7

10:45 am ‐11:45 am

386460 Sandra Rumyantsev 5B‐250 Drug induced erectile dysfunction: a case report

Tuesday, December 8

11:30 am ‐ 12:30 pm

388431 Meagan Rusby 2‐125 Pharmacoepidemiology of pediatric patients with bronchiolitis

Monday, December 7

10:45 am ‐11:45 am

384751 Emily Russell 2‐409 Student perceptions of interprofessionality experienced in an international missions Advanced Pharmacy Practice Experience (APPE)

Monday, December 7

10:45 am ‐11:45 am

388002 Kathy Russell 2‐030 Impact of a specialty pharmacy‐based oral chemotherapy adherence program on patient adherence

Monday, December 7

10:45 am ‐11:45 am

386934 Adaisha Rutledge 3‐112 The effectiveness of various teaching styles in P3 pharmacy students

Monday, December 7

12:00 pm ‐ 1:00 pm

385924 Yasmin Saafan 5B‐251 Evaluation of anticoagulant order stacking post‐computerized physician order

Tuesday, December 8

11:30 am ‐ 12:30 pm


149 | P a g e

Submission ID



entry (CPOE) implementation in a health system

388474 Catalina Saenz 5A‐334 Evaluation of a phenytoin dosing protocol in traumatic brain injury patients

Tuesday, December 8

10:00 am ‐ 11:00 am

388088 Lisa Sagardia 5A‐161 Pharmacy student perceptions regarding understanding of and confidence in literature evaluation following a student chapter journal club

Tuesday, December 8

10:00 am ‐ 11:00 am

385968 Agafe Saguros 5A‐176 Relationship between faculty‐led advanced pharmacy practice experience (APPE) rotations and student capstone exam scores

Tuesday, December 8

10:00 am ‐ 11:00 am

389175 gilsy saji 2‐233 Case of suspected paliperidone palmitate‐induced thrombocytopenia

Monday, December 7

10:45 am ‐11:45 am

387220 Stephanie Salch 5A‐212 The use of a surface detection kit to identify occupational hazardous drug exposure: identifying pharmacy practice patterns and predictors associated with surface contamination

Tuesday, December 8

10:00 am ‐ 11:00 am

387739 Shane Salimnejad 3‐149 Vasopressin medication use evaluation (MUE) in a large integrated health system

Monday, December 7

12:00 pm ‐ 1:00 pm

389446 Andrew Sam 5A‐026 Prescription drug monitoring program: attitudes, beliefs, and usage by pharmacists and physicians.

Tuesday, December 8

10:00 am ‐ 11:00 am

384717 Joeanna Sams 5B‐088 Effect of maintenance intravenous fluids on length of stay in critically ill adults

Tuesday, December 8

11:30 am ‐ 12:30 pm

387741 Rahul Samudralwar 3‐195 Perceptions of student pharmacist involvement in a drug information service provided in the ambulatory care setting

Monday, December 7

12:00 pm ‐ 1:00 pm

385951 Jerick San Mateo 5A‐136 Safety and efficacy of hepatitis C infection treatment in a non‐

Tuesday, December 8

10:00 am ‐ 11:00 am


150 | P a g e

Submission ID



profit community health center

385751 Kristyn Sanders 5A‐027 The transition from argatroban to warfarin: a retrospective case series

Tuesday, December 8

10:00 am ‐ 11:00 am

385960 Melissa Sanders 2‐162 Implications of an Immunization Status Survey Conducted Annually Over Five Years at a Regional Immunization Conference

Monday, December 7

10:45 am ‐11:45 am

383203 Taylor Sandvick 3‐425 Evaluation of health care providers knowledge of recreational and medicinal marijuana in the state of Colorado

Monday, December 7

12:00 pm ‐ 1:00 pm

388918 Nikhil Sangave 5B‐252 Mobile health apps: the gateway to real time healthcare

Tuesday, December 8

11:30 am ‐ 12:30 pm

386115 Sana Sankari 3‐365 A meta‐analysis of preclinical and clinical studies comparing the anticancer efficacy of liposomal and conventional doxorubicin

Monday, December 7

12:00 pm ‐ 1:00 pm

383281 Arnold Sano 2‐079 Correlation between state‐level obesity rates and Medicare drug expenditures

Monday, December 7

10:45 am ‐11:45 am

389224 Kimberly Santa Cruz 2‐036 Students attitudes towards media as a teaching tool in pharmacy school psychiatric curriculum

Monday, December 7

10:45 am ‐11:45 am

385306 oscar santalo 5A‐067 Improper blood drawing that leads to the potential causes and errors inappropriate vancomycin trough monitoring

Tuesday, December 8

10:00 am ‐ 11:00 am

388364 Jonathan Santizo 5A‐068 Pharmacy student directed efforts in improving influenza immunization rates in the underserved population at the USF BRIDGE clinic

Tuesday, December 8

10:00 am ‐ 11:00 am

385911 Gustavo Santos 5A‐260 Comparative analysis of biomarkers in dementia of the Alzheimer type disease

Tuesday, December 8

10:00 am ‐ 11:00 am

389238 Nathan Santos 5A‐043 Patient understanding of urinary tract infections in a

Tuesday, December 8

10:00 am ‐ 11:00 am


151 | P a g e

Submission ID



Medically Underserved Population

389588 Sidra Sarker 7‐191 The Efficacy of Fluconazole Prophylaxis in Pediatric Neutropenic Oncology Patients


8:30 am ‐ 9:30 am

386206 Brent Sasaki 5B‐069 Self‐perceived knowledge and confidence regarding infectious diseases of advanced pharmacy practice experience (APPE) students

Tuesday, December 8

11:30 am ‐ 12:30 pm

386513 JoAnne Savage 3‐366 Assessing student perceptions of immunizations utilizing media in a predominately Hispanic, binational university setting

Monday, December 7

12:00 pm ‐ 1:00 pm

386369 Dimitrios Savva 2‐234 Pharmacy students performance and perceptions in an active learning course drug literature evaluation class

Monday, December 7

10:45 am ‐11:45 am

382971 Nicholas Scaturo 5B‐332 Liposomal bupivacaine versus pain cocktail for postoperative pain management status post TKA and THA

Tuesday, December 8

11:30 am ‐ 12:30 pm

389523 Jacob Schaurer 2‐315 Intracerebral hemorrhage associated with use of phentermine and phenelzine

Monday, December 7

10:45 am ‐11:45 am

388579 Kayla Schell 5A‐098 An analysis of pharmacy students perspective of post‐graduate training

Tuesday, December 8

10:00 am ‐ 11:00 am

384725 Danielle Schenck 5B‐253 Therapeutic substitutes for antipsychotics in adults with dementia in long term care facilities: preliminary results from an expert panel survey

Tuesday, December 8

11:30 am ‐ 12:30 pm

387230 Allison Schepers 7‐150 Vaccination status of pediatric patients with pertussis


8:30 am ‐ 9:30 am

387248 Alexandra Scher 2‐316 Evaluation of statin use in patients with diabetes in a city health department

Monday, December 7

10:45 am ‐11:45 am

385862 Chandler Schexnayder 5A‐119 Genistein and Glyceollin effects on ABCC2 (MRP2) and ABCG2 (BCRP) in Caco‐2 cells

Tuesday, December 8

10:00 am ‐ 11:00 am


152 | P a g e

Submission ID



385778 Johlee Schinetsky 2‐110 Point‐of‐care digital pupillometry by a multidisciplinary team is feasible and demonstrates good inter‐rater reliability

Monday, December 7

10:45 am ‐11:45 am

387801 Amy Schnees 2‐392 Clinical decision support for pediatric obesity: accuracy, completeness, and usability of the most popular drug information applications for healthcare practitioners

Monday, December 7

10:45 am ‐11:45 am

387953 Ronald Schneider 2‐144 Evaluation of safety and efficacy of intravenous acetaminophen in post‐cardiothoracic surgery patients

Monday, December 7

10:45 am ‐11:45 am

387144 Matt Schneller 3‐390 CLINIC IMPROVEMENT STUDY: IMPROVING EFFICIENCY TO PROVIDE BETTER QUALITY CARE FOR PATIENTS

Monday, December 7

12:00 pm ‐ 1:00 pm

389172 Andrew Schwartz 5A‐069 Transition of factor products supply chain, verification, and dispensing from blood bank to pharmacy in an academic medical center

Tuesday, December 8

10:00 am ‐ 11:00 am

386264 Madison Schwartz 3‐113 Retrospective utilization review of bolus‐dosed phenylephrine for acute hypotension in the emergency department

Monday, December 7

12:00 pm ‐ 1:00 pm

389198 Erik Scott 2‐393 Utilization of a pharmacy technician to obtain medication histories in a hepatology clinic

Monday, December 7

10:45 am ‐11:45 am

389230 Rachael Scott 5A‐192 Identification of Pharmacologic Factors Contributing to Intensive Care Unit Delirium and Evaluation of Critical Care Nurse Recognition

Tuesday, December 8

10:00 am ‐ 11:00 am

385898 Safiya Searvance 5B‐264 Treatment of diabetes: select to perfect

Tuesday, December 8

11:30 am ‐ 12:30 pm

388241 Megan Seddon 5B‐070 Survey of physicians' and mid‐level practitioners' perceptions of the piperacillin‐tazobactam shortage at a regional medical

Tuesday, December 8

11:30 am ‐ 12:30 pm


153 | P a g e

Submission ID



center

389062 Darren Seegmiller 5A‐309 Use of oral antibiotic treatment for pneumococcal bacteremia in hospitalized patients: a retrospective review

Tuesday, December 8

10:00 am ‐ 11:00 am

387107 Klarita Seitllari 7‐115 Implementation of a transition of care electronic referral process for hospital based ambulatory care pharmacists


8:30 am ‐ 9:30 am

386298 Megan Sell 5B‐333 Evaluation of the self‐reported risk versus benefit of dexamethasone as an antiemetic agent in patients receiving chemotherapy

Tuesday, December 8

11:30 am ‐ 12:30 pm

388676 Soo‐Ah Seo 7‐263 Evaluation of a vancomycin dosing guideline in a community teaching hospital


8:30 am ‐ 9:30 am

382556 Michael Serbin 3‐412 Cost‐Utility Analysis of Lumicaftor‐Ivacaftor in Cystic Fibrosis Patients Homozygous for the F508del CFTR Mutation

Monday, December 7

12:00 pm ‐ 1:00 pm

389626 Jordyn Serpa 5A‐137 Staging an Intervention for America's Opioid Addiction

Tuesday, December 8

10:00 am ‐ 11:00 am

387012 Sarah Servid 2‐354 Better understanding the rationale for antibiotic prescribing on discharge to hospice care

Monday, December 7

10:45 am ‐11:45 am

383164 Julia Sessa 2‐255 Chemical and physical stability of diluted dexrazoxane

Monday, December 7

10:45 am ‐11:45 am

386591 Andrew Shaffer 3‐196 Evaluation of glycemic control with EndoTool Glucose Management System for continuous insulin infusion therapy

Monday, December 7

12:00 pm ‐ 1:00 pm

384309 Megan Shah 5B‐334 Evaluation of antimicrobial use in bacteriuria

Tuesday, December 8

11:30 am ‐ 12:30 pm

383315 Megha Shah 3‐392 Comparison of Yelp Social Media Postings: Corporate vs. Independent Philadelphia County Pharmacies

Monday, December 7

12:00 pm ‐ 1:00 pm

386236 Priyank Shah 5B‐135 Embelin inhibits proliferation, induces apoptosis and alters

Tuesday, December 8

11:30 am ‐ 12:30 pm


154 | P a g e

Submission ID



gene expression profiles in breast cancer cells

386317 Richa Shah 3‐247 Comparison of initial vancomycin trough target achievement in the intravenous drug abuser versus non‐intravenous drug abuser

Monday, December 7

12:00 pm ‐ 1:00 pm

387968 Saloni Shah 2‐235 The Use of Piperacillin‐tazobactam for the Treatment of Bloodstream Infections due to AmpC β‐Lactamase‐Producing Enterobacteriaceae

Monday, December 7

10:45 am ‐11:45 am

387472 Sohan Shah 5A‐338 Impact of clinical surveillance decision support software in optimizing pharmacy‐driven antimicrobial stewardship interventions

Tuesday, December 8

10:00 am ‐ 11:00 am

385869 Justin Shanks 3‐367 The effect of best possible medication histories taken by pharmacy personnel in a teaching hospital: a comparison study

Monday, December 7

12:00 pm ‐ 1:00 pm

385894 Dong Shao 5B‐183 Correlation between personalized care management and improved health outcomes among Medicaid beneficiaries diagnosed with schizophrenia or bipolar disorder

Tuesday, December 8

11:30 am ‐ 12:30 pm

386604 Charu Sharma 7‐174 Patient adherence to oral oncolytics


8:30 am ‐ 9:30 am

384804 Nina Sharma 3‐413 Evaluation of methylnaltrexone utilization at an academic medical center: a quality improvement project

Monday, December 7

12:00 pm ‐ 1:00 pm

386960 Suzanne Shearin 5A‐206 Posaconazole Extended Release Tablet Dosing in a Pediatric Patient with Cystic Fibrosis

Tuesday, December 8

10:00 am ‐ 11:00 am

386407 Muhammad Sheheryar 7‐105 QTc interval prolongation risk stratification assessment of medications


8:30 am ‐ 9:30 am

382945 Eric Shen 5A‐207 Retrospective comparison of outcomes in patients with

Tuesday, December 8

10:00 am ‐ 11:00 am


155 | P a g e

Submission ID



recurrent or refractory ovarian cancer treated with pegylated liposomal doxorubicin at an academic medical center

389576 Yu‐Ting Shen 7‐205 Administration of high dose vigabatrin above the maximum daily dose in pediatric population for the treatment of seizures associated with tuberous sclerosis


8:30 am ‐ 9:30 am

389000 Kristen Sherlin 2‐410 Evaluation of student performance on selected‐response versus constructed‐response examinations in a pathophysiology and therapeutics course

Monday, December 7

10:45 am ‐11:45 am

387815 Luegenia Sherriffe 3‐114 Assessing student pharmacists perception of the zoster virus and shingles vaccinations

Monday, December 7

12:00 pm ‐ 1:00 pm

387732 Candice Sherwood 5B‐335 Evaluation of alvimopan use at Rex Hospital

Tuesday, December 8

11:30 am ‐ 12:30 pm

385631 Soumil Sheth 5A‐158 Medication use evaluation of oral vancomycin

Tuesday, December 8

10:00 am ‐ 11:00 am

384623 Ruixin Shi 7‐151 Analysis of health‐care employee pertussis post‐exposure prophylaxis in University of Michigan Health System: a retrospective observational study


8:30 am ‐ 9:30 am

386902 Janet Shin 2‐058 Do antidepressants reduce substance abuse readmissions in patients suffering from depression and substance abuse?

Monday, December 7

10:45 am ‐11:45 am

386631 Jennifer Shin 7‐264 Evaluation of appropriate quetiapine prescribing practices


8:30 am ‐ 9:30 am

389190 Scott Shipley 3‐019 Rates of emerging resistance between AmpC stable and unstable antibiotics in Enterobacteriaceae infections

Monday, December 7

12:00 pm ‐ 1:00 pm

386753 Julia Shlensky 5B‐184 Retrospective medication use evaluation of sildenafil in

Tuesday, December 8

11:30 am ‐ 12:30 pm


156 | P a g e

Submission ID



pediatric patients

386198 Anastasiya Shulman 2‐267 Evaluation of Hydrocortisone and Impact on Survival in Septic Surgical Intensive Care Patients

Monday, December 7

10:45 am ‐11:45 am

384501 Carina Shults 3‐248 Perphenazine and haloperidol induced neuroleptic malignant syndrome: a case report

Monday, December 7

12:00 pm ‐ 1:00 pm

386335 Avneet Sidhu 7‐265 Impact of an educational initiative regarding appropriate stress ulcer prophylaxis indications on prescribing patterns in ICU patients.


8:30 am ‐ 9:30 am

384660 Sukhwinder Sidhu 2‐067 Acute heart failure admission from skilled nursing facilities versus home: an evaluation of mortality risk and other clinical outcomes

Monday, December 7

10:45 am ‐11:45 am

388971 Christopher Siegler 5B‐136 Veterans Affairs Learning Opportunity Residency (VALOR) Program in Pharmacy Administration: Utilizing succession planning in developing students into future pharmacy leaders

Tuesday, December 8

11:30 am ‐ 12:30 pm

387733 Taylor Sikkenga 7‐152 Point of care testing for chlamydia and gonorrhea with audit and feedback in the emergency department


8:30 am ‐ 9:30 am

386584 Janet Simon 3‐115 Evaluation of patients treated with direct oral anticoagulants for stroke prevention in atrial fibrillation at a large academic medical center

Monday, December 7

12:00 pm ‐ 1:00 pm

389120 Nancy Simon 2‐236 Pharmacy student involvement in the pre‐screening of patients for a clinical trial as part of an advanced pharmacy practice experience (APPE)

Monday, December 7

10:45 am ‐11:45 am

387474 Sarah Simpson 2‐411 Assessing the Effect of Attitudes and Functional Health Literacy on Patient Adherence to Heart Health Medications

Monday, December 7

10:45 am ‐11:45 am


157 | P a g e

Submission ID



389026 Krystal Sing 7‐153 Evaluating the impact of glucose variability in patients with diabetes mellitus (DM) and receiving parenteral nutrition (TPN)


8:30 am ‐ 9:30 am

386340 Mohini Singal 3‐184 Using d‐dimer values to identify the risk of readmission in recently hospitalized patients

Monday, December 7

12:00 pm ‐ 1:00 pm

388643 David Singer 5B‐336 Retrospective evaluation of hepatitis C cure rates in patients prescribed all‐oral treatment regimens at Duke University Medical Center

Tuesday, December 8

11:30 am ‐ 12:30 pm

388063 Ashley Singleton 7‐037 Evaluation of the quantity and quality of geriatric specific recommendations in clinical practice guidelines


8:30 am ‐ 9:30 am

386970 Michelle Singson 5A‐288 Effects of caffeinated energy drinks on central blood pressure in young healthy adults

Tuesday, December 8

10:00 am ‐ 11:00 am

387260 Heather Sink 7‐266 Impact of missed doses due to automatic medication administration record (MAR) holds post‐ procedure at a large community teaching hospital


8:30 am ‐ 9:30 am

384659 Jaclyn Skradski 7‐154 Empiric antipseudomonal monotherapy versus combination therapy in the treatment of pneumonia in ventilated patients: a retrospective study


8:30 am ‐ 9:30 am

385883 Matthew Slagle 2‐156 Eight month evaluation of transitioning to a warfarin home monitoring program in high risk anticoagulated adult patients

Monday, December 7

10:45 am ‐11:45 am

382725 Adam Smith 5A‐159 Implementation of pharmacy student intern ambassador program as a strategy to improve patients perception of access to pharmacy and

Tuesday, December 8

10:00 am ‐ 11:00 am


158 | P a g e

Submission ID



knowledge of purpose and side effects of medications

386737 Allison Smith 5B‐254 Physiological lab data in transgender patients: a multi‐disciplinary review

Tuesday, December 8

11:30 am ‐ 12:30 pm

385824 Brandon Smith 5B‐426 Limited oral antimicrobial options for the treatment of neonatal mastitis

Tuesday, December 8

11:30 am ‐ 12:30 pm

387191 Cole Smith 5B‐185 FOOD AND DRUG INTERACTIONS: ANALYZING PUBLIC KNOWLEDGE BEFORE AND AFTER VIEWING AN INTERACTIVE EDUCATION WEBSITE

Tuesday, December 8

11:30 am ‐ 12:30 pm

385635 Devlin Smith 2‐394 Evaluation of utilization and prescribing trends of the new oral anticoagulants (NOACs) among Medicare beneficiaries

Monday, December 7

10:45 am ‐11:45 am

389324 Elisha Smith 7‐038 Attitudes of medical residents toward pharmacist‐physician collaboration


8:30 am ‐ 9:30 am

384567 Emily Smith 5B‐186 Pharmacy students' understanding and perception of ambulatory care pharmacy

Tuesday, December 8

11:30 am ‐ 12:30 pm

388459 Jessica Smith 3‐116 Posaconazole utilization across a large, multi‐hospital community health‐system

Monday, December 7

12:00 pm ‐ 1:00 pm

388172 Jessica Smith 5B‐071 Comparative efficacy of phenytoin and levetiracetam for seizure prophylaxis

Tuesday, December 8

11:30 am ‐ 12:30 pm

389472 Joseph Smith 5B‐411 Development and use of a vancomycin calculator for patient specific AUC monitoring

Tuesday, December 8

11:30 am ‐ 12:30 pm

389351 Leborah Smith 7‐039 Evaluation of appropriate cholesterol management in a hospital based ambulatory care clinic serving indigent patients with access to medication therapy


8:30 am ‐ 9:30 am

386968 Rachel Smith 7‐106 Comparison of international postgraduate degree programs in palliative care: a descriptive


8:30 am ‐ 9:30 am


159 | P a g e

Submission ID



report

389390 Tiffany Smith 3‐117 Evaluating the correction of hypoglycemia following an inpatient hypoglycemic episode in patients on insulin

Monday, December 7

12:00 pm ‐ 1:00 pm

385729 Gregory Sneed 2‐145 Impact of twenty‐four hour ambulatory blood pressure monitoring on short and long term clinical outcomes

Monday, December 7

10:45 am ‐11:45 am

388274 Karisa Snow 5B‐368 Assessing the impact of medication knowledge on adherence and hospital admissions in cystic fibrosis patients

Tuesday, December 8

11:30 am ‐ 12:30 pm

387350 John Snyder 2‐237 Transitioning from warfarin to the direct oral anticoagulants (DOAC): Are we afraid of change?

Monday, December 7

10:45 am ‐11:45 am

387828 Jordan Snyder 3‐150 Patient portal utilization in older adults and proxies

Monday, December 7

12:00 pm ‐ 1:00 pm

389510 Lindsey Snyder 5A‐343 Medication‐Use Evaluation (MUE) of Fibrates within a VA Health System

Tuesday, December 8

10:00 am ‐ 11:00 am

384499 Daniel Sokolowski 7‐040 Determining rates of bivalirudin substitution for heparin and cost comparison in a community hospital catheterization laboratory


8:30 am ‐ 9:30 am

387624 Paul Solinsky 3‐249 Review of falls in a long‐term care facility from the pharmacist perspective: a focus on repeat falls

Monday, December 7

12:00 pm ‐ 1:00 pm

389404 Karl‐Eric Solius 3‐044 The addition of indications to prescription bottle labels to improve medication adherence

Monday, December 7

12:00 pm ‐ 1:00 pm

386125 Diana Solomon 3‐250 Impact of appropriateness of protein and energy provision by parenteral nutrition on clinical outcomes

Monday, December 7

12:00 pm ‐ 1:00 pm

386846 Jenna Solomon 3‐292 Evaluating the use of potentially inappropriate drugs in the elderly in medical

Monday, December 7

12:00 pm ‐ 1:00 pm


160 | P a g e

Submission ID



residency programs

383200 Boh Song 5B‐006 Evaluating the newly updated 2014‐2015 palivizumab guideline in relation to respiratory syncytial virus infection

Tuesday, December 8

11:30 am ‐ 12:30 pm

386380 Yong Eun Song 7‐107 Assessment of adherence to the early management bundle for severe sepsis and septic shock in a community‐based hospital: a descriptive quality improvement study


8:30 am ‐ 9:30 am

386152 Brendan Sorrento 5A‐193 Evaluation of protocol driven enoxaparin dose adjustments in an academic acute care medical center.

Tuesday, December 8

10:00 am ‐ 11:00 am

386783 Diane Soto 7‐267 Differences in CYP3A5*3 frequencies between Korean‐Americans compared to a Caucasian population


8:30 am ‐ 9:30 am

387050 JoAnna Souksavong 2‐059 Impact of student pharmacists on community members' stroke preparedness and knowledge of primary prevention

Monday, December 7

10:45 am ‐11:45 am

389226 Ashley Soule 7‐155 Intentional teaching to improve student performance on pharmaceutical calculations


8:30 am ‐ 9:30 am

388177 Joylaina Speaks 5B‐072 Descriptive comparison of pharmacy curricula in the United States

Tuesday, December 8

11:30 am ‐ 12:30 pm

389267 Tara Spencer 5B‐358 Implementation of, making improvements in diabetes by achieving set goals (MIDAS), a patient‐driven, goal‐setting based multidisciplinary group diabetes clinic

Tuesday, December 8

11:30 am ‐ 12:30 pm

386661 Casey Spitzer 5B‐266 Increasing patient referrals from physicians to a pharmacist run comprehensive medication review (CMR) program

Tuesday, December 8

11:30 am ‐ 12:30 pm

386002 Thitinan Sraubol 5A‐170 Impact of concomitant use of azoles and amiodarone therapy

Tuesday, December 8

10:00 am ‐ 11:00 am


161 | P a g e

Submission ID



on QT prolongation

387089 Melani St. Pierre 5B‐337 Use of fosaprepitant in adult inpatient hematology and oncology patients receiving chemotherapy

Tuesday, December 8

11:30 am ‐ 12:30 pm

389555 Theodore Stachulski 5B‐255 An HIV/HCV co‐infected patient's experience taking ledipasvir/sofosbuvir in combination with ART

Tuesday, December 8

11:30 am ‐ 12:30 pm

387991 Candace Stacy 2‐111 Evaluation of the understanding and utilization of mobile health (mHealth) among student pharmacists

Monday, December 7

10:45 am ‐11:45 am

385615 Kelsey Stalvey 5A‐241 Use of cidofovir in patients receiving extracorporeal membrane oxygenation (ECMO) for severe adenovirus pneumonia: a case report and review of the literature

Tuesday, December 8

10:00 am ‐ 11:00 am

384553 Matthew Stankowicz 3‐118 Impact of restriction on daptomycin utilization at a community hospital

Monday, December 7

12:00 pm ‐ 1:00 pm

387229 Amy Staples 5A‐110 Identifying sources of error in electronic prescriptions

Tuesday, December 8

10:00 am ‐ 11:00 am

388007 Rachel Steele 5B‐187 Correlation and impact of pharmacist intervention(s) on diabetes, dyslipidemia, and hypertension related outcomes at a worksite clinic

Tuesday, December 8

11:30 am ‐ 12:30 pm

388062 Allison Stefanski 3‐293 HSV PCR testing and acyclovir use in children: a five year review.

Monday, December 7

12:00 pm ‐ 1:00 pm

384729 Laura Steffens 5B‐369 Assessment of triple versus dual antithrombotic therapy in subjects undergoing percutaneous coronary intervention on direct‐acting oral anticoagulants

Tuesday, December 8

11:30 am ‐ 12:30 pm

384757 Adam Steg 7‐041 The role of pharmacogenomics in predicting response to hedgehog antagonists in human cancers


8:30 am ‐ 9:30 am


162 | P a g e

Submission ID



385176 Samantha Steiger 3‐029 Evaluation of current heparin infusion dosing protocol on increased bleeding events at a community teaching hospital

Monday, December 7

12:00 pm ‐ 1:00 pm

386523 Roman Steiner 3‐185 Free Open Access Medical Education on Experiential Learning Experiences in Emergency Medicine Pharmacy

Monday, December 7

12:00 pm ‐ 1:00 pm

387055 Adrian Stephens 7‐042 Long‐term effects of attention deficit hyperactivity disorder stimulants in Auburn University college students


8:30 am ‐ 9:30 am

382629 Kelsey Stephens 5A‐164 Analysis of institutional continuing education providers fulfilling specific accreditation council for pharmacy education requirements

Tuesday, December 8

10:00 am ‐ 11:00 am

388999 Amy Stewart 5B‐392 Medication reconciliation in a community hospital: a preliminary data review

Tuesday, December 8

11:30 am ‐ 12:30 pm

384386 Emily Stewart 5A‐335 Evaluation of tigecycline indications for use at an academic medical center

Tuesday, December 8

10:00 am ‐ 11:00 am

386469 Michelle Stewart 7‐156 Identifying patients at risk for prescription opioid overdose and for whom a naloxone distribution program would benefit


8:30 am ‐ 9:30 am

383147 Allison Stilwell 5A‐213 Implementation of a pharmacist‐driven immunization initiative designed to improve overall vaccination rates among the low‐income, uninsured patients at a free clinic.

Tuesday, December 8

10:00 am ‐ 11:00 am

388769 Kevin Stock 5A‐327 Evaluation of a transitions of care pharmacist program for reducing high‐risk patient readmissions

Tuesday, December 8

10:00 am ‐ 11:00 am

389275 Jamie Stocker 5B‐188 Effect of daptomycin dosing in obese patients based on adjusted body weight versus

Tuesday, December 8

11:30 am ‐ 12:30 pm


163 | P a g e

Submission ID



total body weight on clinical outcomes and safety

388105 Patrick Stolz 3‐414 Evaluation of intravenous acetaminophen for drug therapy appropriateness

Monday, December 7

12:00 pm ‐ 1:00 pm

384783 Ryan Stormont 2‐163 Milk‐alkaline syndrome following frequent administration of calcium carbonate

Monday, December 7

10:45 am ‐11:45 am

389464 Phoebe Stracener 5A‐328 Review of discharge medication list completeness and accuracy in a community hospital

Tuesday, December 8

10:00 am ‐ 11:00 am

385288 Ashley Street 7‐268 Out with the old: characteristics of medications and participants of a drug take back event


8:30 am ‐ 9:30 am

386147 Paige Street 3‐314 Novel puromycin‐based antimicrobials for the treatment of drug resistant pathogens

Monday, December 7

12:00 pm ‐ 1:00 pm

386222 Brittany Strong 2‐105 A case of epoprostenol‐induced acute kidney injury (AKI)

Monday, December 7

10:45 am ‐11:45 am

387282 Lauren Stummer 2‐268 Reducing potentially inappropriate use of sedative‐hypnotic medications among the elderly: A pharmacist's role in population management

Monday, December 7

10:45 am ‐11:45 am

389572 Sarah Louise Suerte 3‐368 Antibiotic administration for sternal wound infections in pediatric patients with delayed sternal closure (DSC) after cardiac surgery

Monday, December 7

12:00 pm ‐ 1:00 pm

384716 Leslie Sugiyama 5B‐256 Assessing the Use of Apixaban for Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE)

Tuesday, December 8

11:30 am ‐ 12:30 pm

386958 Kathryn Suko 5A‐044 The impact of energy drinks on cardiac transmural dispersion of repolarization

Tuesday, December 8

10:00 am ‐ 11:00 am

388009 Meagan Sullivan 5B‐338 Assessment of accuracy and implementation of weight‐based heparin nomogram compared to fixed‐dose

Tuesday, December 8

11:30 am ‐ 12:30 pm


164 | P a g e

Submission ID



adjustment heparin nomogram

386242 Rachel Sullivan 5A‐329 Chronic alcohol consumption enhances ZAG expression and exacerbates caner‐associated adipose tissue loss in tumor‐bearing mice

Tuesday, December 8

10:00 am ‐ 11:00 am

388407 Emily Sum 3‐251 Retrospective quality review of antimicrobial indications upon prescriber order entry at a community teaching hospital

Monday, December 7

12:00 pm ‐ 1:00 pm

384625 Casey Summers 5B‐393 The Removal of Zolpidem from Standardized Order Sets and its Effect on the Rate of Inpantient Falls in a Community Teaching Hospital

Tuesday, December 8

11:30 am ‐ 12:30 pm

386638 Holly Summey 5B‐073 Evaluation of epoetin alfa utilization in the intensive care units of a community hospital

Tuesday, December 8

11:30 am ‐ 12:30 pm

388789 Shawn Sun 2‐414 Enhancing medication safety, communication skills, and patient care through interprofessional education: a pharmacy‐nursing student collaborative exercise.

Monday, December 7

10:45 am ‐11:45 am

386534 Karina Sundar 5A‐339 Budget impact and waste analysis of conversion of 10‐mL floor stock vials to 3‐mL individual patient supply.

Tuesday, December 8

10:00 am ‐ 11:00 am

386515 Jamie Sundin 5B‐189 Increasing the maximum activity of technetium‐99m labeled tetrofosmin kits

Tuesday, December 8

11:30 am ‐ 12:30 pm

387466 Hyojin Sung 2‐037 Evaluation of smoking related policies and programs in housing programs for homeless in San Francisco

Monday, December 7

10:45 am ‐11:45 am

386230 Subin Sunny 3‐252 Impact of inappropriate advancement of parenteral nutrition on subsequent metabolic complications

Monday, December 7

12:00 pm ‐ 1:00 pm

387541 Robert Sutton 3‐253 Abbreviated and targeted technician training for pharmacy interns in a large

Monday, December 7

12:00 pm ‐ 1:00 pm


165 | P a g e

Submission ID



academic medical center

389097 Allison Sweat 2‐395 Hydrogen peroxide contributes to cisplatin‐mediated toxicity in neuroblastoma

Monday, December 7

10:45 am ‐11:45 am

386918 Nichole Szczerbowski 5B‐190 Assessment of medical writing across U.S. schools of pharmacy and student interest in writing: development of leadership, self‐awareness and interprofessional co‐curricular opportunities

Tuesday, December 8

11:30 am ‐ 12:30 pm

385267 Paul Szostak 5B‐191 Analysis of parenteral anticoagulant prescribing patterns prior to initiation of rivaroxaban and apixaban.

Tuesday, December 8

11:30 am ‐ 12:30 pm

388093 Adrienne Szymkowiak 3‐275 Evaluation of acute management of severe hyperglycemia in hemodialysis patients in a hospital setting

Monday, December 7

12:00 pm ‐ 1:00 pm

387045 Nguyen Ta 2‐068 California pharmacists' knowledge and perceptions of the interface between oral and overall health

Monday, December 7

10:45 am ‐11:45 am

386987 Jessica Tahara 2‐238 Characterization of drug‐related problems identified by doctor of pharmacy students on an ambulatory care advanced pharmacy practice experience (APPE) rotation

Monday, December 7

10:45 am ‐11:45 am

387919 Nisha Tahiliani 3‐119 Outpatient pharmacy identification of electronic prescription discrepancies and education of prescribers after transitioning to a new outpatient electronic health record

Monday, December 7

12:00 pm ‐ 1:00 pm

386467 Cheng‐Hsiao Tai 2‐239 Drug‐drug interaction alerts in a hospital setting: the impact of removing unnecessary drug‐drug interaction alerts on patient safety

Monday, December 7

10:45 am ‐11:45 am


166 | P a g e

Submission ID



389236 Rachael Talaski 7‐157 Impact of new cholesterol guidelines on high‐intensity statin prescribing for primary prevention in a family medicine residency clinic


8:30 am ‐ 9:30 am

388945 Christopher Talbot 5B‐257 Therapeutic interventions: a comprehensive analysis of pharmacy student contributions at an inpatient teaching facility

Tuesday, December 8

11:30 am ‐ 12:30 pm

384571 Josephine Tan 5A‐163 Utilization of pharmacy services to improve the medication reconciliation process at an academic comprehensive cancer center

Tuesday, December 8

10:00 am ‐ 11:00 am

389494 Xing Tan 5B‐192 Feasibility of current electrocardiogram (ECG) assessments performed in early‐phase studies to replace thorough QTc (TQT) study using exposure‐response (ER) analysis

Tuesday, December 8

11:30 am ‐ 12:30 pm

388240 Caroline Tang 3‐415 Medication Utilization Evaluation (MUE) of Antibiotic Irrigation Use in the Operating Room

Monday, December 7

12:00 pm ‐ 1:00 pm

385757 Lisa Tang 7‐071 Investigate the contribution of ERK signaling on cigarette smoke and estrogen induced effects of ovarian cancer cells


8:30 am ‐ 9:30 am

385428 Valerie Tapia 5B‐089 30‐day readmission rates of congestive heart failure (CHF) patients involved in student counseling project in a community hospital setting compared to the national averages

Tuesday, December 8

11:30 am ‐ 12:30 pm

389341 Saad Tariq 7‐108 Eliciting caregiver priorities for children with a developmental disability and coexisting mental health condition, using best‐worst scaling


8:30 am ‐ 9:30 am

386434 Meredith Tate 7‐043 Student pharmacists' level of Wednesday, 8:30 am ‐ 9:30 am


167 | P a g e

Submission ID



confidence in providing DSME prior to entering P4 rotations

December 9

389574 Abigail Taylor 5A‐047 Investigating Health Claims Provided on Dietary Supplement Packaging

Tuesday, December 8

10:00 am ‐ 11:00 am

385242 Brooke Taylor 2‐146 Pharmacy student medication reconciliation improves the accuracy of discharge medication instructions at a community hospital

Monday, December 7

10:45 am ‐11:45 am

389371 Heather Taylor 5B‐339 Analysis of anticoagulation reversal with human prothrombin complex concentrate and anti‐inhibitor coagulant complex

Tuesday, December 8

11:30 am ‐ 12:30 pm

386027 Preston Taylor 7‐049 Randomized trial of the use of smart phone applications to promote medication adherence in a postsecondary student population


8:30 am ‐ 9:30 am

384795 Samantha Taylor 5A‐208 Trends in the prescribing of contraceptives to female adolescents aged 12 to 17 for years 2003 through 2010

Tuesday, December 8

10:00 am ‐ 11:00 am

389361 Amanda Teachey 5B‐340 Evaluation of an institution‐specific nurse‐driven diabetic ketoacidosis protocol

Tuesday, December 8

11:30 am ‐ 12:30 pm

388674 Elena Telebak 5B‐137 Surviving sepsis targets in a real world clinical environment

Tuesday, December 8

11:30 am ‐ 12:30 pm

389105 Zachary Temple 3‐315 Adequacy of empiric antibiotic selection for Enterobacteriaceae urinary tract infection at an academic medical center

Monday, December 7

12:00 pm ‐ 1:00 pm

385846 Elizabeth Tencza 3‐030 Use of four factor prothrombin complex concentrate for mitigation of rivaroxaban‐ induced bleeding in an emergent coronary artery bypass graft procedure

Monday, December 7

12:00 pm ‐ 1:00 pm

385561 Ally Tepe 2‐396 Evaluation of the use of adjusted body weight dosing

Monday, December 7

10:45 am ‐11:45 am


168 | P a g e

Submission ID



for intravenous acyclovir in obese patients

389233 Constance Terrell 5B‐074 Nailed it or just got nailed? Presumed onychomycosis infections: proper pathological diagnosis could lead to more successful treatment outcomes

Tuesday, December 8

11:30 am ‐ 12:30 pm

388973 Lauren Terrell 2‐397 Interdisciplinary osteoporosis risk assessment in a Veteran Affairs community living center

Monday, December 7

10:45 am ‐11:45 am

387628 Alexandra Terry 5B‐138 Evaluation of corticosteroid dose in acute exacerbation of chronic obstructive pulmonary disease (COPD)

Tuesday, December 8

11:30 am ‐ 12:30 pm

384570 Joanne Thai 3‐254 Anticholinergic toxicity and acute renal failure: a case report

Monday, December 7

12:00 pm ‐ 1:00 pm

383194 Stephanie Theard 5B‐075 Development of an oncology elective in a pharmacy school

Tuesday, December 8

11:30 am ‐ 12:30 pm

389550 Helen

Tesfaye 2‐422 Pregnancy labeling replaces letter categories: effects of ruling on commonly prescribed medications

Monday, December 7

10:45 am ‐11:45 am

388030 Hannah Thomas 5B‐076 Evaluation of a pain, agitation, and delirium protocol and the impact on elderly critically ill trauma patients

Tuesday, December 8

11:30 am ‐ 12:30 pm

386656 Maggie Thomas 5B‐197 Evaluation of off label use of dexmedetomidine in a single center university hospital

Tuesday, December 8

11:30 am ‐ 12:30 pm

382965 Sharon Thomas 5A‐284 Attention deficit hyperactivity disorder (ADHD) treatment educational session for advocates of foster children

Tuesday, December 8

10:00 am ‐ 11:00 am

387866 Brianna Thompson 3‐255 Results of drug‐drug interaction evaluations for patients starting direct‐acting antiviral therapy for hepatitis C: implications for treatment

Monday, December 7

12:00 pm ‐ 1:00 pm

388562 Brittany Thompson 3‐316 Perception of sleep habits on glycemic control among patients with type 2 diabetes

Monday, December 7

12:00 pm ‐ 1:00 pm


169 | P a g e

Submission ID



mellitus at a rural‐health family medicine clinic

387347 Kayla Thompson 5B‐144 Child and parent pairs: a new opportunity for student pharmacists to practice counseling

Tuesday, December 8

11:30 am ‐ 12:30 pm

384496 Mary Thompson 2‐069 United States pharmacy student perceptions and desired implementation of oral examinations and presentations in a doctoral pharmacy curriculum

Monday, December 7

10:45 am ‐11:45 am

386289 Andrew Thorne 5B‐341 Acute kidney injury in patients treated with high‐dose cisplatin, dexamethasone, and cytarabine (DHAP): a retrospective study

Tuesday, December 8

11:30 am ‐ 12:30 pm

386428 Emmalee Thornton 2‐355 Clinical rationale and outcomes associated with adding long‐acting opioids to short‐acting opioids for the treatment of chronic, non‐malignant pain

Monday, December 7

10:45 am ‐11:45 am

389639 Glenn Thorp 5A‐209 Innovative paramedic program includes student pharmacist to reduce hospital readmission rates.

Tuesday, December 8

10:00 am ‐ 11:00 am

388040 Erin Tibbetts 3‐294 Blood glucose control in children with type I diabetes at a pediatric diabetes camp

Monday, December 7

12:00 pm ‐ 1:00 pm

385961 Ansley Tidwell 5B‐077 Vancomycin process medication use evaluation

Tuesday, December 8

11:30 am ‐ 12:30 pm

388200 Annie Tien 3‐256 Impact of empathy on career goals of pharmacy students ‐ a two year study

Monday, December 7

12:00 pm ‐ 1:00 pm

383189 Sela Tiet 5B‐078 Serotonin syndrome following administration of methylene blue after cardiac surgery in a patient taking paroxetine

Tuesday, December 8

11:30 am ‐ 12:30 pm

389656 Heather Tilley 5A‐330 Psychiatric disease state based medication teaching and adherence modules for a voluntary inpatient psychiatric

Tuesday, December 8

10:00 am ‐ 11:00 am


170 | P a g e

Submission ID



unit

386281 Monica Timmerman 5B‐268 Oral lorazepam for seizure prophylaxis in adult patients treated with high dose intravenous busulfan before hematopoietic stem cell transplantation: A retrospective study

Tuesday, December 8

11:30 am ‐ 12:30 pm

385995 Jennifer To 2‐060 Incidence of hypoglycemic events in critically ill patients on continuous insulin infusion

Monday, December 7

10:45 am ‐11:45 am

386967 WaHin To 3‐197 Lithium toxicity from a drug interaction with naproxen: a case report

Monday, December 7

12:00 pm ‐ 1:00 pm

384569 Kaley Tolar 5A‐331 Characterization of hospitalized pediatric oncology patients diagnosed with Clostridium difficile diarrhea

Tuesday, December 8

10:00 am ‐ 11:00 am

384879 Dallas Tolbard 7‐109 Use of Methylnaltrexone in the Emergency Department at Peninsula Regional Medical Center


8:30 am ‐ 9:30 am

387227 John Toler 5B‐272 Impact of a prescriber‐focused best practice alert (BPA) concerning intravenous (IV) chlorothiazide on ordering and utilization

Tuesday, December 8

11:30 am ‐ 12:30 pm

388425 Rebecca Toor 3‐120 Debate as an alternative method for medical literature evaluation

Monday, December 7

12:00 pm ‐ 1:00 pm

388041 Brian Torabi 5A‐285 Poverty simulation: engaging pharmacy students in interprofessional education and empathy development

Tuesday, December 8

10:00 am ‐ 11:00 am

387251 Sahar Torabi 2‐398 Evaluating the impact of interprofessional learning on the perceived knowledge of teamwork and the roles of various healthcare professional students

Monday, December 7

10:45 am ‐11:45 am

388996 Claudia Torres 3‐138 Extremes temperatures and its effect on medications delivered

Monday, December 7

12:00 pm ‐ 1:00 pm


171 | P a g e

Submission ID



to homes and pharmacies in south Florida

385149 Elisa Torres 5A‐194 Clinical use of sodium‐glucose cotransporter‐2 (SGLT‐2) inhibitors for the management of type 2 diabetes in a patient centered medical home

Tuesday, December 8

10:00 am ‐ 11:00 am

388014 Nidia Torres Pena 3‐121 Evaluation of the safety and effectiveness of a community hospital's vancomycin dosing protocol in obese patients

Monday, December 7

12:00 pm ‐ 1:00 pm

387829 Brian Tran 5A‐138 Design and synthesis of analogs of Bromophycolide A as novel antimalarial agents

Tuesday, December 8

10:00 am ‐ 11:00 am

385639 Christine Tran 3‐416 Quality of anticoagulant management for atrial fibrillation patients in an outpatient setting

Monday, December 7

12:00 pm ‐ 1:00 pm

388057 Henry Tran 7‐158 Improving alert compliance of patient‐controlled analgesia smart pumps in a tertiary care academic children's hospital


8:30 am ‐ 9:30 am

387435 Ky Tran 2‐126 Pharmacoepidemiology of Enterobacter infections at a level two tertiary medical center

Monday, December 7

10:45 am ‐11:45 am

384310 Lilian Tran 5A‐286 Assessment of Post‐Exposure Blood Chemistry Panels of Non‐human Primates Immunized against Ebola by Various Routes

Tuesday, December 8

10:00 am ‐ 11:00 am

389375 Maithi Tran 5B‐079 Evaluation of methods predicting and preventing Clostridium difficile infection

Tuesday, December 8

11:30 am ‐ 12:30 pm

387774 Stacy Tran 5A‐070 Impact of pre‐injury HMG‐CoA reductase inhibitors on outcomes in older, seriously injured trauma patients with a moderate to severe traumatic brain injury

Tuesday, December 8

10:00 am ‐ 11:00 am

388102 Tram Tran 3‐369 Pharmacist‐led Medication Therapy Management service as the solution for reducing

Monday, December 7

12:00 pm ‐ 1:00 pm


172 | P a g e

Submission ID



non‐adherence at an acute psychiatric hospital.

389444 Uyen Uyen Tran 3‐370 Estradiol micropheres formulation for controlled release drug delivery

Monday, December 7

12:00 pm ‐ 1:00 pm

386485 Salematou Traore 5A‐160 Medication use evaluation of intravenous acetaminophen

Tuesday, December 8

10:00 am ‐ 11:00 am

383197 Luc Trinh 5A‐139 Isoniazid overdose: rational for 1:1 pyridoxal antidotal therapy

Tuesday, December 8

10:00 am ‐ 11:00 am

383719 Nam Trinh 5B‐080 Evaluation of enoxaparin automatic consult implementation for patient safety and efficacy

Tuesday, December 8

11:30 am ‐ 12:30 pm

389602 Jaclyn Tripptree 2‐240 Pharmacy student use of smartphone applications for drug information

Monday, December 7

10:45 am ‐11:45 am

387432 Daniel Trobare 2‐339 Adherence and barriers to diabetic eye exams: a survey of patients with type 2 diabetes

Monday, December 7

10:45 am ‐11:45 am

389619 Megan Trout 2‐152 Cefazolin: Medication Use Evaluation

Monday, December 7

10:45 am ‐11:45 am

382970 Anthony Trovato 5B‐370 Rates of nonvaccination of pneumococcal polysaccharide vaccine among patients with diabetes, asthma, and cigarette smoking in a family medicine residency clinic

Tuesday, December 8

11:30 am ‐ 12:30 pm

385590 Lena Truong 7‐110 Association between medication adherence report scale (MARS‐5) and caregiver‐reported leukotriene modifier use in inner city children with asthma


8:30 am ‐ 9:30 am

389279 Mitchell Truong 5B‐094 Appropriateness of argatroban use for suspected heparin‐induced thrombocytopenia (HIT) at a community hospital setting

Tuesday, December 8

11:30 am ‐ 12:30 pm

389617 Thao Truong 5A‐028 Improving vancomycin trough level acquisition through a checklist tool

Tuesday, December 8

10:00 am ‐ 11:00 am

384980 Lindsay Tsai 2‐317 Improving adherence to health Monday, 10:45 am ‐11:45 am


173 | P a g e

Submission ID



effectiveness data information set (HEDIS) performance measures for the pharmacotherapeutic management of chronic obstructive pulmonary disease (COPD) exacerbation

December 7

386217 Tiffany Tsai 3‐020 Efficacy and safety of twice‐ versus once‐daily dosing of lisinopril for the treatment of hypertension

Monday, December 7

12:00 pm ‐ 1:00 pm

386262 Jordan Tullos 7‐192 Assessment of pharmacist adherence to protocol guidelines and its impact in a surgical intensive care unit


8:30 am ‐ 9:30 am

386991 Kelsey Turcotte 5A‐273 Project population health and rural medicine (PHaRM): assessing the effects of functional health literacy on patient adherence to heart health medications

Tuesday, December 8

10:00 am ‐ 11:00 am

386537 Kaitlin Turk 2‐318 Naloxone use in non‐ emergency department patients

Monday, December 7

10:45 am ‐11:45 am

386500 Merika Tuvell 5A‐079 An evaluation of the new CLSI carbapenem breakpoints: a meta‐analysis study

Tuesday, December 8

10:00 am ‐ 11:00 am

387140 Tiffany Tweed 5B‐342 Sodium‐glucose cotransporter‐2 (SGLT2) inhibitors may be a treatment option for patients with type 1 diabetes: two case reports

Tuesday, December 8

11:30 am ‐ 12:30 pm

385581 Sarah Ullman 2‐241 Evaluating the use of vitamin K: is it in accordance with evidence‐based medicine?

Monday, December 7

10:45 am ‐11:45 am

388447 Vanessa Ulloa 5A‐071 Descriptive analysis of workflow processes associated with the operation of a student‐run free clinic

Tuesday, December 8

10:00 am ‐ 11:00 am

388967 MARVELIN UMEH 5A‐140 Gene expression differences between Asians, blacks, and whites in breast cancer

Tuesday, December 8

10:00 am ‐ 11:00 am


174 | P a g e

Submission ID



386490 Stefanie Underwood 3‐371 Vancomycin plus piperacillin‐tazobactam induced acute kidney injury (AKI) proven by renal biopsy: a case series

Monday, December 7

12:00 pm ‐ 1:00 pm

389245 Sinziana Ungureanu 5A‐072 Clinical outcomes in patients receiving maximum dose haloperidol decanoate every two weeks versus every four weeks in a long term inpatient psychiatric facility

Tuesday, December 8

10:00 am ‐ 11:00 am

386953 Kate Unterberger 2‐356 Evaluation of anti‐incontinence therapy in a veteran population post formulary conversion from extended‐release tolterodine

Monday, December 7

10:45 am ‐11:45 am

388564 Jarred Uy 5A‐141 Implementation and outcomes of a shared medical visit for patients with diabetes

Tuesday, December 8

10:00 am ‐ 11:00 am

385847 Meera Vachhani 3‐257 Comparison of normal saline and plasma‐lyte for fluid resuscitation in septic shock

Monday, December 7

12:00 pm ‐ 1:00 pm

389131 Sabina Vaichys 3‐258 Evaluation of appropriateness of vaccination procedures of the 13‐valent pneumococcal conjugate vaccine and the 23‐valent pneumococcal polysaccharide vaccine in a hospital setting

Monday, December 7

12:00 pm ‐ 1:00 pm

386759 Sara Valanejad 5A‐214 Impact of demographic and socioeconomic variables on the recommended vaccination in teenage males for human papillomavirus in the United States

Tuesday, December 8

10:00 am ‐ 11:00 am

386907 Delia Valerio 2‐106 Quantifying the proportion of hospital admissions to an inpatient nephrology service due to patient noncompliance

Monday, December 7

10:45 am ‐11:45 am

382527 Nabila Valles 7‐202 Efficacy of ginger (Zingiber officinale) in chemotherapy‐induced nausea and vomiting


8:30 am ‐ 9:30 am

387316 Jerry Van 7‐269 Impact of a resource management tool (RMT) on


8:30 am ‐ 9:30 am


175 | P a g e

Submission ID



project planning in a public health sector

386311 Katie Vanbuskirk 7‐193 Caregivers' understanding of measuring children's liquid medications


8:30 am ‐ 9:30 am

387789 Halden VanCleave 2‐399 Possible metronidazole induced serum sickness‐like reaction in a pediatric patient

Monday, December 7

10:45 am ‐11:45 am

382646 Gary Vandyne 5B‐386 Transition of care pharmacy: analysis of pharmacy interventions to improve clinical outcomes

Tuesday, December 8

11:30 am ‐ 12:30 pm

385734 Keni VanGalder 7‐159 Pharmacist's knowledge of the cost of laboratory data


8:30 am ‐ 9:30 am

384398 Linzee Vargas 5A‐029 Impact of pharmacy mobile application on student performance on North American Pharmacist Licensure Examination (NAPLEX)‐based questionnaire

Tuesday, December 8

10:00 am ‐ 11:00 am

388626 Lincy Varughese 3‐372 A survey of graduating fourth year pharmacy students regarding residency application preparation and training after the match and post‐match scramble process.

Monday, December 7

12:00 pm ‐ 1:00 pm

382720 David Veasey 5B‐081 Drug‐eluting bead transarterial chemoembolization (DEBTACE) vs. transarterial radioembolization (TARE) in the treatment of liver cancer: a retrospective analysis

Tuesday, December 8

11:30 am ‐ 12:30 pm

385647 Anthony Vecchione 2‐242 Prescribing patterns of prophylactic anti‐epileptic drugs in the neurosurgical intensive care unit

Monday, December 7

10:45 am ‐11:45 am

382972 Ana Vega 3‐122 Inter‐professional collaboration conducting transitions of care for heart failure patients.

Monday, December 7

12:00 pm ‐ 1:00 pm

389287 Alexandra Vender 5B‐258 Cardiovascular risks associated with hormonal contraceptive in women

Tuesday, December 8

11:30 am ‐ 12:30 pm


176 | P a g e

Submission ID



388560 Lilia Vera 3‐373 Evaluate the incidence of palbociclib‐related toxicities at a cancer center

Monday, December 7

12:00 pm ‐ 1:00 pm

387899 Reina Vera 3‐374 PKD and the role of tolvaptan and octreotide

Monday, December 7

12:00 pm ‐ 1:00 pm

388610 Daniel Vergel de Dios 5A‐030 Improving the safety protocols for SinfoniaRx's cost savings algorithms

Tuesday, December 8

10:00 am ‐ 11:00 am

387065 Divya Verma 2‐331 Impact of clinical pharmacist interventions on direct medication cost savings in a complex healthcare clinic

Monday, December 7

10:45 am ‐11:45 am

385143 Benjamin Vermillion 2‐357 Reducing aluminum content of parenteral nutrition solutions for neonatal patients

Monday, December 7

10:45 am ‐11:45 am

387418 Tyler Vest 2‐416 Sensitivity analysis estimating the associated costs of pharmacy technician turnover

Monday, December 7

10:45 am ‐11:45 am

389250 Samantha Vickers 5B‐387 Determination of the accuracy of Cockcroft‐Gault equation variants compared to lab calculated glomerular filtration rate

Tuesday, December 8

11:30 am ‐ 12:30 pm

385427 Jessah Villamor 3‐186 Evaluation of a 4‐factor prothrombin complex concentrate protocol for rapid anticoagulant reversal

Monday, December 7

12:00 pm ‐ 1:00 pm

384481 Isabella Villegas 3‐045 Use of web‐based applications for the documentation of pharmacists' patient care activities within the HIV care continuum

Monday, December 7

12:00 pm ‐ 1:00 pm

389247 Ruffa Villota 7‐160 Evaluation of weight based fluconazole regimen utilization in patients with invasive candidiasis


8:30 am ‐ 9:30 am

383294 Kelsey Villwock 7‐072 Analysis of the appropriateness of beta‐blocker use in a geriatric clinic


8:30 am ‐ 9:30 am

385780 Claire Vines 2‐002 Etomidate does not increase susceptibility to pneumoina in critically ill, non‐trauma

Monday, December 7

10:45 am ‐11:45 am


177 | P a g e

Submission ID



patients

389557 Wassamon Viriyakitja 7‐044 Evaluation of LY2963016 insulin glargine biosimilar for the treatment of type 1 and type 2 diabetes mellitus


8:30 am ‐ 9:30 am

389195 Rachel Visage 5A‐048 Automating translation of instructions into Spanish for discharge inhaler relabels

Tuesday, December 8

10:00 am ‐ 11:00 am

389306 Kristina Vishnevetskaya 5A‐197 Dementia screening tests: value in assisted living facilities in NJ

Tuesday, December 8

10:00 am ‐ 11:00 am

387981 Brittany Vogel 7‐270 What are the legal requirements in the state of Virginia for free clinics to be in accordance with the board statutes?


8:30 am ‐ 9:30 am

385137 Matthew Voghel 3‐031 Medication use evaluation (MUE) of the prescribing of cyclosporine ophthalmic emulsion 0.05% at VA Connecticut Healthcare System (VACHS)

Monday, December 7

12:00 pm ‐ 1:00 pm

384633 Lindsey Voigt 2‐127 Development of a simple, robust method for stability chromatographic analysis of gentamicin sulfate in institution compounded IV solutions

Monday, December 7

10:45 am ‐11:45 am

388155 Hannah VonWahlde 3‐417 Evaluation of the utilization of oral valganciclovir at an academic medical center

Monday, December 7

12:00 pm ‐ 1:00 pm

387322 Cassandra Votruba 5A‐031 Retrospective analysis of home medication list completeness before and after surescripts implementation in a community hospital setting

Tuesday, December 8

10:00 am ‐ 11:00 am

389560 Alaina Vrontikis 5B‐371 Internventions: a quantitative analysis of clinical interventions made by inpatient pharmacy interns

Tuesday, December 8

11:30 am ‐ 12:30 pm

388098 Kha Vu 2‐358 Medication use evaluation of dimethyl fumarate at a Multiple Sclerosis (MS) Clinic

Monday, December 7

10:45 am ‐11:45 am


178 | P a g e

Submission ID



387663 Adam Wagner 2‐359 Prevention of post‐transfusion Rh alloimmunization following postpartum hemorrhagic shock

Monday, December 7

10:45 am ‐11:45 am

388476 Mary Russell Wagstaff 5A‐210 Impact of the JUPITER trial on US statin prescribing after 2008 for primary prevention of cardiovascular disease (CVD) in adults 18 years or greater

Tuesday, December 8

10:00 am ‐ 11:00 am

385169 Melissa Waineo 3‐123 Implementation of a prescription patient assistance program in an indigent clinic by pharmacy student volunteers

Monday, December 7

12:00 pm ‐ 1:00 pm

386142 Robert Walchack 3‐259 Comparison of macrolide‐based treatment options for community‐acquired pneumonia: a two‐year analysis of thirty day revisit rates to an urban emergency department

Monday, December 7

12:00 pm ‐ 1:00 pm

386851 Christopher Walczak 2‐319 Effect of cyclosporine, tacrolimus or sirolimus dose reductions due to drug‐drug interaction with azole antifungals on their serum concentrations in pediatric patients.

Monday, December 7

10:45 am ‐11:45 am

384658 Holly Waldecker 2‐320 The Safety and Efficacy of Probiotics in the Promotion of Natural Flora

Monday, December 7

10:45 am ‐11:45 am

386596 Lauren Walden 2‐400 Mapping chemotherapy regimen protocols for integration into an evidence‐based application used to manage oncology treatment plans

Monday, December 7

10:45 am ‐11:45 am

383293 JACQUELINE WALKER 3‐124 Faculty perception of facebook utilization in pharmacy school

Monday, December 7

12:00 pm ‐ 1:00 pm

387583 Kim Walker 5B‐343 Clinical predictors of out of hospital cardiac arrest

Tuesday, December 8

11:30 am ‐ 12:30 pm

388157 Patrick Walker 5B‐090 Demonstration of clinical extenders as resources for implementation of new insulin management practices in a

Tuesday, December 8

11:30 am ‐ 12:30 pm


179 | P a g e

Submission ID



large academic medical center

389354 Karlee Walklett 3‐125 Evaluating the interaction of herbal supplements with antiretroviral (ARV) agents

Monday, December 7

12:00 pm ‐ 1:00 pm

385814 Kirsten Wallskog 5B‐193 Sedation practices in cardiogenic shock and impact on patient outcomes

Tuesday, December 8

11:30 am ‐ 12:30 pm

387327 Megan Walters 7‐045 Pharmacy Schools' Preparation of Students for the Residency Match Process


8:30 am ‐ 9:30 am

386837 Angelo Walton 5B‐259 Evaluation of vitamin K use in patients taking warfarin

Tuesday, December 8

11:30 am ‐ 12:30 pm

385889 Amy Wang 2‐128 Incidence of depression among pharmacy residents

Monday, December 7

10:45 am ‐11:45 am

388690 Hongmei Wang 3‐375 Association between Braden Scale for Predicting Pressure Sore Risk and incident skin adverse reactions among surgical intensive care unit patients

Monday, December 7

12:00 pm ‐ 1:00 pm

388037 Jun Wang 3‐376 Outcomes of in‐hospital cardiac arrest

Monday, December 7

12:00 pm ‐ 1:00 pm

386959 Michelle Wang 5B‐082 Gauging the effectiveness of hospital protocol in preventing contrast induced acute kidney injury in patients undergoing radiological procedures

Tuesday, December 8

11:30 am ‐ 12:30 pm

388534 Ashley Warcola 3‐418 Evaluation of dexmedetomidine utilization in patients with alcohol withdrawal syndrome

Monday, December 7

12:00 pm ‐ 1:00 pm

383206 Jacqueline Ware 3‐317 Upregulation of cancer genes in breast tumors with faciodigitogenital dysplasia 1( FGD1) expression

Monday, December 7

12:00 pm ‐ 1:00 pm

385227 Haroon Waseem 2‐107 Hotspotting: interprofessional student patient navigators in new orleans

Monday, December 7

10:45 am ‐11:45 am

388892 Tim Wasielewski 7‐161 Impact of rapid blood culture identification panel on the clinical management of adult inpatients with gram positive bacteremia


8:30 am ‐ 9:30 am


180 | P a g e

Submission ID



385570 Allie Wasik 7‐162 Heparin protocol changes implementation and review: munson medical center


8:30 am ‐ 9:30 am

386807 Paige Watkins 5B‐199 Evaluation of rasburicase use following the implementation of a standardized dosing protocol

Tuesday, December 8

11:30 am ‐ 12:30 pm

387186 Andre Watson 5B‐394 Impact of technician intervention of bulk intravenous medication waste in a pediatric hospital setting

Tuesday, December 8

11:30 am ‐ 12:30 pm

385235 Lindsey Watson 5A‐274 Improving patients' knowledge of their treatment plans

Tuesday, December 8

10:00 am ‐ 11:00 am

388655 Bria Way 3‐126 The public's perception on the relative value of pharmacists in comparison to other health professionals

Monday, December 7

12:00 pm ‐ 1:00 pm

383947 Anais Webster 5B‐412 Evaluation of immune globulin infusion reactions and administration practices at a tertiary academic medical center

Tuesday, December 8

11:30 am ‐ 12:30 pm

386166 Markie Webster 3‐318 Hypothermia associated with thioridazine in an intellectually disabled patient

Monday, December 7

12:00 pm ‐ 1:00 pm

387756 Cody Weidenhaft 3‐426 Evaluation of providers knowledge of necessary baseline and follow‐up monitoring parameters for commonly prescribed medications

Monday, December 7

12:00 pm ‐ 1:00 pm

386957 Katherine Weigartz 7‐046 Evaluation of nebulized heparin in burn inhalation injury


8:30 am ‐ 9:30 am

387149 Rachel Wein 7‐163 Evaluation of pharmacist review of real‐time positive blood culture results as part of the pharmacy practice model initiative (PPMI)


8:30 am ‐ 9:30 am

385402 Sara Weinstein 5A‐032 Reducing inappropriate polypharmacy within home based primary care by implementing a checklist

Tuesday, December 8

10:00 am ‐ 11:00 am


181 | P a g e

Submission ID



389529 Morgan Weiss 7‐164 Missed Medication Report Analysis


8:30 am ‐ 9:30 am

389469 Emily Weisz 5B‐083 Evaluating the utility and impact of the adult sepsis screening tool and a sepsis response team in patients developing sepsis during hospitalization

Tuesday, December 8

11:30 am ‐ 12:30 pm

386462 Hanna Welch 7‐165 Effect of antimicrobial stewardship intervention on patient outcomes in Clostridium difficile colitis


8:30 am ‐ 9:30 am

385944 Brittany Weldon 3‐377 Effectiveness of the cooling process using a hypothermia order set in neuro critically ill patients

Monday, December 7

12:00 pm ‐ 1:00 pm

388561 Amanda Welk 7‐111 Effect of various treatment modalities on adverse effects versus short acting opioid use for chronic pain in the ambulatory care setting


8:30 am ‐ 9:30 am

387810 Fidele Welle 3‐187 Drug utilization evaluation (DUE) of romiplostim (Nplate) for the treatment of thrombocytopenia

Monday, December 7

12:00 pm ‐ 1:00 pm

387514 Caroline Wells 2‐401 Bridging gaps in patient care in a specialty pharmacy setting

Monday, December 7

10:45 am ‐11:45 am

387408 Justin Wells 2‐321 Developing an interprofessional ambulatory care pharmacotherapy rotation for advanced pharmacy practice experience (APPE) students and post‐graduate year 1 (PGY1) medical residents

Monday, December 7

10:45 am ‐11:45 am

388992 Ashley West 3‐032 Potential for use of target specific oral anticoagulants at Mary Hitchcock Memorial Hospital (MHMH)

Monday, December 7

12:00 pm ‐ 1:00 pm

384787 Andrea White 2‐108 Mental wellness awareness among pharmacy students

Monday, December 7

10:45 am ‐11:45 am

387168 Courtney White 5A‐211 Adherence to expert panel report‐3: guidelines for the

Tuesday, December 8

10:00 am ‐ 11:00 am


182 | P a g e

Submission ID



diagnosis and management of asthma

382635 Courtney White 7‐271 Characteristics of older adults receiving IV acetaminophen who did and did not experience delirium during their neuroscience ICU stay


8:30 am ‐ 9:30 am

384573 April Whitlock 2‐340 Emergency department discharge prescription errors in an academic medical center: a pilot study

Monday, December 7

10:45 am ‐11:45 am

387426 Jangus Whitner 2‐322 Smoking initiation and smoking cessation: timing and magnitude of the smoking‐warfarin interaction, two example cases

Monday, December 7

10:45 am ‐11:45 am

385907 Colleen Whyte 5B‐413 Characterization of the use of recombinant tissue plasminogen activator (rtPA) for pulmonary embolism during cardiac arrest

Tuesday, December 8

11:30 am ‐ 12:30 pm

384767 Rebecca Widder 2‐323 Making "scents" of essential oils and aromatherapy

Monday, December 7

10:45 am ‐11:45 am

388275 Kristin Widmer 5B‐414 Bar Code Medication Administration (BCMA) Optimization in an Academic Emergency Department

Tuesday, December 8

11:30 am ‐ 12:30 pm

386005 Lindsey Wiegmann 2‐147 Evaluation of post‐osteoporotic fracture management in Mercy Clinic Family Medicine

Monday, December 7

10:45 am ‐11:45 am

388823 Rachel Wilde 2‐324 Multi‐disciplinary team shared medical appointments impact on heart failure readmission

Monday, December 7

10:45 am ‐11:45 am

388087 Tessa Wiley 2‐010 Prognostic significance of stratified elevations of lactate values in patients with severe sepsis or septic shock

Monday, December 7

10:45 am ‐11:45 am

388302 Michelle Wilkin 5B‐095 Comparing outcomes of empirically treated hospitalized patients with extended spectrum beta‐lactamase Escherichia coli isolated from

Tuesday, December 8

11:30 am ‐ 12:30 pm


183 | P a g e

Submission ID



urine samples

386929 Ciara Will 3‐378 Evaluation of meropenem in the pediatric intensive care

Monday, December 7

12:00 pm ‐ 1:00 pm

384558 Robert Willborn 2‐259 What can and can't be learned from recent FDA approvals for heart failure?

Monday, December 7

10:45 am ‐11:45 am

388130 Haley Willett 2‐402 Evaluating the utilization of an ABCDE bundle protocol for mechanically ventilated patients in a community hospital

Monday, December 7

10:45 am ‐11:45 am

388019 Colin Williams 2‐166 Survey of student pharmacists in a mentorship program: 3‐year follow‐up

Monday, December 7

10:45 am ‐11:45 am

386875 Daniel Williams 5B‐001 High‐throughput screening assay for heat shock factor (HSF) inhibitors

Tuesday, December 8

11:30 am ‐ 12:30 pm

386478 Kevin Williams 2‐325 Procalcitonin assay as a means of decreasing duration of antibiotic therapy in a large community teaching hospital

Monday, December 7

10:45 am ‐11:45 am

388246 Marlon Williams 2‐112 Protein kinase CK2 expression predicts relapse survival in ER dependent breast cancer, and modulates ER expression in vitro

Monday, December 7

10:45 am ‐11:45 am

384794 Megan Williams 2‐148 Evaluation of heart failure education consults at an urban safety net hospital

Monday, December 7

10:45 am ‐11:45 am

389501 Victoryn Williams 5B‐260 Biomarker development to improve prognosis and therapeutic recommendations for prostate cancer patients

Tuesday, December 8

11:30 am ‐ 12:30 pm

385138 Raven Williamson 7‐272 Topical and local anesthetic induced methemoglobinemia : the silent adverse event in the medicine cabinet


8:30 am ‐ 9:30 am

385526 Brittany Wills 3‐260 Medication reconciliation in patients admitted to the medical intensive care unit

Monday, December 7

12:00 pm ‐ 1:00 pm

387225 Charity Wilson 2‐129 Evaluation of ceftolozane/tazobactam

Monday, December 7

10:45 am ‐11:45 am


184 | P a g e

Submission ID



susceptibilities in Pseudomonas aeruginosa bloodstream isolates at level II trauma tertiary hospital

388675 Jennifer Wilson 5B‐344 Comparison of time to extubation in dexmedetomidine and propofol based sedation regimens in the medical intensive care unit of a large academic medical center

Tuesday, December 8

11:30 am ‐ 12:30 pm

388366 William Wilson 3‐198 Beyond the antibiogram: a novel evaluation of antibiotic susceptibilities of gram‐negative isolates in the cardiothoracic intensive care unit (CTICU)

Monday, December 7

12:00 pm ‐ 1:00 pm

389594 Dexter Wimer 5A‐195 IV acetaminophen compared to oral acetaminophen for pediatric patients in the post‐operative period

Tuesday, December 8

10:00 am ‐ 11:00 am

386423 Mary Joyce Wingler 7‐047 Emergency department utilization of ceftriaxone at a veterans healthcare system


8:30 am ‐ 9:30 am

387010 Natalie Winters 2‐243 Statin adherence rates in patients utilizing a patient centered medical home based pharmacy

Monday, December 7

10:45 am ‐11:45 am

385301 Cheryl Wisseh 5B‐345 Evaluation of the level of knowledge patients at the UNC Center for Latino Health (CELAH) have regarding their current medications

Tuesday, December 8

11:30 am ‐ 12:30 pm

383302 Robert Wolf 5A‐340 Acid suppressive therapy across the continuum of care: an evaluation of stress ulcer prophylaxis initiated in critically‐ill patients at an urban, non‐teaching community hospital

Tuesday, December 8

10:00 am ‐ 11:00 am

389216 Allen Wolford 3‐046 Assessing the Appropriateness of Outpatient Use of Gastroprotective Agents

Monday, December 7

12:00 pm ‐ 1:00 pm


185 | P a g e

Submission ID



387369 Amber Woller 5B‐372 Evaluation of outcomes associated with four factor prothrombin complex concentrate for warfarin reversal at an adult academic medical center emergency department

Tuesday, December 8

11:30 am ‐ 12:30 pm

389416 Albert Won 5B‐388 Awareness Level Among Students at the University of Charleston School of Pharmacy of the Bill 4190 to Grant Pharmacists Non‐Physician Provider Status

Tuesday, December 8

11:30 am ‐ 12:30 pm

388197 Carmen Wong 2‐061 Evaluating the use of rasburicase for hyperuricemia associated with acute kidney injury

Monday, December 7

10:45 am ‐11:45 am

389278 Tommy Wong 5A‐242 Outcomes associated with selected initial dosing of regorafenib for metastatic colorectal cancer

Tuesday, December 8

10:00 am ‐ 11:00 am

385616 Elizabeth Wood 7‐048 Vitamin D supplementation in critically ill children: a prospective trial and dose evaluation


8:30 am ‐ 9:30 am

387533 Jenna Wood 5A‐318 A retrospective and observational analysis of missing and delayed medications at a large community teaching hospital

Tuesday, December 8

10:00 am ‐ 11:00 am

388043 Jordan Wood 5B‐346 Implementation of electronic prescribing of controlled susbtances (EPCS) within an academic medical center

Tuesday, December 8

11:30 am ‐ 12:30 pm

386364 Leslie Wooten 5B‐194 Direct oral anticoagulant (DOAC) drug utilization review and process improvement in the emergency department observation unit: A retrospective chart review and process improvement with subsequent chart review

Tuesday, December 8

11:30 am ‐ 12:30 pm


186 | P a g e

Submission ID



387401 Sara Worzella 5B‐415 Characterizing initiation of antibiotic treatment of asymptomatic and symptomatic bacteriuria in the emergency department

Tuesday, December 8

11:30 am ‐ 12:30 pm

385962 Andrew Wright 5B‐347 Examination of the sociodemographic and clinical barriers to adequate pertussis vaccination in adolescents

Tuesday, December 8

11:30 am ‐ 12:30 pm

388731 Alena Wu 7‐166 Incidence of oral mucositis in patients receiving everolimus


8:30 am ‐ 9:30 am

387836 Anna Wu 5A‐252 Assessing Allegheny County pharmacists' opinions on the sale of syringes without a prescription

Tuesday, December 8

10:00 am ‐ 11:00 am

388260 Perry Wu 5A‐045 Biopharmaceutical and pharmacological properties of fluorine in pharmaceuticals

Tuesday, December 8

10:00 am ‐ 11:00 am

389113 Ting‐Ting Wu 3‐157 The role of P2Y12 platelet inhibition test in predicting  response to treatment and clinical outcome  in acute coronary syndromes (ACS)patients undergoing primary coronary intervention (PCI)

Monday, December 7

12:00 pm ‐ 1:00 pm

385765 Jason Xu 3‐379 Outpatient treatment of osteomyelitis with telavancin: a retrospective chart review

Monday, December 7

12:00 pm ‐ 1:00 pm

382645 Matthew Yacobucci 2‐244 In‐vitro analysis of a spray‐dried murine breast cancer microparticulate vaccine

Monday, December 7

10:45 am ‐11:45 am

384666 Catherine Yang 7‐167 Impact of a pharmacist‐directed comprehensive anticoagulation service on patients with left ventricular assist devices


8:30 am ‐ 9:30 am

382558 Heng Yang 3‐380 Evaluation of timeliness of first dose antimicrobials administration to critically ill patients at a community medical center

Monday, December 7

12:00 pm ‐ 1:00 pm


187 | P a g e

Submission ID



387713 Mingyao Yang 5B‐389 Updated analysis on the clinical utility of nares swabs as a predictor of MRSA pneumonia

Tuesday, December 8

11:30 am ‐ 12:30 pm

389655 Sophia Yang 3‐261 Assessing impact of discharge medication discrepancy data on the predictive validity of the LACE Index to identify pharmacist intervention opportunities during transitions of care

Monday, December 7

12:00 pm ‐ 1:00 pm

385982 Tianrui Yang 3‐381 Post‐discharge healthcare utilization at a comprehensive cancer center: pre‐implementation of pharmacy driven transition‐of‐care program

Monday, December 7

12:00 pm ‐ 1:00 pm

387627 Yanmen Yang 7‐168 Caregivers of people with intellectual or developmental disabilities (IDD) experience with the medication use process


8:30 am ‐ 9:30 am

386572 Emily Yarborough 5B‐348 Development of an empiric regimen for hospital‐acquired bloodstream infections (HA‐BSI) based on local susceptibility data

Tuesday, December 8

11:30 am ‐ 12:30 pm

385828 Nicholas Yarbrough 3‐382 Evaluation of emergency department factors on acute ischemic stroke treatment

Monday, December 7

12:00 pm ‐ 1:00 pm

385390 Deirdre Yarosh 5A‐253 Examining Health Mentor perceptions of student teamwork

Tuesday, December 8

10:00 am ‐ 11:00 am

385758 Jarah Yates 3‐127 Patient health outcomes: the role of trust and health literacy in patient‐provider relationships

Monday, December 7

12:00 pm ‐ 1:00 pm

388309 Adele Ye 5B‐261 Novel abortive therapies for acute refractory cyclic vomiting syndrome (CVS) in a pediatric patient

Tuesday, December 8

11:30 am ‐ 12:30 pm

386926 Ting Ye 5B‐349 Association of corticosteroid dose and outcomes in the

Tuesday, December 8

11:30 am ‐ 12:30 pm


188 | P a g e

Submission ID



treatment of exacerbations of chronic obstructive pulmonary disease (COPD) in a community hospital

389122 Ntumbong Yochembeng 7‐273 Effects of pre‐operative blood glucose control on operative outcomes following cardiac surgery


8:30 am ‐ 9:30 am

387491 Mariko Yokokura 2‐062 Patient characteristics and pharmacist interventions associated with 30‐day hospital readmissions

Monday, December 7

10:45 am ‐11:45 am

386861 Charles Yoo 7‐169 Predicting cost related non‐adherence (CRNA): impact of pharmacy setting, insurance type and pharmaceutical expenditure


8:30 am ‐ 9:30 am

388777 YeSeul Yoo 7‐112 Cost evaluation of argatroban versus bivalirudin use in patients with heparin‐induced thrombocytopenia


8:30 am ‐ 9:30 am

385917 Grace Yoon 2‐269 Drug‐use evaluation: zolpidem use in an inpatient setting

Monday, December 7

10:45 am ‐11:45 am

387719 Kwangchae Yoon 3‐158 Description of pharmacist interventions for inpatient diuretic dosing of heart failure patients

Monday, December 7

12:00 pm ‐ 1:00 pm

389098 Amber Yopp 5B‐350 Adherence to American Psychiatric Association (APA) depression guidelines at a long‐term care facility

Tuesday, December 8

11:30 am ‐ 12:30 pm

384777 Kristina York 5A‐275 Evaluation of mucormycosis treatment and outcomes in burn patients.

Tuesday, December 8

10:00 am ‐ 11:00 am

387660 Matthew Young 5A‐073 Smoking cessation community health outreach event and collaboration with area health education center (AHEC)

Tuesday, December 8

10:00 am ‐ 11:00 am

386845 Mark Youssef 3‐188 Efficacy of liposomal bupivacaine in orthopedic surgery

Monday, December 7

12:00 pm ‐ 1:00 pm

386042 Amanda Yu 3‐262 Appropriateness of parenteral Monday, 12:00 pm ‐ 1:00 pm


189 | P a g e

Submission ID



nutrition utilization before and after implementation of a drop‐down menu requiring selection of parenteral nutrition indication at initiation

December 7

382530 Collin Yu 2‐412 Prevalence and Effects of Potentially Inappropriate Medication Ordering for Drugs with Sedative Effects in Acute Geriatric Inpatient Care using Electronic Health Records

Monday, December 7

10:45 am ‐11:45 am

386568 Connie Yu 5B‐139 Evaluation of time to next dose for piperacillin/tazobactam based on timing of first‐dose in the emergency department.

Tuesday, December 8

11:30 am ‐ 12:30 pm

388191 Jessica Yu 2‐063 Educational attainment of deans and chairs at US schools of pharmacy in 2015

Monday, December 7

10:45 am ‐11:45 am

386461 Victoria Yu 7‐274 Documentation rates of patient education for target specific oral anticoagulants (dabigatran, apixaban, and rivaroxaban) in an outpatient cardiology clinic at a large teaching institution


8:30 am ‐ 9:30 am

386945 Yeon Hee Yu 2‐245 Enhancing the care of CHF patients in a newly established Pharmacy Brown Bag Clinic

Monday, December 7

10:45 am ‐11:45 am

382617 Wendy Yuen 3‐128 Direct oral anticoagulant evaluation in a large academic medical center

Monday, December 7

12:00 pm ‐ 1:00 pm

388594 Jennifer Zahn 3‐129 Carvedilol use in patients with cocaine‐induced chest pain (CICP)

Monday, December 7

12:00 pm ‐ 1:00 pm

382522 Chelsea Zavilla 3‐263 Implementation of a new dantrolene formulation for care of patients with malignant hyperthermia across a 15‐facility health care system

Monday, December 7

12:00 pm ‐ 1:00 pm

388119 Peter Zepke 5B‐416 De‐escalation of antibiotics in culture‐positive critically ill adults with pneumonia

Tuesday, December 8

11:30 am ‐ 12:30 pm

387522 Veronica Zewdu 7‐275 Root cause analysis of Wednesday, 8:30 am ‐ 9:30 am


190 | P a g e

Submission ID



therapeutic duplication prn (as needed) pain medications at an academic medical center

December 9

387796 Limin Zhang 5B‐195 Race/ethnicity and health‐related quality of life in persons with diabetes mellitus

Tuesday, December 8

11:30 am ‐ 12:30 pm

388801 LiChao Zhao 3‐383 Evaluate the significance of time in therapeutic range (TTR) with end‐stage renal disease (ESRD) patients on warfarin therapy

Monday, December 7

12:00 pm ‐ 1:00 pm

388291 Xiao (Tom) Zhao 2‐038 Correlation of telemetry and ECG for QTc monitoring in critically ill adults

Monday, December 7

10:45 am ‐11:45 am

383198 Rona Zhou 2‐031 Asessing the helpfulness of an interactive approach to educate older adults and caregivers on Alzheimers disease

Monday, December 7

10:45 am ‐11:45 am

386249 Jessica Zook 5B‐390 Five‐year evaluation of antiretroviral prescribing trends and lipid control in outpatients with HIV

Tuesday, December 8

11:30 am ‐ 12:30 pm

387013 Mei Zou 5B‐262 Thiopurine methyltransferase (TPMT) in pediatric acute lymphoid leukemia (ALL) patients: Is genotyping beneficial for optimal mercaptopurine (6‐MP) or azathiopurine (AZA) therapy?

Tuesday, December 8

11:30 am ‐ 12:30 pm

388034 Yiwen Zou 5B‐359 Admission and discharge: medication knowledge and the role of the pharmacist

Tuesday, December 8

11:30 am ‐ 12:30 pm

386303 Quratulain (Anna)

Zulfiqar 3‐384 Medication‐use evaluation of daptomycin within an inpatient rehabilitation teaching hospital

Monday, December 7

12:00 pm ‐ 1:00 pm

389034 Andrew Zurlinden 2‐326 Cystic fibrosis patient specialty pharmacy satisfaction: before and after in‐house specialty pharmacy implementation

Monday, December 7

10:45 am ‐11:45 am

Documents

MCM15 Student Poster Listing